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Preface
Elastography, the science of creating noninvasive images of mechanical 
characteristics of tissues, has been rapidly evolving in recent years. The advantage
of this technique is its ability to rapidly detect and quantify the changes in soft
tissue stiffness resulting from specific pathological or physiological processes. 
Ultrasound elastography is nowadays applied especially on the liver and breast, but
the technique has been increasingly used for other tissues including the thyroid, 
lymph nodes, spleen, pancreas, gastrointestinal tract, kidney, prostate, and the
musculoskeletal and vascular systems.
This book presents some of the applications of strain and shear-wave ultrasound 
elastography in hepatic, pancreatic, breast and musculoskeletal conditions.
Most of the book is focused on diffuse liver conditions, since the evaluation of
diffuse liver disease is the best validated application of ultrasound elastography
and has been widely adopted for non-invasive detection and staging of liver
fibrosis and steatosis, for the diagnosis of cirrhosis and its complications, as well 
as for monitoring disease progression. The main elastographic techniques in these
conditions are reviewed, namely Vibration Controlled Transient Elastography
(VCTE), point-Shear Waves Elastography, and 2D Share Wave Elastography.
The use of elastography in breast conditions is also discussed; specifically, the
technique is used for differentiating benign focal lesions from suspicious focal 
lesions (in general, benign lesions have low stiffness, while malignant lesions have
high stiffness). Both strain and shear-wave methods have been evaluated for
improving the generally high sensitivity and specificity of the Breast Imaging 
Reporting and Data System (BIRADS) and it is recommended that they are used to
enhance the usual ultrasound examination.
Another chapter reviews pancreatic elastography, a challenging new procedure
used for inflammatory and tumoral conditions. Certain technical difficulties, such
as the deep location of the organ, impede the accurate assessment of pancreatic
stiffness, but the new software for both conventional and endoscopic ultrasound 
offer promise for the differential diagnosis between malignant tumors and different
forms of chronic pancreatitis.
The last chapter includes some preliminary data on the strain-based elastography
assessment of patients with De Quervain tenosynovitis.
Evidently, further research with unbiased large-scale studies is still required, but
ultrasound elastography holds immense potential for various clinical applications, 
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Because of the limitations and invasive nature of liver biopsy, other noninvasive 
means are being tested for the evaluation of diffuse liver diseases. One of these methods 
is vibration-controlled transient elastography (VCTE). This chapter reviews the princi-
ple of VCTE, the examination technique, the normal range for liver stiffness values, the 
pathological changes that may influence liver stiffness, as well as the diagnostic perfor-
mance in several diffuse liver diseases, especially chronic hepatitis C, chronic hepatitis 
B, nonalcoholic steatohepatitis, and alcoholic liver disease. Apart from the assessment 
of fibrosis stages, we will also discuss the diagnosis of cirrhosis and its complications as 
well as other applications of VCTE, reviewing its advantages and limitations.
Keywords: diffuse liver disease, fibrosis, noninvasive,  
vibration-controlled transient elastography, Fibroscan
1. Introduction
Chronic liver diseases are an important public health issue. Extensive research 
has been made lately on the development of noninvasive diagnostic methods, 
able to accurately assess fibrosis and steatosis. Among these, an important place is 
reserved for elastographic techniques and especially vibration-controlled transient 
elastography (Fibroscan).
2. Principle
Vibration-controlled transient elastography is performed with the 
Fibroscan® equipment (Echosens, Paris) [1]. The transducer of the device is 
placed in an intercostal space above the right liver lobe, in a point of maximal 
hepatic dullness. A mechanical vibrator is mounted on the axis of the device; the 
vibrator generates a painless vibration, inducing a train of elastic waves, which 
propagate through the skin and subcutaneous tissue to the liver. In parallel to 
the vibration, the transducer performs ultrasound acquisitions, at a frequency 
of 4 kHz [1–3] By comparing the ultrasonographic signals thus obtained, tissue 
deformation records, induced by the propagation of the elastic wave, can be 
drawn. The time necessary for the train of waves to propagate along the interest 
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area, as well as the velocity of propagation, is recorded. The liver stiffness can 
afterwards be calculated using the formula: E = 3ρVs2 (E, the elasticity module; 
ρ, density; Vs, the elastic wave velocity in the liver parenchyma). The stiffer the 
tissue, the higher the velocity of the wave train [1–3].
On the other hand, knowing that fat impairs ultrasound propagation and 
induces attenuation, the producers of the Fibroscan equipment have developed 
a software able to precisely quantify the ultrasound attenuation. This controlled 
attenuation parameter (CAP) is expressed in dB/m and is calculated using the same 
radio-frequency data, and the same region of interest, as the region used to assess 
the liver stiffness [4, 5].
3. Examination technique
The patient is placed in a dorsal decubitus position, with the right arm in 
maximum abduction above the head, in order to best expose the right abdominal 
quadrant, perpendicularly to the intercostal space, in an area of maximal dull-
ness, free of any large vascular structure [1, 3]. When pressing the transducer 
button, the vibration is generated and transmitted to the liver. The software of the 
equipment analyzes the tissue deformation records and measures the stiffness of 
the parenchyma. The results are expressed in kilopascals (kPa) and represent the 
median value of 10 valid measurements. The equipment can measure values rang-
ing between 2.5 and 75 kPa [1, 3]. At the same time, the software can measure both 
the liver stiffness (for the assessment of fibrosis) and the controlled attenuation 
parameter, CAP (for the assessment of steatosis).
It is important to choose the correct transducer for the examinations (S, M, or 
XL). The choice is made according to the circumference of the thorax: if below 
75 cm, the S probe is chosen (either S1 < 45 cm or S2 for 45–75 cm and the M probe 
for a thoracic circumference above 75 cm). The XL transducer will be chosen if the 
distance between the skin and the liver capsule exceeds 25 mm. It is worth mention-
ing that, when measured with the XL probe, the median liver stiffness is signifi-
cantly lower than that measured with the M probe [6].
The examination should be performed after an overnight fast, or at least 2 hours 
after a meal, because a postprandial examination would raise the stiffness value 
due to increased hepatic blood flow [7, 8]. In addition, the patient should remain at 
rest for 10 minutes before the examination [9] and hold his or her breath during the 
examination [10].
A proper measurement can be performed even by a technician after a training 
period (approximately 100 cases) [6, 10], but the clinical interpretation of results 
must always be issued by an expert taking into account the demographic data, 
disease etiology, and biochemical profile at the moment of the examination [3, 11].
Following the manufacturer’s recommendation, the assessment is reliable only 
when 10 valid readings and an IQR ≤ 30% of the median (IQR/M ≤ 30%) are 
obtained [9].
4. Normal range of liver stiffness
The mean value of liver stiffness in healthy subjects, without any known 
liver disease and with normal biochemistry and hematology tests, is 5.5 ± 1.6 kPa 
according to some authors [12] and 4.8 ± 1.3 kPa according to others [13]. Age 
does not appear to influence this value, but stiffness is higher in men than in 
women (5.8 ± 1.6 kPa vs. 5.2 ± 1.6 kPa) as well as in subjects with a BMI > 30 kg/m2 
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(6.3 ± 1.9 kPa vs. 5.4 ± 1.5 kPa) [14]. It is very difficult to establish the normal range 
of liver stiffness without biopsy, but the reverse is not feasible. In a group of HCV 
patients, without pathological changes on the biopsy sample, the liver stiffness was 
4.84 ± 1.49 kPa [15]. In our unit, values of or above 5.3 kPa have a positive predictive 
value of 90% for the prediction of a fibrosis stage of at least F1.
5. Pathological changes influencing liver stiffness
Although liver stiffness correlates very well with fibrosis, just a single physical 
parameter (stiffness) cannot be used to completely describe a complex biological 
system, in which fibrosis is just a part [2]. Liver stiffness is increased by hepatic 
inflammation (often but not exclusively revealed by an elevated transaminase level) 
[16–18], obstructive cholestasis [19], hepatic congestion [20], amyloidosis, lympho-
mas, and extramedullary hematopoiesis [9]. These error factors must be taken into 
consideration when interpreting the liver stiffness values.
Necroinflammatory activity leads to an increase in liver stiffness alongside the 
degree of histologic activity [21–23]. For instance, the tissue changes occurring 
during an acute hepatitis can associate a rise in liver stiffness reaching sometimes 
cirrhotic values, due to cellular intumescence and sometimes to severe cholestasis 
[24]. The contribution of these non-fibrotic alterations on stiffness has been dem-
onstrated by recording the progressive decrease in stiffness alongside the decrease 
in transaminase levels [17, 18]. On the other hand, in patients with relapsed chronic 
hepatitis, the higher stiffness values are caused not only by pre-existing fibrosis but 
also to the superimposed cellular intumescence [16]. Therefore, caution is advised 
when interpreting the liver stiffness values in patients with increased ALT: if the 
ALT values exceed a 2.5-fold increase, there is a risk of overestimating the fibrosis 
stage which should be specified in the written report [15].
Extrahepatic cholestasis can increase the stiffness independently from fibrosis 
[19], and after biliary drainage, the liver stiffness values decrease at a mean rate 
of 1.2 ± 0.56 kPa for every 1 g/dL decrease in bilirubin levels. It would therefore 
be prudent to exclude a possible cholestasis through imaging and lab tests before 
interpreting liver stiffness values in order to avoid overestimating the fibrosis stage.
Congestive heart failure may lead to increased liver stiffness reaching even cir-
rhotic levels, due to a higher liver blood volume, in up to 60% of patients [25–27].
Liver steatosis influence on liver stiffness values remains controversial. In some 
studies, steatosis did not significantly affect stiffness values, even after adjust-
ing for fibrosis stage, but the proportion of patients with severe steatosis was too 
low to allow accurate quantification of a potential influence [1, 21, 28]. Other 
studies, however, have proven that, for the same fibrosis stage and the same 
 necroinflammation grade, the presence of steatosis leads to a significant increase in 
liver stiffness [29]; furthermore, the morphometric analysis of biopsy samples has 
proven that steatosis does change liver stiffness independently from fibrosis. This 
influence is negligible in cirrhotic patients, but significant in non-cirrhotic patients. 
Further studies are however required to clarify this issue [28].
6. Diagnostic performance of VCTE
6.1 Chronic hepatitis C (CHC)
The first patients to have benefited from vibration-controlled transient elastogra-
phy were those diagnosed with chronic C viral hepatitis (HCV). Studies performed 
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on large groups of HCV patients indicate that the liver stiffness values are strongly 
correlated with fibrosis stage, but there is some degree of overlap between adjacent 
stages. The practical utility of the method is based on establishing certain threshold 
stiffness values for each fibrosis stage. The diagnosis of stages F ≥ 2, F ≥ 3, and 
cirrhosis is based on the following stiffness values: 5.2–9.5 kPa, 9.5–9.6 kPa, and 
11–15 kPa, respectively, as proposed by certain studies [15, 21, 30–34]. As sug-
gested by studies assessing other noninvasive methods [35], the difference between 
these values can be explained by the varying prevalence of each fibrosis stage in 
the analyzed groups as well as by the different aims of the investigation (screening 
strategy vs. exclusion strategy). Therefore, although the already-defined cutoffs may 
be relevant to a certain population, they may not be applicable in another population 
with different prevalence of fibrosis stage and with another diagnostic aim for per-
forming VCTE. In any case, according to the EFSUMB guidelines, “TE can be used as 
the first-line assessment for the severity of liver fibrosis in patients with chronic viral 
hepatitis C. It performs best with regard to the ruling out of cirrhosis” [9].
6.2 Chronic hepatitis B (CHB)
In patients with CHB, VCTE has a similar performance as in CHC patients 
[9]. For this type of patients, Marcellin and collaborators [36], considering the 
METAVIR scoring system, have suggested as early as 2009 the 7.2 kPa stiffness value 
as the cutoff for the prediction of F ≥ 2 (Se 70%, Sp 83%, PPV 80%, NPV 73%, 
AUROC 0.81), 8.1 kPa for F ≥ 3 (Se 86%, Sp 85%, PPV 65%, NPV 95%, AUROC 
0.93), and 11 kPa for the prediction of cirrhosis (Se 93%, Sp 87%, PPV 38%, NPV 
99%, AUROC 0.93).
Other articles [37–42] have confirmed the performance of the method, yield-
ing AUROC values raging between 0.80 and 0.90 (for the prediction of significant 
fibrosis) and liver stiffness cutoffs varying between 6.6 and 8.8 kPa [9, 43–47]. With 
regard to the prediction of cirrhosis, AUROCs vary between 0.81 and 0.97 and the 
cutoffs between 9.4 and 13.4 kPa [44, 45]. The meta-analyses have suggested that a 
liver stiffness above 11.7 kPa should raise the suspicion of cirrhosis in patients with 
CHB [9, 45].
Generally, the cutoff value used for the cirrhosis prediction is lower in CHB 
than in CHC patients. One explanation could be the fact that HBV infection is one 
of the causes of macronodular cirrhosis, so that the predominant macronodular 
regeneration and the fine fibrous septa surrounding the nodules mean a smaller 
quantity of fibrosis than in micronodular cirrhosis with thick fibrous septa. It fol-
lows that, generally, liver stiffness is lower in macronodular than in micronodular 
cirrhosis.
On the other hand, liver stiffness values below 5 kPa in patients with normal 
ALT and low serum HBV DNA levels (<2000 IU/ml) are characteristic for inactive 
HBV carriers [9, 48, 49]. VCTE can be used to rule out significant fibrosis and cir-
rhosis in HBV inactive carriers, which is the best indication for VCTE in HBV.
According to the EFSUMB guidelines, “TE is useful in patients with CHB 
to identify those with cirrhosis, but concomitant assessment of transaminases 
is required to exclude flare-ups (elevation > 5 times upper limit of normal)”. In 
addition, TE is useful in inactive HBV carriers to rule out fibrosis, in case the liver 
stiffness is below 5 kPa [9].
6.3 Nonalcoholic steatohepatitis (NASH)
In NASH patients, the correlation between stiffness and fibrosis is weaker than 
in patients with chronic viral hepatitis, because of a different fibrosis distribution 
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pattern (in chronic viral hepatitis, fibrosis appears early in the periportal areas and 
gives rise to a dense, stellate, and regularly distributed portal fibrosis; in steatohep-
atitis, however, the fibrosis is located in the perisinusoidal space of the centrilobular 
area and in the walls of the centrilobular vein) [28, 50]. There is a direct proportion 
between the amount of dense, stellate portal fibrosis and liver stiffness, whereas 
perisinusoidal fibrosis distributed preferentially in the centrilobular areas does not 
proportionally increase the liver stiffness values, as was proven by morphometric 
studies [28].
A meta-analysis including 854 NASH patients examined with the M probe [51] 
has proven the very good performance of VCTE in diagnosing stages F ≥ 3 (Se 82%, 
Sp 82%) and F4 (Se 92%, Sp 92%) and its moderate performance in diagnosing 
significant fibrosis F ≥ 2 (Se 79%, Sp 75%). The cutoff yielded by various studies 
varies between 6.6 and 7.7 kPa (for F ≥ 2), 8–10.4 kPa (for F ≥ 3), and 10.3–17.5 kPa 
(for the prediction of cirrhosis) [50, 52–57].
The available data indicate that, in patients with NAFLD, VCTE is a highly accu-
rate, noninvasive method for the exclusion of advanced fibrosis and a moderately 
accurate method for the exclusion of significant fibrosis. According to the EFSUMB 
and EASL Guidelines and Recommendations on the clinical use of liver ultrasound 
elastography, “TE can be used in NAFLD patients to confidently exclude severe 
fibrosis and especially cirrhosis,” with a high negative predictive value (around 
90%) [9, 34].
6.4 Alcoholic liver disease (ALD)
There is no consensus regarding the optimal cutoffs for the prediction of fibrosis 
stages in ALD patients [9, 58]. In various studies, the cutoffs range between 7.8 and 
9.6 kPa for significant fibrosis, 8.0–17.0 kPa for severe fibrosis, and 7.15–34.9 kPa 
for cirrhosis prediction; the explanation for this variation lies in the difference 
in prevalence of fibrosis stages in the analyzed groups, as well as in the different 
patient selection methods (with or without exclusion of acute alcoholic hepatitis or 
of patients with decompensated disease) [59–62].
In a meta-analysis by Pavlov, the cutoffs used for the prediction of fibrosis stages 
were the following: 5.9 kPa for ≥F1 (Se 83%, Sp 86%, PPV 97.6%, NPV 35.3%, and 
AUROC 0.84), 7.5 kPa for ≥F2 (Se 94%, Sp 89%, positive likelihood ratio 8.2, nega-
tive likelihood ratio 0.07), and 9.5 kPa for ≥F3 (Se 92%, Sp 68%, positive likelihood 
ratio 2.9, negative likelihood ratio 0.11) [63]. For the prediction of cirrhosis, the 
proposed 12.5 kPa cutoff had a 95% sensitivity and 71% specificity, a 3.3 positive 
likelihood ratio, and a 0.07 negative likelihood ratio [63].
The proposed cutoff values for the different stages of hepatic fibrosis may be 
used in clinical practice, but with caution, since those reported values were simply 
the most common cutoff values used by the study authors and are insufficiently 
validated while, additionally, there is always the risk of overestimation of LS values 
in patients who are not abstinent from alcohol consumption.
It is also important to consider the AST levels when using VCTE to assess fibrosis 
in ALD patients. For AST levels above 100 U/L, the liver stiffness may increase 
independently from fibrosis, as a result of steatohepatitis, leading to interpretation 
errors [59]. On the other hand, liver stiffness decreased significantly after alcohol 
cessation over a long period of follow-up. It follows that liver stiffness measure-
ments in alcoholic liver disease should be interpreted with caution and assessed in 
regard to the current alcohol consumption. Large-scale prospective studies should 
be performed to determine the different optimal cutoff values according to alcohol 
consumption, and more data are required to determine the best delay after alcohol 
cessation prior to VCTE evaluation.
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VCTE is more suited to rule out than to rule in cirrhosis. At a Young’s modulus of 
12.5 kPa, VCTE may rule out cirrhosis with a negative likelihood ratio of 0.07 if the 
disease prevalence is 50% or lower.
In conclusion, according to the EFSUMB guidelines, “TE can be used to exclude 
cirrhosis in patients with alcoholic liver disease, provided that acute alcoholic 
hepatitis is not present” [9]. The current alcohol drinking status is also relevant.
6.5 Other chronic liver diseases
The performance of VCTE in identifying significant fibrosis was also assessed in 
other chronic liver diseases, such as HCV-HIV coinfection [64, 65], post liver trans-
plantation status [66–69], cholestatic liver diseases (primitive biliary cirrhosis or 
primary sclerosing cholangitis) [70], and hemochromatosis [71]: the results yielded 
AUROC values between 0.74 and 0.93 for the prediction of significant fibrosis, at 
cutoffs ranging between 4 and 10.1 kPa.
6.6 The diagnosis of cirrhosis and its complications
One of the most important applications of VCTE is the noninvasive diagnosis of 
liver cirrhosis. The diagnostic accuracy of VCTE is far better in the prediction of cir-
rhosis than that of other stages of fibrosis, with areas under the ROC curve (AUROCs) 
ranging between 0.90 and 0.99 at cutoffs between 9 and 26.6 kPa. In a meta-analysis 
performed by Friedrich-Rust [72], the mean AUROC for the diagnosis of cirrhosis 
was 0.94, and the optimal cutoff for cirrhosis prediction proved to be 13.01 kPa. In 
Stebbing’s meta-analysis [73], the 15.08 kPa cutoff had 84.45% sensitivity and 94.69% 
specificity for the prediction of cirrhosis. Tsochatzis [74] assessed the diagnostic 
accuracy of VCTE in the prediction of cirrhosis in a meta-analysis of 30 studies, which 
yielded a LS optimal cutoff of 15 ± 4.1 kPa (median, 14.5 kPa, ranging between 9 and 
26.5 kPa in the various studies analyzed), with 83% sensitivity and 89% specificity. It 
is however important to keep in mind that the cutoffs proposed by the various studies 
were chosen based on the AUROCs providing the maximal sum between sensitivity 
and specificity. As was suggested in certain studies performed for the assessment of 
other noninvasive methods, the difference between these values can, however, be 
explained by the difference in prevalence of cirrhosis in the analyzed groups [35].
On the other hand, interpreting the LS value as compatible with the diagnosis 
of cirrhosis can only be made after excluding some other conditions: significant 
cytolysis, significant cholestasis, right heart failure, or performing the examina-
tion after a meal. Nevertheless, even if the liver stiffness values are not typical 
for cirrhosis, cirrhosis may however be present in 3% of cases. This is the case of 
macronodular cirrhosis (more frequent in HBV infection, but also in other liver 
diseases) where the nodules are surrounded by fine fibrous septa, which do not 
increase the liver stiffness to “cirrhotic” levels.
6.6.1 Portal hypertension screening
Various studies have reported on the correlation between the LS value and portal 
hypertension (PHT), identified either through the presence of esophageal varices 
(EV) during upper digestive endoscopy [75–77] or by measuring the hepatic venous 
pressure gradient (HVPG), considered the gold standard in the assessment of portal 
hypertension [66, 77–79].
Despite an excellent correlation at HVPG values below 10 or 12 mm Hg, the 
comparison did not yield valuable results at HVPG values > 10 mm Hg (which is 
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the HVPG threshold for the prediction of varices) or > 12 mm Hg (threshold for the 
prediction of other complications, such as variceal effraction or ascites).
When analyzing the relationship between liver stiffness and the presence of 
esophageal varices, the area under the ROC curve for the prediction of varices 
varied between 0.74 and 0.85. When using the 13.9 kPa, 17.6 kPa, and 21.3 kPa 
cutoff values, the authors found high sensitivity for the prediction of varices 
(95%, 90%, and 79%, respectively) but relatively low specificity (43, 43, and 
70%, respectively) [3, 75–77].
Some authors claim that there is a correlation between liver stiffness values 
and variceal size [75, 76, 78], while others could find no proof of this correlation 
[77]. For the prediction of grade 2 and 3 varices, TE had a high sensitivity  
(91% and 76%) at the 19 kPa and 30.5 kPa cutoffs, respectively, but with low speci-
ficity (60% and 80%, respectively) and positive predictive value (48% and 54%,  
respectively) [75, 76].
According to the Baveno VI criteria [80], in patients with compensated chronic 
liver diseases of viral etiology, the noninvasive methods may predict the clinically 
significant portal hypertension, identifying the proportion of patients at risk of 
having endoscopic markers of PHT. For that purpose, liver stiffness measurements 
above 20–25 kPa can be used alone or in combination with platelet levels and spleen 
size. Liver stiffness below 20 kPa and platelet levels above 150,000 indicate a very 
low risk of esophageal varices requiring treatment, and therefore endoscopic 
screening can be avoided. These patients must be followed-up annually (VCTE and 
platelet levels), and an endoscopy must be performed in case of increasing stiffness 
or decreasing platelets.
The assessment of spleen stiffness has emerged as a new technique in hepatol-
ogy, which may provide useful information on the presence and degree of portal 
hypertension and the prediction of its complications.
6.6.2 Prognostic significance of LS in patients with liver cirrhosis
Some studies suggested that VCTE could be used as a risk marker for the 
development of a hepatocarcinoma in patients with hepatitis C [81, 82], who have 
a fivefold increase in risk at liver stiffness values above 25 kPa. On the other hand, 
in our experience, in patients with hepatitis C-related cirrhosis, a liver stiffness 
value > 38 kPa and an IQR > 30% of the median value (after previous exclusion of 
gross technical errors) are important markers which suggest the need for further 
imaging investigations in search of a possible hepatocarcinoma (HCC) [83]. Some 
authors have found that an increase in LS of more than 1 kPa at 3 years is cor-
related with a worse prognosis and with an increase in mortality rate in the next 
2 years; for every 1 kPa increase over the median LS found in any given patient, 
the relative risk for a severe clinical event in that particular patient increases: 1.07 
for hepatic decompensation, 1.11 for HCC, and 1.22 for death [84]. Nevertheless, 
these results require confirmation through prospective studies performed on large 
groups of patients, in order to confirm whether liver stiffness can indeed predict 
complications in decompensated cirrhosis [11]. In case it does, elastography may 
serve as a method of fast noninvasive screening, in order to classify each patient 
in a risk category [85].
6.7 Other applications of VCTE
The assessment of liver stiffness using VCTE is useful in the monitoring of 
adverse effects of hepatotoxic medication [86] as well as that of the effect of 
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6.7 Other applications of VCTE
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adverse effects of hepatotoxic medication [86] as well as that of the effect of 
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antiviral therapy. Of course, in the latter situation, it is difficult to establish with 
certainty to what extent the decrease in liver stiffness is caused by a regression in 
fibrosis, a stabilization of necroinflammation, or both: however, a decrease in LS 
values in parallel with antiviral treatment exhibited favorable short- and long-term 
outcomes in patients with chronic viral hepatitis.
7. Advantages of VCTE
The technique is easy to use, painless, noninvasive and does not require hos-
pitalization. It can measure at the same time liver stiffness (for the prediction of 
 fibrosis) and the controlled attenuation parameter (CAP) for the prediction of 
steatosis, in a volume 100 times larger than that examined during a liver biopsy.
8. Limitations of VCTE
Liver fibrosis cannot be evaluated by VCTE in 5–8% of the cases [3], especially in 
the case of obesity, ascites, or narrow intercostal spaces. In the case of obesity, using 
the XL probe helps to lower the measurement failure. The measurement failure is 
significantly less frequent when using the XL probe than the standard M probe [54]. 
The XL probe can still yield unreliable results, but only in 25%, as opposed to 50% 
of cases with the M probe [87]. The main limiting factors for the XL probe are a 
skin-to-liver capsule distance > 3.4 cm and extreme obesity (BMI > 40 kg/m2) [54].
9. Conclusions
In conclusion, vibration-controlled transient elastography (VCTE) is a useful 
method in the assessment and monitoring of diffuse liver diseases. It is important to 
perform the technique correctly and to interpret the results considering the clinical 
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skin-to-liver capsule distance > 3.4 cm and extreme obesity (BMI > 40 kg/m2) [54].
9. Conclusions
In conclusion, vibration-controlled transient elastography (VCTE) is a useful 
method in the assessment and monitoring of diffuse liver diseases. It is important to 
perform the technique correctly and to interpret the results considering the clinical 








1 Department of Medical Imaging, Iuliu Hatieganu University of Medicine and 
Pharmacy, Cluj-Napoca, Romania
2 Regional Institute of Gastroenterology and Hepatology “Prof. Dr. Octavian 
Fodor”, Cluj-Napoca, Romania
*Address all correspondence to: monica.lupsor@umfcluj.ro
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
12
Ultrasound Elastography
[1] Sandrin L, Fourquet B, 
Hasquenoph JM, Yon S, Fournier C, 
Mal F, et al. Transient elastography: 
A new noninvasive method for 
assessment of hepatic fibrosis. 
Ultrasound in Medicine and Biology. 
2003;29(12):1705-1713. DOI: 10.1016/j.
ultrasmedbio
[2] Yeh WC, Li PC, Jeng YM, Hsu HC, 
Kuo PL, Li ML, et al. Elastic modulus 
measurements of human liver 
and correlation with pathology. 
Ultrasound in Medicine and Biology. 
2002;28(4):467-474
[3] Lupsor M, Stefanescu H, Feier D, 
Badea R. Non-invasive evaluation of 
liver steatosis, fibrosis and cirrhosis in 
hepatitis C virus infected patients using 
unidimensional transient elastography 
(Fibroscan®). In: Tagaya N, editor. 
Liver Biopsy—Indications, Procedures, 
Results. Croatia: Intech; 2012. pp. 209-
234. DOI: 10.5772/52621
[4] Sasso M, Beaugrand M, de 
Ledinghen V, Douvin C, Marcellin P, 
Poupon R, et al. Controlled attenuation 
parameter (CAP): A novel VCTE™ 
guided ultrasonic attenuation 
measurement for the evaluation of 
hepatic steatosis: Preliminary study 
and validation in a cohort of patients 
with chronic liver disease from various 
causes. Ultrasound in Medicine and 
Biology. 2010;36(11):1825-1835. DOI: 
10.1016/j.ultrasmedbio.2010.07.005
[5] Sasso M, Miette V, Sandrin L, 
Beaugrand M. The controlled 
attenuation parameter (CAP): A novel 
tool for the non-invasive evaluation 
of steatosis using Fibroscan. Clinics 
and Research in Hepatology and 
Gastroenterology. 2012;36(1):13-20. 
DOI: 10.1016/j.clinre.2011.08.001
[6] Kettaneh A, Marcellin P, Douvin C, 
Poupon R, Ziol M, Beaugrand M, et al. 
Features associated with success 
rate and performance of FibroScan 
measurements for the diagnosis of 
cirrhosis in HCV patients: A prospective 
study of 935 patients. Journal of 
Hepatology. 2007;46(4):628-634. DOI: 
10.1016/j.jhep.2006.11.010
[7] Mederacke I, Wursthorn K, 
Kirschner J, Rifai K, Manns MP, 
Wedemeyer H, et al. Food intake 
increases liver stiffness in patients 
with chronic or resolved hepatitis C 
virus infection. Liver International. 
2009;29(10):1500-1506. DOI: 
10.1111/j.1478-3231.2009.02100.x
[8] Arena U, Lupsor Platon M, Stasi C, 
Moscarella S, Assarat A, Bedogni G, 
et al. Liver stiffness is influenced by 
a standardized meal in patients with 
chronic HCV hepatitis at different 
stages of fibrotic evolution. Hepatology. 
2013;58(1):65-72. DOI: 10.1002/
hep.26343
[9] Dietrich CF, Bamber J, Berzigotti A, 
Bota S, Cantisani V, Castera L, et al. 
EFSUMB guidelines and recommendations 
on the clinical use of liver ultrasound 
elastography, update 2017 (long 
version). Ultraschall in der 
Medizin. 2017;38(4):e16-e47. DOI: 
10.1055/s-0043-103952
[10] Boursier J, Konate A, Guilluy M, 
Gorea G, Sawadogo A, Quemener E, 
et al. Learning curve and interobserver 
reproducibility evaluation of liver 
stiffness measurement by transient 
elastography. European Journal of 
Gastroenterology and Hepatology. 
2008;20(7):693-701. DOI: 10.1097/
MEG.0b013e3282f51992
[11] Castera L, Forns X, Alberti A. Non-
invasive evaluation of liver fibrosis 
using transient elastography. Journal of 
Hepatology. 2008;48(5):835-847
[12] Roulot D, Czernichow S, Le 
Clésiau H, Costes JL, Vergnaud AC, 
References
13
Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
Beaugrand M. Liver stiffness values in 
apparently healthy subjects: Influence of 
gender and metabolic syndrome. Journal 
of Hepatology. 2008;48(4):606-613
[13] Sirli R, Sporea I, Tudora A, Deleanu A, 
Popescu A. Transient elastographic 
evaluation of subjects without 
known hepatic pathology: Does age 
change the liver stiffness? Journal of 
Gastrointestinal and Liver Diseases. 
2009;18(1):57-60
[14] Corpechot C, El Naggar A, 
Poupon R. Gender and liver: Is the 
liver stiffness weaker in weaker sex? 
Hepatology. 2006;44(2):513-514
[15] Lupsor Platon M, Stefanescu H, 
Feier D, Maniu A, Badea R. Performance 
of unidimensional transient 
elastography in staging chronic hepatitis 
C. Results from a cohort of 1,202 
biopsied patients from one single center. 
Journal of Gastrointestinal and Liver 
Diseases. 2013;22(2):157-166
[16] Coco B, Oliveri F, Maina AM, 
Ciccorossi P, Sacco R, Colombatto P, 
et al. Transient elastography: A new 
surrogate marker of liver fibrosis 
influenced by major changes of 
transaminases. Journal of Viral 
Hepatitis. 2007;14(5):360-369. DOI: 
10.1111/j.1365-2893.2006.00811.x
[17] Sagir A, Erhardt A, Schmitt M, 
Häussinger D. Transient elastography 
is unreliable for detection of cirrhosis 
in patients with acute liver damage. 
Hepatology. 2008;47(2):592-595. DOI: 
10.1002/hep.22056
[18] Arena U, Vizzutti F, Corti G, 
Ambu S, Stasi C, Bresci S, et al. Acute 
viral hepatitis increases liver 
stiffness values measured by 
transient elastography. Hepatology. 
2008;47(2):380-384. DOI: 10.1002/
hep.22007
[19] Millonig G, Reimann FM, Friedrich S, 
Fonouni H, Mehrabi A, Büchler MW, 
et al. Extrahepatic cholestasis increases 
liver stiffness (FibroScan) 
irrespective of fibrosis. Hepatology. 
2008;48(5):1718-1723. DOI: 10.1002/
hep.22577
[20] Millonig G, Friedrich S, Adolf S, 
Fonouni H, Golriz M, Mehrabi A, et al. 
Liver stiffness is directly influenced 
by central venous pressure. Journal of 
Hepatology. 2010;52(2):206-210. DOI: 
10.1016/j.jhep.2009.11.018
[21] Arena U, Vizzutti F, Abraldes JG, 
Corti G, Stasi C, Moscarella S, et al. 
Reliability of transient elastography 
for the diagnosis of advanced 
fibrosis in chronic hepatitis C. Gut. 
2008;57(9):1288-1293. DOI: 10.1136/
gut.2008.149708
[22] Fraquelli M, Rigamonti C, Casazza G, 
Conte D, Donato MF, Ronchi G, et al. 
Reproducibility of transient elastography 
in the evaluation of liver fibrosis in 
patients with chronic liver disease. Gut. 
2007;56(7):968-973
[23] Chan HL, Wong GL, Choi PC, 
Chan AW, Chim AM, Yiu KK, et al. 
Alanine aminotransferase-based 
algorithms of liver stiffness 
measurement by transient elastography 
(Fibroscan) for liver fibrosis in 
chronic hepatitis B. Journal of Viral 
Hepatitis. 2009;16(1):36-44. DOI: 
10.1111/j.1365-2893.2008.01037.x
[24] Kim SU, Han KH, Park JY, 
Ahn SH, Chung MJ, Chon CY, et al. 
Liver stiffness measurement using 
FibroScan is influenced by serum 
total bilirubin in acute hepatitis. Liver 
International. 2009;29(6):810-815. DOI: 
10.1111/j.1478-3231.2008.01894.x
[25] Pozzoni P, Prati D, Berzuini A, 
et al. Liver stiffness values measured by 
transient elastography are increased in 
patients with acutely decompensated 




[1] Sandrin L, Fourquet B, 
Hasquenoph JM, Yon S, Fournier C, 
Mal F, et al. Transient elastography: 
A new noninvasive method for 
assessment of hepatic fibrosis. 
Ultrasound in Medicine and Biology. 
2003;29(12):1705-1713. DOI: 10.1016/j.
ultrasmedbio
[2] Yeh WC, Li PC, Jeng YM, Hsu HC, 
Kuo PL, Li ML, et al. Elastic modulus 
measurements of human liver 
and correlation with pathology. 
Ultrasound in Medicine and Biology. 
2002;28(4):467-474
[3] Lupsor M, Stefanescu H, Feier D, 
Badea R. Non-invasive evaluation of 
liver steatosis, fibrosis and cirrhosis in 
hepatitis C virus infected patients using 
unidimensional transient elastography 
(Fibroscan®). In: Tagaya N, editor. 
Liver Biopsy—Indications, Procedures, 
Results. Croatia: Intech; 2012. pp. 209-
234. DOI: 10.5772/52621
[4] Sasso M, Beaugrand M, de 
Ledinghen V, Douvin C, Marcellin P, 
Poupon R, et al. Controlled attenuation 
parameter (CAP): A novel VCTE™ 
guided ultrasonic attenuation 
measurement for the evaluation of 
hepatic steatosis: Preliminary study 
and validation in a cohort of patients 
with chronic liver disease from various 
causes. Ultrasound in Medicine and 
Biology. 2010;36(11):1825-1835. DOI: 
10.1016/j.ultrasmedbio.2010.07.005
[5] Sasso M, Miette V, Sandrin L, 
Beaugrand M. The controlled 
attenuation parameter (CAP): A novel 
tool for the non-invasive evaluation 
of steatosis using Fibroscan. Clinics 
and Research in Hepatology and 
Gastroenterology. 2012;36(1):13-20. 
DOI: 10.1016/j.clinre.2011.08.001
[6] Kettaneh A, Marcellin P, Douvin C, 
Poupon R, Ziol M, Beaugrand M, et al. 
Features associated with success 
rate and performance of FibroScan 
measurements for the diagnosis of 
cirrhosis in HCV patients: A prospective 
study of 935 patients. Journal of 
Hepatology. 2007;46(4):628-634. DOI: 
10.1016/j.jhep.2006.11.010
[7] Mederacke I, Wursthorn K, 
Kirschner J, Rifai K, Manns MP, 
Wedemeyer H, et al. Food intake 
increases liver stiffness in patients 
with chronic or resolved hepatitis C 
virus infection. Liver International. 
2009;29(10):1500-1506. DOI: 
10.1111/j.1478-3231.2009.02100.x
[8] Arena U, Lupsor Platon M, Stasi C, 
Moscarella S, Assarat A, Bedogni G, 
et al. Liver stiffness is influenced by 
a standardized meal in patients with 
chronic HCV hepatitis at different 
stages of fibrotic evolution. Hepatology. 
2013;58(1):65-72. DOI: 10.1002/
hep.26343
[9] Dietrich CF, Bamber J, Berzigotti A, 
Bota S, Cantisani V, Castera L, et al. 
EFSUMB guidelines and recommendations 
on the clinical use of liver ultrasound 
elastography, update 2017 (long 
version). Ultraschall in der 
Medizin. 2017;38(4):e16-e47. DOI: 
10.1055/s-0043-103952
[10] Boursier J, Konate A, Guilluy M, 
Gorea G, Sawadogo A, Quemener E, 
et al. Learning curve and interobserver 
reproducibility evaluation of liver 
stiffness measurement by transient 
elastography. European Journal of 
Gastroenterology and Hepatology. 
2008;20(7):693-701. DOI: 10.1097/
MEG.0b013e3282f51992
[11] Castera L, Forns X, Alberti A. Non-
invasive evaluation of liver fibrosis 
using transient elastography. Journal of 
Hepatology. 2008;48(5):835-847
[12] Roulot D, Czernichow S, Le 
Clésiau H, Costes JL, Vergnaud AC, 
References
13
Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
Beaugrand M. Liver stiffness values in 
apparently healthy subjects: Influence of 
gender and metabolic syndrome. Journal 
of Hepatology. 2008;48(4):606-613
[13] Sirli R, Sporea I, Tudora A, Deleanu A, 
Popescu A. Transient elastographic 
evaluation of subjects without 
known hepatic pathology: Does age 
change the liver stiffness? Journal of 
Gastrointestinal and Liver Diseases. 
2009;18(1):57-60
[14] Corpechot C, El Naggar A, 
Poupon R. Gender and liver: Is the 
liver stiffness weaker in weaker sex? 
Hepatology. 2006;44(2):513-514
[15] Lupsor Platon M, Stefanescu H, 
Feier D, Maniu A, Badea R. Performance 
of unidimensional transient 
elastography in staging chronic hepatitis 
C. Results from a cohort of 1,202 
biopsied patients from one single center. 
Journal of Gastrointestinal and Liver 
Diseases. 2013;22(2):157-166
[16] Coco B, Oliveri F, Maina AM, 
Ciccorossi P, Sacco R, Colombatto P, 
et al. Transient elastography: A new 
surrogate marker of liver fibrosis 
influenced by major changes of 
transaminases. Journal of Viral 
Hepatitis. 2007;14(5):360-369. DOI: 
10.1111/j.1365-2893.2006.00811.x
[17] Sagir A, Erhardt A, Schmitt M, 
Häussinger D. Transient elastography 
is unreliable for detection of cirrhosis 
in patients with acute liver damage. 
Hepatology. 2008;47(2):592-595. DOI: 
10.1002/hep.22056
[18] Arena U, Vizzutti F, Corti G, 
Ambu S, Stasi C, Bresci S, et al. Acute 
viral hepatitis increases liver 
stiffness values measured by 
transient elastography. Hepatology. 
2008;47(2):380-384. DOI: 10.1002/
hep.22007
[19] Millonig G, Reimann FM, Friedrich S, 
Fonouni H, Mehrabi A, Büchler MW, 
et al. Extrahepatic cholestasis increases 
liver stiffness (FibroScan) 
irrespective of fibrosis. Hepatology. 
2008;48(5):1718-1723. DOI: 10.1002/
hep.22577
[20] Millonig G, Friedrich S, Adolf S, 
Fonouni H, Golriz M, Mehrabi A, et al. 
Liver stiffness is directly influenced 
by central venous pressure. Journal of 
Hepatology. 2010;52(2):206-210. DOI: 
10.1016/j.jhep.2009.11.018
[21] Arena U, Vizzutti F, Abraldes JG, 
Corti G, Stasi C, Moscarella S, et al. 
Reliability of transient elastography 
for the diagnosis of advanced 
fibrosis in chronic hepatitis C. Gut. 
2008;57(9):1288-1293. DOI: 10.1136/
gut.2008.149708
[22] Fraquelli M, Rigamonti C, Casazza G, 
Conte D, Donato MF, Ronchi G, et al. 
Reproducibility of transient elastography 
in the evaluation of liver fibrosis in 
patients with chronic liver disease. Gut. 
2007;56(7):968-973
[23] Chan HL, Wong GL, Choi PC, 
Chan AW, Chim AM, Yiu KK, et al. 
Alanine aminotransferase-based 
algorithms of liver stiffness 
measurement by transient elastography 
(Fibroscan) for liver fibrosis in 
chronic hepatitis B. Journal of Viral 
Hepatitis. 2009;16(1):36-44. DOI: 
10.1111/j.1365-2893.2008.01037.x
[24] Kim SU, Han KH, Park JY, 
Ahn SH, Chung MJ, Chon CY, et al. 
Liver stiffness measurement using 
FibroScan is influenced by serum 
total bilirubin in acute hepatitis. Liver 
International. 2009;29(6):810-815. DOI: 
10.1111/j.1478-3231.2008.01894.x
[25] Pozzoni P, Prati D, Berzuini A, 
et al. Liver stiffness values measured by 
transient elastography are increased in 
patients with acutely decompensated 




[26] Lebray P, Varnous S, Charlotte F, 
Varaut A, Poynard T, Ratziu V. Liver 
stiffness is an unreliable marker 
of liver fibrosis in patients with 
cardiac insufficiency. Hepatology. 
2008;48(6):2089. DOI: 10.1002/
hep.22594
[27] Bioulac-Sage P, Couffinhal T, 
Foucher J, Balabaud CP. Interpreting 
liver stiffness in the cirrhotic range. 
Journal of Hepatology. 2009;50(2):423-
424. DOI: 10.1016/j.jhep.2008.11.003
[28] Ziol M, Kettaneh A, Ganne- 
Carrié N, Barget N, Tengher-Barna I, 
Beaugrand M. Relationships between 
fibrosis amounts assessed by 
morphometry and liver stiffness 
measurements in chronic hepatitis 
or steatohepatitis. European Journal 
of Gastroenterology and Hepatology. 
2009;21(11):1261-1268. DOI: 10.1097/
MEG.0b013e32832a20f5
[29] Lupşor M, Badea R, Stefănescu H, 
Grigorescu M, Sparchez Z, Serban A, 
et al. Analysis of histopathological 
changes that influence liver stiffness 
in chronic hepatitis C. Results from 
a cohort of 324 patients. Journal of 
Gastrointestinal and Liver Diseases. 
2008;17(2):155-163
[30] Ziol M, Handra-Luca A, 
Kettaneh A, Christidis C, Mal F, 
Kazemi F, et al. Noninvasive assessment 
of liver fibrosis by measurement 
of stiffness in patients with 
chronic hepatitis C. Hepatology. 
2005;41(1):48-54
[31] Castéra L, Vergniol J, Foucher J, Le 
Bail B, Chanteloup E, Haaser M, et al. 
Prospective comparison of transient 
elastography, Fibrotest, APRI, and liver 
biopsy for the assessment of fibrosis in 
chronic hepatitis C. Gastroenterology. 
2005;128(2):343-350
[32] Sporea I, Sirli R, Deleanu A, 
Tudora A, Curescu M, Cornianu M, 
et al. Comparison of the liver stiffness 
measurement by transient elastography 
with the liver biopsy. World 
Journal of Gastroenterology. 
2008;14(42):6513-6517
[33] Nitta Y, Kawabe N, Hashimoto S, 
Harata M, Komura N, Kobayashi K, 
et al. Liver stiffness measured by 
transient elastography correlates with 
fibrosis area in liver biopsy in patients 
with chronic hepatitis C. Hepatology 
Research. 2009;39(7):675-684. DOI: 
10.1111/j.1872-034X.2009.00500.x
[34] European Association for Study 
of Liver, Asociacion Latinoamericana 
para el Estudio del Higado. EASL-ALEH 
clinical practice guidelines: Non-
invasive tests for evaluation of liver 
disease severity and prognosis. Journal 
of Hepatology. 2015;63(1):237-264. DOI: 
10.1016/j.jhep.2015.04.006
[35] Poynard T, Halfon P, Castera L, 
Munteanu M, Imbert-Bismut F, Ratziu V, 
et al. Standardization of ROC curve 
areas for diagnostic evaluation of liver 
fibrosis markers based on prevalences 
of fibrosis stages. Clinical Chemistry. 
2007;53(9):1615-1622
[36] Marcellin P, Ziol M, Bedossa P, 
Douvin C, Poupon R, de Lédinghen V, 
et al. Non-invasive assessment of liver 
fibrosis by stiffness measurement in 
patients with chronic hepatitis B. Liver 
International. 2009;29(2):242-247. DOI: 
10.1111/j.1478-3231.2008.01802.x
[37] Degos F, Perez P, Roche B, 
Mahmoudi A, Asselineau J, Voitot H, 
et al. Diagnostic accuracy of FibroScan 
and comparison to liver fibrosis 
biomarkers in chronic viral hepatitis: 
A multicenter prospective study 
(the FIBROSTIC study). Journal of 
Hepatology. 2010;53(6):1013-1021. DOI: 
10.1016/j.jhep.2010.05.035
[38] Cardoso AC, Carvalho-Filho RJ, 
Stern C, Dipumpo A, Giuily N, 
Ripault MP, et al. Direct comparison 
of diagnostic performance of transient 
15
Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
elastography in patients with chronic 
hepatitis B and chronic hepatitis C. Liver 
International. 2012;32(4):612-621. DOI: 
10.1111/j.1478-3231.2011.02660.x
[39] Viganò M, Paggi S, Lampertico P, 
Fraquelli M, Massironi S, Ronchi G, 
et al. Dual cut-off transient elastography 
to assess liver fibrosis in chronic 
hepatitis B: A cohort study with internal 
validation. Alimentary Pharmacology 
and Therapeutics. 2011;34(3):353-362. 
DOI: 10.1111/j.1365-2036.2011.04722.x
[40] Oliveri F, Coco B, Ciccorossi P, 
Colombatto P, Romagnoli V, 
Cherubini B, et al. Liver stiffness in the 
hepatitis B virus carrier: A non-invasive 
marker of liver disease influenced 
by the pattern of transaminases. 
World Journal of Gastroenterology. 
2008;14(40):6154-6162
[41] Lesmana CR, Salim S, Hasan I, 
Sulaiman AS, Gani RA, Pakasi LS, et al. 
Diagnostic accuracy of transient 
elastography (FibroScan) versus the 
aspartate transaminase to platelet 
ratio index in assessing liver fibrosis 
in chronic hepatitis B: The role in 
primary care setting. Journal of Clinical 
Pathology. 2011;64(10):916-920. DOI: 
10.1136/jclinpath-2011-200044
[42] Verveer C, Zondervan PE, ten 
Kate FJ, Hansen BE, Janssen HL, de 
Knegt RJ. Evaluation of transient 
elastography for fibrosis assessment 
compared with large biopsies in 
chronic hepatitis B and C. Liver 
International. 2012;32(4):622-628. DOI: 
10.1111/j.1478-3231.2011.02663.x
[43] Seo YS, Kim MN, Kim SU, Kim SG, 
Um SH, Han KH, et al. Risk assessment 
of hepatocellular carcinoma using 
transient elastography vs. liver biopsy 
in chronic hepatitis B patients receiving 
antiviral therapy. Medicine (Baltimore). 
2016;95:e2985. DOI: 10.1097/
MD.0000000000002985
[44] Meng F, Zheng Y, Zhang Q , Mu X, 
Xu X, Zhang H, et al. Noninvasive 
evaluation of liver fibrosis using real-
time tissue elastography and transient 
elastography (FibroScan). Journal of 
Ultrasound in Medicine. 2015;34:403-
410. DOI: 10.7863/ultra.34.3.403
[45] Chon YE, Choi EH, Song KJ, 
Park JY, Kim DY, Han KH, et al. 
Performance of transient elastography 
for the staging of liver fibrosis in 
patients with chronic hepatitis 
B: A meta-analysis. PLoS One. 
2012;7:e44930. DOI: 10.1371/journal.
pone.0044930
[46] Xu X, Su Y, Song R, Sheng Y, Ai W, 
Wu X, et al. Performance of transient 
elastography assessing fibrosis of single 
hepatitis B virus infection: A systematic 
review and meta-analysis of a diagnostic 
test. Hepatology International. 
2015;9:558-566. DOI: 10.1007/
s12072-015-9643-z
[47] Li Y, Huang YS, Wang ZZ, Yang ZR, 
Sun F, Zhan SY, et al. Systematic review 
with meta-analysis: The diagnostic 
accuracy of transient elastography for 
the staging of liver fibrosis in patients 
with chronic hepatitis B. Alimentary 
Pharmacology and Therapeutics. 
2016;43:458-469. DOI: 10.1111/
apt.13488
[48] Castéra L, Bernard PH, Le 
Bail B, Foucher J, Trimoulet P, 
Merrouche W, et al. Transient 
elastography and biomarkers for liver 
fibrosis assessment and follow-up 
of inactive hepatitis B carriers. 
Alimentary Pharmacology and 
Therapeutics. 2011;33:455-465. DOI: 
10.1111/j.1365-2036.2010.04547.x
[49] Dong CF, Xiao J, Shan LB, Li HY, 
Xiong YJ, Yang GL, et al. Combined 
acoustic radiation force impulse, 
aminotransferase to platelet ratio index 
and Forns index assessment for hepatic 
fibrosis grading in hepatitis B. World 




[26] Lebray P, Varnous S, Charlotte F, 
Varaut A, Poynard T, Ratziu V. Liver 
stiffness is an unreliable marker 
of liver fibrosis in patients with 
cardiac insufficiency. Hepatology. 
2008;48(6):2089. DOI: 10.1002/
hep.22594
[27] Bioulac-Sage P, Couffinhal T, 
Foucher J, Balabaud CP. Interpreting 
liver stiffness in the cirrhotic range. 
Journal of Hepatology. 2009;50(2):423-
424. DOI: 10.1016/j.jhep.2008.11.003
[28] Ziol M, Kettaneh A, Ganne- 
Carrié N, Barget N, Tengher-Barna I, 
Beaugrand M. Relationships between 
fibrosis amounts assessed by 
morphometry and liver stiffness 
measurements in chronic hepatitis 
or steatohepatitis. European Journal 
of Gastroenterology and Hepatology. 
2009;21(11):1261-1268. DOI: 10.1097/
MEG.0b013e32832a20f5
[29] Lupşor M, Badea R, Stefănescu H, 
Grigorescu M, Sparchez Z, Serban A, 
et al. Analysis of histopathological 
changes that influence liver stiffness 
in chronic hepatitis C. Results from 
a cohort of 324 patients. Journal of 
Gastrointestinal and Liver Diseases. 
2008;17(2):155-163
[30] Ziol M, Handra-Luca A, 
Kettaneh A, Christidis C, Mal F, 
Kazemi F, et al. Noninvasive assessment 
of liver fibrosis by measurement 
of stiffness in patients with 
chronic hepatitis C. Hepatology. 
2005;41(1):48-54
[31] Castéra L, Vergniol J, Foucher J, Le 
Bail B, Chanteloup E, Haaser M, et al. 
Prospective comparison of transient 
elastography, Fibrotest, APRI, and liver 
biopsy for the assessment of fibrosis in 
chronic hepatitis C. Gastroenterology. 
2005;128(2):343-350
[32] Sporea I, Sirli R, Deleanu A, 
Tudora A, Curescu M, Cornianu M, 
et al. Comparison of the liver stiffness 
measurement by transient elastography 
with the liver biopsy. World 
Journal of Gastroenterology. 
2008;14(42):6513-6517
[33] Nitta Y, Kawabe N, Hashimoto S, 
Harata M, Komura N, Kobayashi K, 
et al. Liver stiffness measured by 
transient elastography correlates with 
fibrosis area in liver biopsy in patients 
with chronic hepatitis C. Hepatology 
Research. 2009;39(7):675-684. DOI: 
10.1111/j.1872-034X.2009.00500.x
[34] European Association for Study 
of Liver, Asociacion Latinoamericana 
para el Estudio del Higado. EASL-ALEH 
clinical practice guidelines: Non-
invasive tests for evaluation of liver 
disease severity and prognosis. Journal 
of Hepatology. 2015;63(1):237-264. DOI: 
10.1016/j.jhep.2015.04.006
[35] Poynard T, Halfon P, Castera L, 
Munteanu M, Imbert-Bismut F, Ratziu V, 
et al. Standardization of ROC curve 
areas for diagnostic evaluation of liver 
fibrosis markers based on prevalences 
of fibrosis stages. Clinical Chemistry. 
2007;53(9):1615-1622
[36] Marcellin P, Ziol M, Bedossa P, 
Douvin C, Poupon R, de Lédinghen V, 
et al. Non-invasive assessment of liver 
fibrosis by stiffness measurement in 
patients with chronic hepatitis B. Liver 
International. 2009;29(2):242-247. DOI: 
10.1111/j.1478-3231.2008.01802.x
[37] Degos F, Perez P, Roche B, 
Mahmoudi A, Asselineau J, Voitot H, 
et al. Diagnostic accuracy of FibroScan 
and comparison to liver fibrosis 
biomarkers in chronic viral hepatitis: 
A multicenter prospective study 
(the FIBROSTIC study). Journal of 
Hepatology. 2010;53(6):1013-1021. DOI: 
10.1016/j.jhep.2010.05.035
[38] Cardoso AC, Carvalho-Filho RJ, 
Stern C, Dipumpo A, Giuily N, 
Ripault MP, et al. Direct comparison 
of diagnostic performance of transient 
15
Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
elastography in patients with chronic 
hepatitis B and chronic hepatitis C. Liver 
International. 2012;32(4):612-621. DOI: 
10.1111/j.1478-3231.2011.02660.x
[39] Viganò M, Paggi S, Lampertico P, 
Fraquelli M, Massironi S, Ronchi G, 
et al. Dual cut-off transient elastography 
to assess liver fibrosis in chronic 
hepatitis B: A cohort study with internal 
validation. Alimentary Pharmacology 
and Therapeutics. 2011;34(3):353-362. 
DOI: 10.1111/j.1365-2036.2011.04722.x
[40] Oliveri F, Coco B, Ciccorossi P, 
Colombatto P, Romagnoli V, 
Cherubini B, et al. Liver stiffness in the 
hepatitis B virus carrier: A non-invasive 
marker of liver disease influenced 
by the pattern of transaminases. 
World Journal of Gastroenterology. 
2008;14(40):6154-6162
[41] Lesmana CR, Salim S, Hasan I, 
Sulaiman AS, Gani RA, Pakasi LS, et al. 
Diagnostic accuracy of transient 
elastography (FibroScan) versus the 
aspartate transaminase to platelet 
ratio index in assessing liver fibrosis 
in chronic hepatitis B: The role in 
primary care setting. Journal of Clinical 
Pathology. 2011;64(10):916-920. DOI: 
10.1136/jclinpath-2011-200044
[42] Verveer C, Zondervan PE, ten 
Kate FJ, Hansen BE, Janssen HL, de 
Knegt RJ. Evaluation of transient 
elastography for fibrosis assessment 
compared with large biopsies in 
chronic hepatitis B and C. Liver 
International. 2012;32(4):622-628. DOI: 
10.1111/j.1478-3231.2011.02663.x
[43] Seo YS, Kim MN, Kim SU, Kim SG, 
Um SH, Han KH, et al. Risk assessment 
of hepatocellular carcinoma using 
transient elastography vs. liver biopsy 
in chronic hepatitis B patients receiving 
antiviral therapy. Medicine (Baltimore). 
2016;95:e2985. DOI: 10.1097/
MD.0000000000002985
[44] Meng F, Zheng Y, Zhang Q , Mu X, 
Xu X, Zhang H, et al. Noninvasive 
evaluation of liver fibrosis using real-
time tissue elastography and transient 
elastography (FibroScan). Journal of 
Ultrasound in Medicine. 2015;34:403-
410. DOI: 10.7863/ultra.34.3.403
[45] Chon YE, Choi EH, Song KJ, 
Park JY, Kim DY, Han KH, et al. 
Performance of transient elastography 
for the staging of liver fibrosis in 
patients with chronic hepatitis 
B: A meta-analysis. PLoS One. 
2012;7:e44930. DOI: 10.1371/journal.
pone.0044930
[46] Xu X, Su Y, Song R, Sheng Y, Ai W, 
Wu X, et al. Performance of transient 
elastography assessing fibrosis of single 
hepatitis B virus infection: A systematic 
review and meta-analysis of a diagnostic 
test. Hepatology International. 
2015;9:558-566. DOI: 10.1007/
s12072-015-9643-z
[47] Li Y, Huang YS, Wang ZZ, Yang ZR, 
Sun F, Zhan SY, et al. Systematic review 
with meta-analysis: The diagnostic 
accuracy of transient elastography for 
the staging of liver fibrosis in patients 
with chronic hepatitis B. Alimentary 
Pharmacology and Therapeutics. 
2016;43:458-469. DOI: 10.1111/
apt.13488
[48] Castéra L, Bernard PH, Le 
Bail B, Foucher J, Trimoulet P, 
Merrouche W, et al. Transient 
elastography and biomarkers for liver 
fibrosis assessment and follow-up 
of inactive hepatitis B carriers. 
Alimentary Pharmacology and 
Therapeutics. 2011;33:455-465. DOI: 
10.1111/j.1365-2036.2010.04547.x
[49] Dong CF, Xiao J, Shan LB, Li HY, 
Xiong YJ, Yang GL, et al. Combined 
acoustic radiation force impulse, 
aminotransferase to platelet ratio index 
and Forns index assessment for hepatic 
fibrosis grading in hepatitis B. World 




[50] Lupsor M, Badea R, Stefanescu H, 
Grigorescu M, Serban A, Radu C, et al. 
Performance of unidimensional 
transient elastography in staging 
non-alcoholic steatohepatitis. Journal 
of Gastrointestinal and Liver Diseases. 
2010;19(1):53-60
[51] Kwok R, Tse YK, Wong GL, Ha Y, 
Lee AU, Ngu MC, et al. Systematic 
review with metaanalysis: Non-invasive 
assessment of non-alcoholic fatty 
liver disease—The role of transient 
elastography and plasma cytokeratin-18 
fragments. Alimentary Pharmacology 
and Therapeutics. 2014;39(3):254-269. 
DOI: 10.1111/apt.12569
[52] Kumar R, Rastogi A, Sharma MK, 
Bhatia V, Tyagi P, Sharma P, et al. Liver 
stiffness measurements in patients with 
different stages of nonalcoholic fatty 
liver disease: Diagnostic performance 
and clinicopathological correlation. 
Digestive Diseases and Sciences. 
2013;58(1):265-274. DOI: 10.1007/
s10620-012-2306-1
[53] Gaia S, Carenzi S, Barilli AL, 
Bugianesi E, Smedile A, Brunello F, et al. 
Reliability of transient elastography 
for the detection of fibrosis in non-
alcoholic fatty liver disease and chronic 
viral hepatitis. Journal of Hepatology. 
2011;54(1):64-71. DOI: 10.1016/j.
jhep.2010.06.022
[54] Myers RP, Pomier-Layrargues G, 
Kirsch R, Pollett A, Duarte-Rojo A, 
Wong D, et al. Feasibility and diagnostic 
performance of the FibroScan XL 
probe for liver stiffness measurement 
in overweight and obese patients. 
Hepatology. 2012;55(1):199-208. DOI: 
10.1002/hep.24624
[55] Petta S, Vanni E, Bugianesi E, Di 
Marco V, Cammà C, Cabibi D, et al. 
The combination of liver stiffness 
measurement and NAFLD fibrosis 
score improves the noninvasive 
diagnostic accuracy for severe liver 
fibrosis in patients with nonalcoholic 
fatty liver disease. Liver International. 
2015;35:1566-1573. DOI: 10.1111/
liv.12584
[56] Wong VW, Vergniol J, Wong GL, 
Foucher J, Chan HL, Le Bail B, et al. 
Diagnosis of fibrosis and cirrhosis 
using liver stiffness measurement 
in nonalcoholic fatty liver disease. 
Hepatology. 2010;51(2):454-462. DOI: 
10.1002/hep.23312
[57] Yoneda M, Yoneda M, Mawatari H, 
Fujita K, Endo H, Iida H, et al. 
Noninvasive assessment of liver fibrosis 
by measurement of stiffness in patients 
with nonalcoholic fatty liver disease 
(NAFLD). Digestive and Liver Disease. 
2008;40(5):371-378. DOI: 10.1016/j.
dld.2007.10.019
[58] Lupsor-Platon M, Badea R. 
Noninvasive assessment of alcoholic 
liver disease using unidimensional 
transient elastography (Fibroscan(®)). 
World Journal of Gastroenterology. 
2015;21(42):11914-11923. DOI: 10.3748/
wjg.v21.i42.11914
[59] Mueller S, Millonig G, Sarovska L, 
Friedrich S, Reimann FM, Pritsch M, 
et al. Increased liver stiffness in 
alcoholic liver disease: Differentiating 
fibrosis from steatohepatitis. 
World Journal of Gastroenterology. 
2010;16:966-972. DOI: 10.3748/wjg.v16.
i8.966
[60] Nahon P, Kettaneh A, Tengher- 
Barna I, Ziol M, de Lédinghen V, 
Douvin C, et al. Assessment of liver 
fibrosis using transient elastography 
in patients with alcoholic liver disease. 
Journal of Hepatology. 2008;49:1062-
1068. DOI: 10.1016/j.jhep.2008.08.011
[61] Janssens F, de Suray N, 
Piessevaux H, Horsmans Y, de Timary P, 
Stärkel P. Can transient elastography 
replace liver histology for determination 
of advanced fibrosis in alcoholic 
patients: A real-life study. Journal 
of Clinical Gastroenterology. 
17




[62] Thiele M, Detlefsen S, Sevelsted 
Møller L, Madsen BS, Fuglsang 
Hansen J, Fialla AD, et al. Transient and 
2-dimensional shear-wave elastography 
provide comparable assessment of 
alcoholic liver fibrosis and cirrhosis. 
Gastroenterology. 2016;150:123-133. 
DOI: 10.1053/j.gastro.2015.09.040
[63] Pavlov CS, Casazza G, Nikolova D, 
Tsochatzis E, Burroughs AK, 
Ivashkin VT, et al. Transient elastography 
for diagnosis of stages of hepatic fibrosis 
and cirrhosis in people with alcoholic 
liver disease. Cochrane Database of 
Systematic Reviews. 2015;1:CD010542. 
DOI: 10.1002/14651858.CD010542.pub2
[64] de Lédinghen V, Douvin C,  
Kettaneh A, Ziol M, Roulot D, 
Marcellin P, et al. Diagnosis of hepatic 
fibrosis and cirrhosis by transient 
elastography in HIV/hepatitis C virus-
coinfected patients. Journal of Acquired 
Immune Deficiency Syndromes. 
2006;41(2):175-179
[65] Vergara S, Macías J, Rivero A, 
et al. The use of transient elastometry 
for assessing liver fibrosis in patients 
with HIV and hepatitis C virus 
coinfection. Clinical Infectious 
Diseases. 2007;45(8):969-974. DOI: 
10.1086/521857
[66] Carrion JA, Navasa M, Bosch J, 
Bruguera M, Gilabert R, Forns X. Transient 
elastography for diagnosis of advanced 
fibrosis and portal hypertension in 
patients with hepatitis C recurrence 
after liver transplantation. Liver 
Transplantation. 2006;12(12):1791-
1798. DOI: 10.1002/lt.20857
[67] Rigamonti C, Donato MF, 
Fraquelli M, Agnelli F, Ronchi G, 
Casazza G, et al. Transient elastography 
predicts fibrosis progression in 
patients with recurrent hepatitis 
C after liver transplantation. Gut. 
2008;57(6):821-827. DOI: 10.1136/
gut.2007.135046
[68] Corradi F, Piscaglia F, Flori S, 
D’Errico-Grigioni A, Vasuri F, 
Tamé MR, et al. Assessment of liver 
fibrosis in transplant recipients with 
recurrent HCV infection: Usefulness of 
transient elastography. Digestive and 
Liver Disease. 2009;41(3):217-225. DOI: 
10.1016/j.dld.2008.06.009
[69] Harada N, Soejima Y, Taketomi A, 
Yoshizumi T, Ikegami T, Yamashita Y, 
et al. Assessment of graft fibrosis by 
transient elastography in patients with 
recurrent hepatitis C after living donor 
liver transplantation. Transplantation. 
2008;85(1):69-74. DOI: 10.1097/01.
tp.0000297248.18483.16
[70] Corpechot C, El Naggar A, 
Poujol-Robert A, Ziol M, Wendum D, 
Chazouillères O, et al. Assessment 
of biliary fibrosis by transient 
elastography in patients with PBC and 
PSC. Hepatology. 2006;43(5):1118-1124. 
DOI: 10.1002/hep.21151
[71] Adhoute X, Foucher J, Laharie D, 
Terrebonne E, Vergniol J, Castéra L, 
et al. Diagnosis of liver fibrosis using 
FibroScan and other noninvasive 
methods in patients with 
hemochromatosis: A prospective 
study. Gastroentérologie Clinique et 
Biologique. 2008;32(2):180-187
[72] Friedrich-Rust M, Ong MF, 
Martens S, et al. Performance of 
transient elastography for the 
staging of liver fibrosis: A meta-
analysis. Gastroenterology. 
2008;134(4):960-974
[73] Stebbing J, Farouk L, Panos G, 
Anderson M, Jiao LR, Mandalia S, 
et al. A meta-analysis of transient 
elastography for the detection of 





[50] Lupsor M, Badea R, Stefanescu H, 
Grigorescu M, Serban A, Radu C, et al. 
Performance of unidimensional 
transient elastography in staging 
non-alcoholic steatohepatitis. Journal 
of Gastrointestinal and Liver Diseases. 
2010;19(1):53-60
[51] Kwok R, Tse YK, Wong GL, Ha Y, 
Lee AU, Ngu MC, et al. Systematic 
review with metaanalysis: Non-invasive 
assessment of non-alcoholic fatty 
liver disease—The role of transient 
elastography and plasma cytokeratin-18 
fragments. Alimentary Pharmacology 
and Therapeutics. 2014;39(3):254-269. 
DOI: 10.1111/apt.12569
[52] Kumar R, Rastogi A, Sharma MK, 
Bhatia V, Tyagi P, Sharma P, et al. Liver 
stiffness measurements in patients with 
different stages of nonalcoholic fatty 
liver disease: Diagnostic performance 
and clinicopathological correlation. 
Digestive Diseases and Sciences. 
2013;58(1):265-274. DOI: 10.1007/
s10620-012-2306-1
[53] Gaia S, Carenzi S, Barilli AL, 
Bugianesi E, Smedile A, Brunello F, et al. 
Reliability of transient elastography 
for the detection of fibrosis in non-
alcoholic fatty liver disease and chronic 
viral hepatitis. Journal of Hepatology. 
2011;54(1):64-71. DOI: 10.1016/j.
jhep.2010.06.022
[54] Myers RP, Pomier-Layrargues G, 
Kirsch R, Pollett A, Duarte-Rojo A, 
Wong D, et al. Feasibility and diagnostic 
performance of the FibroScan XL 
probe for liver stiffness measurement 
in overweight and obese patients. 
Hepatology. 2012;55(1):199-208. DOI: 
10.1002/hep.24624
[55] Petta S, Vanni E, Bugianesi E, Di 
Marco V, Cammà C, Cabibi D, et al. 
The combination of liver stiffness 
measurement and NAFLD fibrosis 
score improves the noninvasive 
diagnostic accuracy for severe liver 
fibrosis in patients with nonalcoholic 
fatty liver disease. Liver International. 
2015;35:1566-1573. DOI: 10.1111/
liv.12584
[56] Wong VW, Vergniol J, Wong GL, 
Foucher J, Chan HL, Le Bail B, et al. 
Diagnosis of fibrosis and cirrhosis 
using liver stiffness measurement 
in nonalcoholic fatty liver disease. 
Hepatology. 2010;51(2):454-462. DOI: 
10.1002/hep.23312
[57] Yoneda M, Yoneda M, Mawatari H, 
Fujita K, Endo H, Iida H, et al. 
Noninvasive assessment of liver fibrosis 
by measurement of stiffness in patients 
with nonalcoholic fatty liver disease 
(NAFLD). Digestive and Liver Disease. 
2008;40(5):371-378. DOI: 10.1016/j.
dld.2007.10.019
[58] Lupsor-Platon M, Badea R. 
Noninvasive assessment of alcoholic 
liver disease using unidimensional 
transient elastography (Fibroscan(®)). 
World Journal of Gastroenterology. 
2015;21(42):11914-11923. DOI: 10.3748/
wjg.v21.i42.11914
[59] Mueller S, Millonig G, Sarovska L, 
Friedrich S, Reimann FM, Pritsch M, 
et al. Increased liver stiffness in 
alcoholic liver disease: Differentiating 
fibrosis from steatohepatitis. 
World Journal of Gastroenterology. 
2010;16:966-972. DOI: 10.3748/wjg.v16.
i8.966
[60] Nahon P, Kettaneh A, Tengher- 
Barna I, Ziol M, de Lédinghen V, 
Douvin C, et al. Assessment of liver 
fibrosis using transient elastography 
in patients with alcoholic liver disease. 
Journal of Hepatology. 2008;49:1062-
1068. DOI: 10.1016/j.jhep.2008.08.011
[61] Janssens F, de Suray N, 
Piessevaux H, Horsmans Y, de Timary P, 
Stärkel P. Can transient elastography 
replace liver histology for determination 
of advanced fibrosis in alcoholic 
patients: A real-life study. Journal 
of Clinical Gastroenterology. 
17




[62] Thiele M, Detlefsen S, Sevelsted 
Møller L, Madsen BS, Fuglsang 
Hansen J, Fialla AD, et al. Transient and 
2-dimensional shear-wave elastography 
provide comparable assessment of 
alcoholic liver fibrosis and cirrhosis. 
Gastroenterology. 2016;150:123-133. 
DOI: 10.1053/j.gastro.2015.09.040
[63] Pavlov CS, Casazza G, Nikolova D, 
Tsochatzis E, Burroughs AK, 
Ivashkin VT, et al. Transient elastography 
for diagnosis of stages of hepatic fibrosis 
and cirrhosis in people with alcoholic 
liver disease. Cochrane Database of 
Systematic Reviews. 2015;1:CD010542. 
DOI: 10.1002/14651858.CD010542.pub2
[64] de Lédinghen V, Douvin C,  
Kettaneh A, Ziol M, Roulot D, 
Marcellin P, et al. Diagnosis of hepatic 
fibrosis and cirrhosis by transient 
elastography in HIV/hepatitis C virus-
coinfected patients. Journal of Acquired 
Immune Deficiency Syndromes. 
2006;41(2):175-179
[65] Vergara S, Macías J, Rivero A, 
et al. The use of transient elastometry 
for assessing liver fibrosis in patients 
with HIV and hepatitis C virus 
coinfection. Clinical Infectious 
Diseases. 2007;45(8):969-974. DOI: 
10.1086/521857
[66] Carrion JA, Navasa M, Bosch J, 
Bruguera M, Gilabert R, Forns X. Transient 
elastography for diagnosis of advanced 
fibrosis and portal hypertension in 
patients with hepatitis C recurrence 
after liver transplantation. Liver 
Transplantation. 2006;12(12):1791-
1798. DOI: 10.1002/lt.20857
[67] Rigamonti C, Donato MF, 
Fraquelli M, Agnelli F, Ronchi G, 
Casazza G, et al. Transient elastography 
predicts fibrosis progression in 
patients with recurrent hepatitis 
C after liver transplantation. Gut. 
2008;57(6):821-827. DOI: 10.1136/
gut.2007.135046
[68] Corradi F, Piscaglia F, Flori S, 
D’Errico-Grigioni A, Vasuri F, 
Tamé MR, et al. Assessment of liver 
fibrosis in transplant recipients with 
recurrent HCV infection: Usefulness of 
transient elastography. Digestive and 
Liver Disease. 2009;41(3):217-225. DOI: 
10.1016/j.dld.2008.06.009
[69] Harada N, Soejima Y, Taketomi A, 
Yoshizumi T, Ikegami T, Yamashita Y, 
et al. Assessment of graft fibrosis by 
transient elastography in patients with 
recurrent hepatitis C after living donor 
liver transplantation. Transplantation. 
2008;85(1):69-74. DOI: 10.1097/01.
tp.0000297248.18483.16
[70] Corpechot C, El Naggar A, 
Poujol-Robert A, Ziol M, Wendum D, 
Chazouillères O, et al. Assessment 
of biliary fibrosis by transient 
elastography in patients with PBC and 
PSC. Hepatology. 2006;43(5):1118-1124. 
DOI: 10.1002/hep.21151
[71] Adhoute X, Foucher J, Laharie D, 
Terrebonne E, Vergniol J, Castéra L, 
et al. Diagnosis of liver fibrosis using 
FibroScan and other noninvasive 
methods in patients with 
hemochromatosis: A prospective 
study. Gastroentérologie Clinique et 
Biologique. 2008;32(2):180-187
[72] Friedrich-Rust M, Ong MF, 
Martens S, et al. Performance of 
transient elastography for the 
staging of liver fibrosis: A meta-
analysis. Gastroenterology. 
2008;134(4):960-974
[73] Stebbing J, Farouk L, Panos G, 
Anderson M, Jiao LR, Mandalia S, 
et al. A meta-analysis of transient 
elastography for the detection of 





[74] Tsochatzis EA, Gurusamy KS, 
Ntaoula S, Cholongitas E, Davidson BR, 
Burroughs AK. Elastography for the 
diagnosis of severity of fibrosis in 
chronic liver disease: A meta-analysis 
of diagnostic accuracy. Journal of 
Hepatology. 2011;54(4):650-659. DOI: 
10.1016/j.jhep.2010.07.033
[75] Castéra L, Le Bail B, Roudot- 
Thoraval F, Bernard PH, Foucher J, 
Merrouche W, et al. Early detection in 
routine clinical practice of cirrhosis and 
oesophageal varices in chronic hepatitis 
C: Comparison of transient elastography 
(FibroScan) with standard laboratory 
tests and non-invasive scores. Journal 
of Hepatology. 2009;50(1):59-68. DOI: 
10.1016/j.jhep.2008.08.018
[76] Kazemi F, Kettaneh A, N’kontchou 
G, Pinto E, Ganne-Carrie N, 
Trinchet JC, et al. Liver stiffness 
measurement selects patients with 
cirrhosis at risk of bearing large 
oesophageal varices. Journal of 
Hepatology. 2006;45(2):230-235. DOI: 
10.1016/j.jhep.2006.04.006
[77] Vizzutti F, Arena U, Romanelli RG, 
Rega L, Foschi M, Colagrande S, et al. 
Liver stiffness measurement predicts 
severe portal hypertension in patients 
with HCV-related cirrhosis. Hepatology. 
2007;45(5):1290-1297. DOI: 10.1002/
hep.21665
[78] Bureau C, Metivier S, Peron JM, 
Selves J, Robic MA, Gourraud PA, 
et al. Transient elastography accurately 
predicts presence of significant 
portal hypertension in patients with 
chronic liver disease. Alimentary 
Pharmacology and Therapeutics. 
2008;27(12):1261-1268. DOI: 
10.1111/j.1365-2036.2008.03701.x
[79] Lemoine M, Katsahian S, Ziol M, 
Nahon P, Ganne-Carrie N, Kazemi F, 
et al. Liver stiffness measurement as a 
predictive tool of clinically significant 
portal hypertension in patients with 
compensated hepatitis C virus or 
alcohol-related cirrhosis. Alimentary 
Pharmacology and Therapeutics. 
2008;28(9):1102-1110. DOI: 
10.1111/j.1365-2036.2008.03825.x
[80] de Franchis R, editor. Portal 
hypertension VI. In: Proceedings of the 
Sixth Baveno Consensus Workshop: 
Stratifying Risk and Individualizing 
Care. Switzerland: Springer 
International Publishing; 2016. DOI: 
10.1007/978-3-319-23018-4
[81] Masuzaki R, Tateishi R, 
Yoshida H, Yoshida H, Sato S, Kato N, 
et al. Risk assessment of hepatocellular 
carcinoma in chronic hepatitis C 
patients by transient elastography. 
Journal of Clinical Gastroenterology. 
2008;42(7):839-843
[82] Masuzaki R, Tateishi R, 
Yoshida H, Goto E, Sato T, Ohki T, 
et al. Prospective risk assessment for 
hepatocellular carcinoma development 
in chronic hepatitis C patients by 
transient elastography. Hepatology. 
2009;49(6):1954-1961. DOI: 10.1002/
hep.22870
[83] Feier D, Lupsor Platon M,  
Stefanescu H, Badea R. Transient 
elastography for the detection of 
hepatocellular carcinoma in viral C 
liver cirrhosis. Is there something else 
than increased liver stiffness? Journal 
of Gastrointestinal and Liver Diseases. 
2013;22(3):283-289
[84] Tapper EB, Castera L, Afdhal NH. 
FibroScan (vibration-controlled 
transient elastography): Where does 
it stand in the United States practice. 
Clinical Gastroenterology and 
Hepatology. 2015;13(1):27-36. DOI: 
10.1016/j.cgh.2014.04.039
[85] Pinzani M. Non-invasive evaluation 
of hepatic fibrosis: Don’t count your 




Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
[86] Laharie D, Zerbib F, Adhoute X,  
Boué-Lahorgue X, Foucher J, Castéra L,  
et al. Diagnosis of liver fibrosis by 
transient elastography (FibroScan) and 
non-invasive methods in Crohn’s disease 
patients treated with methotrexate. 
Alimentary Pharmacology and 
Therapeutics. 2006;23(11):1621-1628. 
DOI: 10.1111/j.1365-2036.2006.02929.x
[87] Castera L, Vilgrain V, Angulo P.  
Noninvasive evaluation of 
NAFLD. Nature Reviews. 





[74] Tsochatzis EA, Gurusamy KS, 
Ntaoula S, Cholongitas E, Davidson BR, 
Burroughs AK. Elastography for the 
diagnosis of severity of fibrosis in 
chronic liver disease: A meta-analysis 
of diagnostic accuracy. Journal of 
Hepatology. 2011;54(4):650-659. DOI: 
10.1016/j.jhep.2010.07.033
[75] Castéra L, Le Bail B, Roudot- 
Thoraval F, Bernard PH, Foucher J, 
Merrouche W, et al. Early detection in 
routine clinical practice of cirrhosis and 
oesophageal varices in chronic hepatitis 
C: Comparison of transient elastography 
(FibroScan) with standard laboratory 
tests and non-invasive scores. Journal 
of Hepatology. 2009;50(1):59-68. DOI: 
10.1016/j.jhep.2008.08.018
[76] Kazemi F, Kettaneh A, N’kontchou 
G, Pinto E, Ganne-Carrie N, 
Trinchet JC, et al. Liver stiffness 
measurement selects patients with 
cirrhosis at risk of bearing large 
oesophageal varices. Journal of 
Hepatology. 2006;45(2):230-235. DOI: 
10.1016/j.jhep.2006.04.006
[77] Vizzutti F, Arena U, Romanelli RG, 
Rega L, Foschi M, Colagrande S, et al. 
Liver stiffness measurement predicts 
severe portal hypertension in patients 
with HCV-related cirrhosis. Hepatology. 
2007;45(5):1290-1297. DOI: 10.1002/
hep.21665
[78] Bureau C, Metivier S, Peron JM, 
Selves J, Robic MA, Gourraud PA, 
et al. Transient elastography accurately 
predicts presence of significant 
portal hypertension in patients with 
chronic liver disease. Alimentary 
Pharmacology and Therapeutics. 
2008;27(12):1261-1268. DOI: 
10.1111/j.1365-2036.2008.03701.x
[79] Lemoine M, Katsahian S, Ziol M, 
Nahon P, Ganne-Carrie N, Kazemi F, 
et al. Liver stiffness measurement as a 
predictive tool of clinically significant 
portal hypertension in patients with 
compensated hepatitis C virus or 
alcohol-related cirrhosis. Alimentary 
Pharmacology and Therapeutics. 
2008;28(9):1102-1110. DOI: 
10.1111/j.1365-2036.2008.03825.x
[80] de Franchis R, editor. Portal 
hypertension VI. In: Proceedings of the 
Sixth Baveno Consensus Workshop: 
Stratifying Risk and Individualizing 
Care. Switzerland: Springer 
International Publishing; 2016. DOI: 
10.1007/978-3-319-23018-4
[81] Masuzaki R, Tateishi R, 
Yoshida H, Yoshida H, Sato S, Kato N, 
et al. Risk assessment of hepatocellular 
carcinoma in chronic hepatitis C 
patients by transient elastography. 
Journal of Clinical Gastroenterology. 
2008;42(7):839-843
[82] Masuzaki R, Tateishi R, 
Yoshida H, Goto E, Sato T, Ohki T, 
et al. Prospective risk assessment for 
hepatocellular carcinoma development 
in chronic hepatitis C patients by 
transient elastography. Hepatology. 
2009;49(6):1954-1961. DOI: 10.1002/
hep.22870
[83] Feier D, Lupsor Platon M,  
Stefanescu H, Badea R. Transient 
elastography for the detection of 
hepatocellular carcinoma in viral C 
liver cirrhosis. Is there something else 
than increased liver stiffness? Journal 
of Gastrointestinal and Liver Diseases. 
2013;22(3):283-289
[84] Tapper EB, Castera L, Afdhal NH. 
FibroScan (vibration-controlled 
transient elastography): Where does 
it stand in the United States practice. 
Clinical Gastroenterology and 
Hepatology. 2015;13(1):27-36. DOI: 
10.1016/j.cgh.2014.04.039
[85] Pinzani M. Non-invasive evaluation 
of hepatic fibrosis: Don’t count your 




Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient…
DOI: http://dx.doi.org/10.5772/intechopen.89970
[86] Laharie D, Zerbib F, Adhoute X,  
Boué-Lahorgue X, Foucher J, Castéra L,  
et al. Diagnosis of liver fibrosis by 
transient elastography (FibroScan) and 
non-invasive methods in Crohn’s disease 
patients treated with methotrexate. 
Alimentary Pharmacology and 
Therapeutics. 2006;23(11):1621-1628. 
DOI: 10.1111/j.1365-2036.2006.02929.x
[87] Castera L, Vilgrain V, Angulo P.  
Noninvasive evaluation of 
NAFLD. Nature Reviews. 





Liver Fibrosis Assessment by 
Point Shear-Wave Elastography 
Techniques
Roxana Șirli, Alina Popescu and Ioan Sporea
Abstract
Point shear-wave elastographic (pSWE) techniques use acoustic radiation 
force impulse (ARFI) to stimulate the liver tissue and to generate shear waves that 
propagate into the liver. The shear-wave velocity (SWV) increases with the sever-
ity of fibrosis. The first type of pSWE was Virtual Touch Quantification (VTQ ) 
developed by Siemens, followed by ElastPQ by Philips, and nowadays pSWE is 
available on other systems (Hitachi, Esaote, Samsung). To evaluate liver fibrosis by 
pSWE, ten valid measurements are performed in the right liver lobe; a median value 
is calculated, with the results expressed in meters/second or in kilopascals (kPa) 
(if the operator chooses). VTQ is a reproducible method, the intraclass correlation 
coefficient (ICC) for inter- and intraobserver measurements ranging from 0.81 
to 0.87. Confounding factors for VTQ are non-fasting conditions, elevated ami-
notransferases, congestive heart failure, and extrahepatic cholestasis. In patients 
with chronic hepatopathies, the AUROCs for predicting significant fibrosis range 
between 0.75 and 0.85 and for predicting cirrhosis between 0.85 and 0.95. There 
were promising results regarding the value of VTQ to predict liver cirrhosis compli-
cations, especially portal hypertension. ElastPQ is a newly developed point shear-
wave elastographic method (from Philips). Only few data were published but with 
promising results.
Keywords: liver fibrosis, liver elastography, point shear-wave elastography, Virtual 
Touch Quantification, ElastPQ
1. Introduction
Evaluation of liver fibrosis severity is essential in chronic hepatopathies, espe-
cially for prognosis, but also for decision regarding treatment in some cases or 
for follow-up [1]. For a long time, liver biopsy was considered to be the reference 
method for fibrosis assessment. Not only mainly due to its invasiveness [2] but also 
due to issues regarding inter-observer variability and sampling errors [3], nonin-
vasive methods have been developed to assess the severity of liver fibrosis. These 
methods can be either biological or elastographic [1].
Elastographic techniques are based on an intrinsic property of tissue elasticity. 
When an extrinsic force is applied to a tissue, it deforms more or less according to 
its elasticity. Less elastic, stiffer tissue deforms less when subjected to an external 
force. Elastographic techniques measure tissue displacement when subjected to 
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an external force. In chronic hepatopathies, as fibrosis progresses, the liver tissue 
becomes stiffer, less elastic; thus, liver stiffness (LS) is considered to be an indicator 
of liver fibrosis severity [1, 4, 5]. Elastographic techniques can be ultrasound-based 
or based on magnetic resonance imaging.
According to the latest guidelines [4–9], ultrasound-based elastographic tech-
niques are divided into strain elastography (which measures longitudinal displace-
ment) and shear-wave elastography (SWE—which measures the speed of the shear 
waves generated into the tissue when an external force is applied). Based on the 
type of impulse that generates the shear waves, SWE is subdivided into transient 
elastography (TE—where a mechanical stimulus is applied to the tissue) and 
acoustic radiation force impulse (ARFI) techniques (where the stimulus deforming 
the tissue is an acoustic “push pulse” generated by the transducer). Subsequently, 
ARFI elastography is subdivided into point SWE (in which LS is measured in a 
region of interest (ROI)) and multidimensional SWE (2D-SWE and 3D-SWE—in 
which a color-coded elastogram is obtained and shear-wave speed is also measured 
in a region of interest).
In the following pages, we will present point shear-wave elastography 
techniques.
2. Point shear-wave elastography: basic principles
pSWE is a type of SWE in which tissue stimulation is performed at a certain 
depth by an acoustic radiation force impulse generated by the transducer (ARFI 
technology), which generates shear waves that propagate into the tissue, perpen-
dicularly on the axis of the initial pulse. Shear-wave velocity (SWV), expressed 
in meters/second (m/s), is measured in a predefined ROI chosen by the operator 
while performing B-mode ultrasonography. The average propagation speed of the 
shear waves, from a point placed on the lateral margin of the ROI to an opposite 
point on the ROI, can be measured by detecting its time of arrival at that point, 
relative to the acoustic “push” pulse [5]. The stiffer the tissue, the higher the shear-
wave velocity [4–9].
Most systems performing pSWE allow the choice to express measurement 
results either in m/s or in kilopascals (kPa). Kilopascal is the unit of the elastic 
modulus, obtained by converting the SWV to an elastic modulus, using an equa-
tion that assumes that the tissue density is always the same and also that the elastic 
modulus is not influenced by the magnitude, frequency, and direction of the 
applied force [5]. Thus, even if kPa is the unit to which users are the most familiar 
(since it was used for Transient Elastography), the most correct one is m/s [5–7].
Two types of pSWE have been more thoroughly evaluated, the ones developed 
by Siemens (Virtual Touch Quantification) and by Philips (ElastPQ ). Currently 
other manufacturers also offer pSWE on their systems: Esaote, Hitachi, and 
Samsung [5].
3. Point shear-wave elastography (pSWE): examination technique
First of all, before performing SWE the operator should be trained [5, 6, 8, 9]. If 
for TE training means performing more than 100 examinations under supervision 
[10], what training means is less precise for pSWE. A study published by Boursier 
concluded that there is no training effect on the accuracy of LS measurements by 
VTQ (ARFI) [11]. Concerning ElastPQ , a published study concluded that after a 
1-year learning curve, or 130 examinations, the accuracy of ElastPQ matches that 
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of TE [12]. Considering that adequate B-mode image is a must for reliable pSWE 
measurements [5, 9], it is sensible to consider that training not only in elastographic 
measurements but also in ultrasonography is needed.
According to the guidelines, the recommended technique of pSWE mea-
surements is with the patient in supine position with the right arm in maximal 
extension, through an intercostal approach, during breath hold, avoiding deep 
inspiration or expiration [5, 6, 8]. The transducer should be perpendicular on the 
liver capsule, and the ROI should be placed in the right liver lobe, as to avoid large 
blood vessels and masses, at a depth of minimum 1 cm below the liver capsule, best 
at 4–5 cm from the transducer [5, 6, 8, 9] (Figures 1 and 2).
A study published by our group demonstrated that the best correlation of VTQ 
measurements with histology was obtained for SWV measurements made 1–2 and 
2–3 cm beneath the liver capsule but with a lower feasibility for deeper measure-
ments [13]. Several studies observed higher SWV by VTQ in the left liver lobe 
vs. the right liver lobe [14–16]. Regarding ElastPQ , measurements made in liver 
segment V had the lowest coefficient of variation, and SWVs at the end-expiration 
were significantly higher than that at the end-inspiration [17].
For an appropriate estimation of fibrosis, the guidelines recommend to perform 
ten pSWE measurements and to calculate the median (M) value [5, 6, 8, 9]. When 
VTQ was launched, the manufacturer did not recommend quality criteria, but 
several studies demonstrated that there is a better correlation between histologic 
fibrosis and pSWE measurements if quality criteria such as interquartile range 
(IQR) and success rate (SR) are met. Regarding VTQ , an IQR/M ≥ 30% was 
associated with a discordance of at least two stages of fibrosis between SWV and 
histologic fibrosis [18]. In another study from our group, a very strong correlation 
of VTQ measurements with histologic fibrosis was observed when quality param-
eters (IQR < 30% and SR ≥ 60%) were met (r = 0.722, p < 0.0001); if not, there 
was no significant correlation (r = 0.268, p = 0.07) [19]. Also, standard deviation 
(SD) of the mean of ten valid SWV measurements by VTQ was evaluated as a 
quality criterion. Exclusion of patients in whom the SD was higher than 30% lead 
to an improved accuracy of VTQ [20]. Regarding ElastPQ®, IQR/M ≤ 30% is also 
the most important quality criterion [21, 22]. European guidelines recommend as 
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recommend an even smaller IQR/M, of less than 15%, if results are expressed in m/s 
[9]. A new multicenter study with ElastPQ® showed that the median value of five 
measurements with an IQR/M ≤ 30% is accurate enough for daily practice [22].
4.  Point shear-wave elastography (pSWE): feasibility and 
reproducibility
As opposed to TE, pSWE is feasible in patients with ascites [5, 6, 8, 9]. 
Furthermore, in published studies, the feasibility is better as compared to TE, being 
higher than 92%, both in VTQ [11, 23–25] and in ElastPQ [26, 27]. In a multicenter 
study on VTQ , older age, higher BMI, and male gender were associated with failed 
and unreliable measurements [25].
Regarding reproducibility of VTQ , several studies demonstrated very good 
inter- and intraobserver reproducibility, with intraclass correlation coefficients 
(ICC) higher than 0.81 [10, 28, 29]. A study that evaluated factors that influenced 
reproducibility found out that intraoperator reproducibility was better than the 
inter-operator one (ICC of 0.90 vs. 0.81) [28]. Both intra- and inter-operator repro-
ducibilities were better in men than in women, in patients with lower BMI, and in 
patients with no ascites and in cirrhotic than in non-cirrhotic patients [28].
ElastPQ was also proved to be a reproducible method, reported ICC ranging 
from 0.798 [30] to 0.96 [31]. In a study published by Fraquelli, the reproducibility 
was influenced by training, but not by age, gender, BMI, liver enzymes, and liver 
etiology [12].
5. Point shear-wave elastography (pSWE): confounding factors
One of the first confounding factors that should be taken into consideration is 
examination in non-fasting conditions. In a study published by our group, it was 
demonstrated that food intake can lead to a significant increase in SWVs measured 
by VTQ in healthy volunteers 1 hour post meal, the values decreasing to baseline 
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observation in VTQ was similar to what happens with TE measurements in non-
fasting patients, and thus the guidelines recommendation that pSWE measure-
ments should be performed in fasting patients [5, 6, 8, 9].
Another factor that can lead to a falsely increased SWV measured by VTQ is 
physical exercise [33]. Thus, the EFSUMB guidelines recommend that SWE should 
be performed after a minimum 10 minutes of rest [5].
An important confounding factor for SWE is liver necroinflammation, objecti-
fied by elevated aminotransferase levels. Several studies demonstrated that elevated 
aminotransferase levels are associated with higher SWVs by VTQ for the same 
severity of liver fibrosis, as compared to those observed in patients with normal 
or only slightly elevated aminotransferases [34, 35]. Also, a significant decrease in 
SWVs was observed in a case report of acute liver failure, in parallel to the normal-
ization of liver function tests [36].
The influence of necroinflammation on SWVs measured by ElastPQ is con-
troversial. In a study by Ma et al., the grade of necroinflammatory activity was 
independently associated with higher ElastPQ values [30], while in the study of 
Ferraioli et al., it had no influence [31].
Similar to TE, other confounding factors, which falsely increase SWVs by pSWE 
are right heart failure [37] and the presence of extrahepatic cholestasis [38].
Considering all the studies mentioned above, EFSUMB and WFUMB guidelines 
caution about the confounding factors for pSWE and state that liver inflammation 
(indicated by AST and/or ALT elevation >5 times the normal limits), obstructive 
cholestasis, liver congestion, acute hepatitis, and infiltrative liver diseases should be 
excluded before pSWE to avoid overestimation of fibrosis and/or should be consid-
ered when interpreting the results [5, 9].
6.  Point shear-wave elastography (pSWE): normal values  
in a healthy liver
The SWV by pSWE in healthy livers were evaluated by several authors. 
Regarding VTQ , normal SWV values ranged between 1.07 and 1.19 m/s [15, 39–42], 
and they were not influenced by gender and age, but higher values were observed in 
the left liver lobe than in the right liver lobe [15].
Regarding ElastPQ , normal values are in the same range as for VTQ [17, 31, 43], 
but a study found higher values in men than in women [17].
Current guidelines state that SWE measurements in the liver in normal range 
can rule out significant fibrosis if they are in accordance with clinical and biologic 
data [5, 9].
7.  Point shear-wave elastography (pSWE) in patients with chronic 
hepatopathies
7.1 Mixed cohorts
Multiple studies have been published regarding the value of VTQ elastography 
in patients with chronic liver diseases, considering biopsy as the reference. We sum-
marized some of them in Table 1.
Four meta-analyses were published regarding the value of VTQ for liver fibrosis 
assessment. The first one, by Friedrich-Rust et al., included 518 patients with 
hepatopathies of various etiologies. The summary AUROCs of VTQ for predicting 
significant fibrosis (F ≥ 2), severe fibrosis (F ≥ 3), and cirrhosis were 0.87, 0.91, 
Ultrasound Elastography
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excluded before pSWE to avoid overestimation of fibrosis and/or should be consid-
ered when interpreting the results [5, 9].
6.  Point shear-wave elastography (pSWE): normal values  
in a healthy liver
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Regarding VTQ , normal SWV values ranged between 1.07 and 1.19 m/s [15, 39–42], 
and they were not influenced by gender and age, but higher values were observed in 
the left liver lobe than in the right liver lobe [15].
Regarding ElastPQ , normal values are in the same range as for VTQ [17, 31, 43], 
but a study found higher values in men than in women [17].
Current guidelines state that SWE measurements in the liver in normal range 
can rule out significant fibrosis if they are in accordance with clinical and biologic 
data [5, 9].
7.  Point shear-wave elastography (pSWE) in patients with chronic 
hepatopathies
7.1 Mixed cohorts
Multiple studies have been published regarding the value of VTQ elastography 
in patients with chronic liver diseases, considering biopsy as the reference. We sum-
marized some of them in Table 1.
Four meta-analyses were published regarding the value of VTQ for liver fibrosis 
assessment. The first one, by Friedrich-Rust et al., included 518 patients with 
hepatopathies of various etiologies. The summary AUROCs of VTQ for predicting 
significant fibrosis (F ≥ 2), severe fibrosis (F ≥ 3), and cirrhosis were 0.87, 0.91, 
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and 0.93, respectively. TE performed significantly better than VTQ for F2 and cir-
rhosis, while for F3 the performances evaluated by AUROC were similar [51].
The second one included 1163 patients with chronic hepatopathies evaluated by 
LB, TE, and VTQ [52]. The first conclusion was that VTQ had a better feasibility 
than TE (unreliable measurements in 2.1 vs. 6.6% cases, respectively, p < 0.001). 
The diagnostic odds ratios were similar for VTQ and TE for detection of significant 
fibrosis and cirrhosis. The mean optimal cutoff value of VTQ for the detection of F2 
was 1.30 ± 0.07 m/s, and for cirrhosis, it was 1.80 ± 0.16 m/s.
The third meta-analysis included 3951 patients with liver biopsy as reference 
method. The AUROCs of VTQ for predicting the presence of F2, F3, and cirrhosis 
were 0.84, 0.89, and 0.91, respectively [53].
Finally, the fourth meta-analysis including 2691 patients calculated global 
sensitivity and specificity of VTQ to predict any stage of fibrosis to be 79 and 86%, 
respectively. The performance of VTQ was higher for more advanced fibrosis: 
for F ≥ 3 84% Se and 90% Sp (AUROC—0.94), while for F4 86% Se and 84% Sp 
(AUROC—0.91) [54].
Regarding ElastPQ , few data are available. In a study that compared ElastPQ 
to TE considered as reference, ElastPQ had a better feasibility than TE: 98.7% vs. 
90.7%. The AUROCs calculated for significant fibrosis, severe fibrosis, and cirrhosis 
were 0.94, 0.97, and 0.97, respectively [27].
7.2 Chronic hepatitis C
There is a lot of published data regarding the performance of VTQ elastography 
for the assessment of liver fibrosis in patients with chronic hepatitis C, as shown in 
Table 2.
To summarize, according to EFSUMB guidelines, VTQ® cutoffs of 1.21–1.34 m/s 
predict significant fibrosis (F ≥ 2) (AUROC 0.85–0.89), while VTQ® cutoffs 
between 1.55 and 2 m/s (AUROC 0.89–0.93) predict cirrhosis [5]. Furthermore, 
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according to recommendation 17 of the same guidelines, “pSWE as demonstrated 
with VTQ® can be used as the first-line assessment for the severity of liver fibrosis 
in patients with chronic viral hepatitis C. It performs best with regard to the ruling 
out of cirrhosis.”
Data regarding the value of ElastPQ for the assessment of liver fibrosis severity 
in chronic hepatitis C is scarce. In a pilot study, the AUROCs of VTQ for predicting 
F2, F3, and F4 were 0.80, 0.88, and 0.95, respectively [31]. Similar results have been 
obtained in a more recent study [60].
Following successful antiviral HCV treatment, a significant decrease of VTQ 
values was observed in a study performed by Goertz et al. [61].
7.3 Chronic hepatitis B
Several studies have been published regarding the value of VTQ for liver fibrosis 
assessment in chronic hepatitis B, as shown in Table 3.
Sub-analysis of data regarding patients with HBV chronic hepatitis from the 
Nierhoff meta-analysis on VTQ calculated AUROCs of 0.88 for F2 and 0.93 for F4, 
with cutoffs of 1.35 and 1.87 m/s, respectively [53].
Data regarding ElastPQ and chronic HBV hepatitis is scarce, and validation is 
needed. In a study that compared ElastPQ to liver biopsy in chronic hepatitis B, 
the authors calculated an AUROC of 0.94 with a cutoff of 6.99 kPa for F2 and an 
AUROC of 0.89 with a cutoff of 9.00 kPa for cirrhosis [30].
Regarding HBV chronic hepatitis and pSWE, EFSUMB guidelines state that 
“pSWE as demonstrated with VTQ is useful in patients with CHB to identify those 
with cirrhosis” [5].
7.4 Nonalcoholic fatty liver disease (NAFLD)
Several studies have been published regarding VTQ in the evaluation of liver 
fibrosis in NAFLD patients. Data is presented in Table 4.
Study Reference 
method











LB—64 p 1.35 0.86 1.55 0.93 1.75 0.95
Lupșor et al. 
[23]
LB—112 p 1.34 0.851 1.61 0.869 2 0.945
Sporea et al. 
[55]
LB—274 p 1.21 0.893 1.58 0.908 1.82 0.937
Sporea et al. 
[56]
LB—914 p 1.33 0.792 1.43 0.829 1.55 0.842
Rizzo et al. 
[57]
LB—139 p 1.3 0.86 1.7 0.94 2 0.89
Chen et al. 
[58]
LB—127 p 1.55 0.847 1.81 0.902 1.98 0.831
Li et al. [59] LB—128 p 1.53 0.775 1.79 0.901 1.79 0.792
Table 2. 
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A recently published meta-analysis including 723 patients who evaluated 
VTQ as a predictor of liver fibrosis in NAFLD patients calculated a summary 
sensitivity and specificity of VTQ in detecting significant fibrosis of 80.2 and 
85.2%, respectively, with a pooled diagnostic odds ratio of 30.13 and with an 
AUROC of 0.898 [68].
Considering all these data, EFSUMB guidelines conclude that VTQ can be used 
to exclude cirrhosis in NAFLD patients [5].
8.  Point shear-wave elastography (pSWE) for the prediction of liver 
cirrhosis complications
Cirrhosis is the final stage of chronic hepatopathies and can have severe com-
plications such as portal hypertension, hepatocellular carcinoma, decompensa-
tion, etc. The measurement of hepatic vein pressure gradient (HVPG) is the most 
accurate method for portal hypertension assessment, but it is an invasive method. 
HVPG >10 mm Hg means clinically significant portal hypertension (CSPH), while 
HVPG >12 mm Hg is predictive for variceal bleeding [69].
8.1 Portal hypertension
An initial study found a good correlation (r = 0.709) of VTQ measurements to 
HVPG measurements in 48 patients, with the AUROC for predicting CSPH being 
0.874 [70]. In a Romanian study in 145 patients, the mean value of VTQ measure-
ments in patients with grades 2 and 3 esophageal varices (EV) was significantly 










Yoneda et al. [65] LB—54 p 1.77 0.973 1.9 0.976
Friedrich-Rust et al. [66] LB—61 p — 0.71 — 0.74
Fierbinteanu et al. [67] LB—64 p — 0.944 — 0.984
Table 4. 
Performance of VTQ in the assessment of liver fibrosis in patients with nonalcoholic fatty liver disease.
Study Reference 
method











LB—133 p — 0.69 — 0.83 — 0.96
Zhang et al. 
[63]
LB—180 p 1.63 0.764 1.74 0.852 2 0.825
Dong et al. 
[64]
LB—81 p 1.29 0.762 1.54 0.882 1.83 0.732
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Several studies have evaluated SWVs in the spleen for the prediction of portal 
hypertension, with conflicting results. In the study by Rifai et al., spleen SWVs per-
formed better than liver SWVs for predicting CSPH [72]. In the study by Vermehren 
et al., spleen SWV and liver SWV had similar AUROCs for predicting the presence 
of at least grade 2 EV, but multiple regression analysis showed that spleen measure-
ments performed better [73]. In the study of Takuma et al., spleen VTQ measure-
ments also performed better than in the liver to predict the presence of varices in a 
cohort of 340 cirrhotic patients [74].
No data is available regarding ElastPQ.
However, according to the EFSUMB guidelines “reliable cut-offs are not avail-
able yet and no strong recommendation regarding the cut-offs to be used can be 
made due to the limited evidence” [5].
8.2 Hepatocellular carcinoma (HCC)
Published data showed only poor value of VTQ to predict the occurrence of 
HCC, with an AUROC of 0.54 [73].
There is no data regarding ElastPQ.
9. Point shear-wave elastography (pSWE): perspectives
Even if pSWE is currently implemented in other systems than from Siemens and 
Philips, published studies are small or missing altogether.
pSWE technique implemented on the Hitachi Ascendus system was evaluated 
by a study published in 2017 [75]. Reliable SWV measurements (SWM) were 
obtained in 87.2% of the 445 patients included. Considering TE as the reference 
method, cutoff values for pSWE from Hitachi had been calculated to rule in and 
rule out patients with significant fibrosis (F ≥ 2) and cirrhosis, respectively. SWV 
were converted to elastic modulus and expressed in kPa. To rule in F ≥ 2, the 
SWM cutoff was 6.78 kPa, while to rule it out, it was 5.55 kPa (AUROC—0.92). To 
rule in cirrhosis, the SWM cutoff was 9.15 kPa, and to rule it out, it was 8.41 kPa 
(AUROC—0.94).
A very interesting idea is to combine several techniques in order to assess not 
only fibrosis severity but also steatosis and inflammation using the same ultrasound 
machine. pSWE was combined with strain elastography on a Hitachi system. A 
study evaluated 388 patients with this combined technique, considering liver biopsy 
as reference method [76]. The AUROCs to predict fibrosis stage were 0.87, 0.80, 
0.83, and 0.80 for F1, F2, F3, and F4, respectively, while the AUROCs for activity 
grade were 0.94, 0.74, and 0.76 for A1, A2, and A3, respectively.
10. Conclusion
pSWE is an easy to perform elastographic technique, integrated into a standard 
ultrasound machine, with similar performance to TE to predict fibrosis severity in 
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Abstract
2D shear wave elastography is a technique embedded in ultrasound machines which 
allows the interrogation of the tissue by acoustic radiation force impulses induced into 
the tissues by focused ultrasonic beams and captures the propagation of resulting shear 
waves in real time. Elasticity is displayed using a color-coded image superimposed on 
a B-mode image, and at the same time, a quantitative estimation of liver stiffness (LS) 
can be performed in a certain region of interest (ROI). The published data showed a 
real value of this method for liver stiffness estimation in patients with chronic hepati-
tis. It has the following advantages: it is integrated into standard ultrasound systems; 
it is a real-time elastographic method; and it is also feasible in patients with ascites and 
with large and adjustable size of the ROI that will be evaluated.
Keywords: 2D shear wave elastography, liver stiffness, liver fibrosis,  
chronic liver diseases, liver cirrhosis
1. Introduction
Chronic liver diseases of different etiologies are still an important health prob-
lem, staging fibrosis being one of the issues that relate to prognosis and treatment 
decision. Liver biopsy, the gold standard method for liver fibrosis assessment, is an 
invasive procedure, with possible complications and lower compliance as compared 
to noninvasive techniques.
Ultrasound-based liver elastography was developed as a noninvasive, easy to 
perform, and well-accepted tool for liver fibrosis assessment and proved to be a very 
dynamic research field in the last years, this being demonstrated also by the large 
number of publications and guidelines published in this field [1–3].
2D shear wave elastography is one of the new developed ultrasound-based 
techniques [1], embedded in ultrasound machines, that allow the interrogation of 
the tissue by dynamic acoustic radiation force impulses induced into the tissues 
by focused ultrasonic beams and capture the propagation of resulting shear waves 
in real time. The technique has the advantage that the elasticity is displayed using 
a color-coded image superimposed on a B-mode image, and at the same time, a 
quantitative estimation of liver stiffness (LS) can be performed in a certain region 
of interest (ROI), the results being expressed in kPa or m/s.
The measurements are performed, similar to other elastography techniques, 
with the patient lying in supine position with the right arm in maximal abduction, 
in the right liver lobe, by placing the probe in between the ribs, in the seventh to 
ninth intercostal space, perpendicular on the liver surface [1]. The examiner  
should apply sufficient pressure on the probe to make good contact with the tissue, 
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decision. Liver biopsy, the gold standard method for liver fibrosis assessment, is an 
invasive procedure, with possible complications and lower compliance as compared 
to noninvasive techniques.
Ultrasound-based liver elastography was developed as a noninvasive, easy to 
perform, and well-accepted tool for liver fibrosis assessment and proved to be a very 
dynamic research field in the last years, this being demonstrated also by the large 
number of publications and guidelines published in this field [1–3].
2D shear wave elastography is one of the new developed ultrasound-based 
techniques [1], embedded in ultrasound machines, that allow the interrogation of 
the tissue by dynamic acoustic radiation force impulses induced into the tissues 
by focused ultrasonic beams and capture the propagation of resulting shear waves 
in real time. The technique has the advantage that the elasticity is displayed using 
a color-coded image superimposed on a B-mode image, and at the same time, a 
quantitative estimation of liver stiffness (LS) can be performed in a certain region 
of interest (ROI), the results being expressed in kPa or m/s.
The measurements are performed, similar to other elastography techniques, 
with the patient lying in supine position with the right arm in maximal abduction, 
in the right liver lobe, by placing the probe in between the ribs, in the seventh to 
ninth intercostal space, perpendicular on the liver surface [1]. The examiner  
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should stabilize the hand and the probe while performing the measurement,  
and should ask the patient to stop breathing and avoid deep inspiration. The ROI 
should be placed in an area free of vessels, at least 1–2 cm and at maximum of 6 cm 
under the liver capsule [1].
The technique has the advantage that can be performed also in patients with 
ascites, but an adequate B-mode ultrasound live image is necessary for reliable 
results. On the other hand, published data showed that for a high feasibility of the 
method, ultrasound experience is needed, especially in difficult cases, for example, 
obese patients or narrow intercostal spaces [1, 4, 5].
First 2D SWE technique was developed by Supersonic Imagine (France)  
(2D SWE.SSI) and embedded in Aixplorer® system (Figure 1). Other companies 
followed with similar techniques, for example, General Electric (2D SWE.GE) 
(Figure 2), 2D SWE technique with a propagation map Canon-Toshiba (Figure 3), 
Philips (ElastQ ), Samsung, etc.
2. 2D SWE.SSI
Published data showed that 2D SWE.SSI is a feasible and reproducible method 
[6]. The manufacturer recommends a minimum of three valid measurements to be 
obtained and rejects any measurement that achieves less than 90% stability index 
(SI), as a reliability criterion. Other authors [7] used standard deviation/median 
liver stiffness of ≤0.10 and measurement depth of <5.6 cm as quality parameters for 
reliable measurements. Most published data showed that reliable LS measurements 
can be obtained in 90–98.9% of cases [5–10] with a good intra- and interobserver 
reproducibility [9, 11, 12].
Figure 3. 
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The values of LS evaluated by 2D SWE.SSI in healthy volunteers varied from 
2.6 to 6.2 kPa [13–15], with higher values in male vs. female patients (6.6 ± 1.5 vs. 
5.7 ± 1.3 kPa, p = 0.01.) [14].
2.2 Confounding factors
Similar to other ultrasound-based elastographic methods, the liver stiffness 
results obtained by 2D SWE.SSI may be influenced by food intake; some authors 
suggest that the values increase significantly in the first hour after food intake and 
decrease after 60 min after meal [16, 17], while in other studies, these results were 
not reproduced [18], suggesting that maybe this method is less influenced by food 
intake. Nevertheless, while more studies are necessary to clarify this issue, the 
measurements should be performed in fasting condition to avoid any errors.
Other studies are also needed to evaluate the effect of cytolysis, cholestasis, or 
congestive heart failure on the liver stiffness values obtained through 2D SWE.
2.3  2D SWE.SSI for predicting liver fibrosis in chronic liver diseases of  
various etiologies
Several studies showed good accuracy for 2D SWE.SSI for predicting significant 
fibrosis and liver cirrhosis in chronic liver diseases of different etiologies (Table 1). 
Overall, the method has good accuracy for evaluating both significant and severe 
fibrosis, slightly better for liver cirrhosis, but with very different cutoff values 
between etiologies and between different studies.
















2014 Mixt 70 F ≥ 2 0.915 8.60 78.2 93.3 97.7 53.8
F = 4 0.878 14.00 77.3 85.4 70.8 89.2
Deffieux 
et al. [21]
2015 Mixt 120 F ≥ 2 0.890 8.90 77.0 79.0 77.0 79.0
F = 4 0.890 10.20 83.0 76.0 38.0 96.0
Sporea 
et al. [22]
2014 Mixt 383 F ≥ 2 0.859 7.8 76.8 82.6 77.9 81.5
F = 4 0.914 11.5 80.6 92.7 60.9 97.1
Sporea 
et al. [23]
2018 Mixt 82 F ≥ 2 0.853 7.1 96.8 78 73.8 97.5
F = 4 0.94 13 78.9 97.7 88.2 95.5
Bavu et al. 
[24]
2011 HCV 113 F ≥ 2 0.950 9.12 81.0 72.0
F = 4 0.970 13.30 80.0 87.0
Ferraioli 
et al. [5]
2012 HCV 121 F ≥ 2 0.920 7.10 90.0 87.5 91.3 85.7
F = 4 0.980 10.40 87.5 96.8 87.5 96.8
Tada et al. 
[25]
2013 HCV 55 F ≥ 2 0.940 8.80 88.9 91.9 84.2 94.4
Leung  
et al. [8]
2013 HBV 226 F ≥ 2 0.880 7.100 84.70 92.10 85.3 91.7
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Two comparative studies between transient elastography, point SWE (VTQ ) 
and 2D SWE.SSI, were proposed by Cassinotto et al. in chronic liver diseases [35] 
and NAFLD patients [30]. The first study enrolled 349 consecutive patients with 
chronic liver diseases who underwent liver biopsy. For each patient, LS was assessed 
by 2D SWE.SSI, pSWE (VTQ ), and transient elastography (FibroScan, M and XL 
probes). 2D SWE.SSI, transient elastography and VTQ , correlated significantly 
with histological fibrosis score (r = 0.79, p < .00001; r = 0.70, p < .00001; r = 0.64, 
p < .00001, respectively) with no significant differences between methods for the 
diagnosis of mild fibrosis and cirrhosis.
The second study [30] included 291 NAFLD patients in whom liver stiff-
ness was assessed by 2D SWE.SSI, transient elastography (M probe), and VTQ 
within 2 weeks prior to liver biopsy. The AUROC for 2D SWE.SSI, transient 
elastography, and VTQ were 0.86, 0.82, and 0.77 for diagnoses of ≥F2; 0.89, 
0.86, and 0.84 for ≥F3; and 0.88, 0.87, and 0.84 for F4, respectively. The cutoff 
values for 2D SWE.SSI and transient elastography for predicting fibrosis with a 
sensitivity ≥90% were very close: 6.3/6.2 kPa for ≥F2, 8.3/8.2 kPa for ≥F3, and 
10.5/9.5 kPa for F4.














F = 4 0.980 10.100 97.40 93.00 60.1 99.6
Zeng et al. 
[26]
2014 HBV 206 F ≥ 2 0.917 7.200 86.36 86.96 88.8 84.2
F = 4 0.945 11.700 91.89 89.70 66.7 98.0
Wu et al. 
[27]
2016 HBV 437 F ≥ 2 0.903 8.200 78.16 85.28 82.6 81.4
F = 4 0.926 11.256 91.80 84.31 48.7 98.4
Zhuang 
et al. [28]
2017 HBV 304 F ≥ 2 0.970 7.600 92.00 90.00 98.4 64.3
F = 4 0.980 10.400 94.60 94.90 95.7 93.5
Zeng et al. 
[29]
2017 HBV 257 F ≥ 2 0.882 7.100 88.89 76.38 76.2 89.0
F = 4 0.926 11.300 93.55 87.25 52.7 98.9
Cassinotto 
et al. [30]
2016 NAFLD 291 F ≥ 2 0.860 8.90 68.0 94.0
F = 4 0.880 10.00 95.0 69.0
Takeuchi 
et al. [31]
2018 NAFLD 71 F ≥ 2 0.750 11.57 52.0 44.0
F = 4 0.900 15.73 100.0 82.0
Thiele 
et al. [32]
2016 Alcohol 199 F ≥ 2 0.940 10.20 82.0 93.0 90.0 88.0
F = 4 0.950 16.40 94.0 91.0 71.0 99.0
Zeng et al. 
[33]
2017 Autoimmune 114 F ≥ 2 0.850 9.70 81.7 81.3 91.8 63.4
F = 4 0.860 16.30 87.0 80.2 52.6 96.1
Li et al. 
[34]
2018 Autoimmune 51 F ≥ 2 0.781 9.15 83.3 72.7
Table 1. 
Diagnostic performance of 2D SWE.SSI for significant fibrosis (F ≥ 2) and cirrhosis (F = 4) in different 




The values of LS evaluated by 2D SWE.SSI in healthy volunteers varied from 
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2014 Mixt 70 F ≥ 2 0.915 8.60 78.2 93.3 97.7 53.8
F = 4 0.878 14.00 77.3 85.4 70.8 89.2
Deffieux 
et al. [21]
2015 Mixt 120 F ≥ 2 0.890 8.90 77.0 79.0 77.0 79.0
F = 4 0.890 10.20 83.0 76.0 38.0 96.0
Sporea 
et al. [22]
2014 Mixt 383 F ≥ 2 0.859 7.8 76.8 82.6 77.9 81.5
F = 4 0.914 11.5 80.6 92.7 60.9 97.1
Sporea 
et al. [23]
2018 Mixt 82 F ≥ 2 0.853 7.1 96.8 78 73.8 97.5
F = 4 0.94 13 78.9 97.7 88.2 95.5
Bavu et al. 
[24]
2011 HCV 113 F ≥ 2 0.950 9.12 81.0 72.0
F = 4 0.970 13.30 80.0 87.0
Ferraioli 
et al. [5]
2012 HCV 121 F ≥ 2 0.920 7.10 90.0 87.5 91.3 85.7
F = 4 0.980 10.40 87.5 96.8 87.5 96.8
Tada et al. 
[25]
2013 HCV 55 F ≥ 2 0.940 8.80 88.9 91.9 84.2 94.4
Leung  
et al. [8]
2013 HBV 226 F ≥ 2 0.880 7.100 84.70 92.10 85.3 91.7
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Two comparative studies between transient elastography, point SWE (VTQ ) 
and 2D SWE.SSI, were proposed by Cassinotto et al. in chronic liver diseases [35] 
and NAFLD patients [30]. The first study enrolled 349 consecutive patients with 
chronic liver diseases who underwent liver biopsy. For each patient, LS was assessed 
by 2D SWE.SSI, pSWE (VTQ ), and transient elastography (FibroScan, M and XL 
probes). 2D SWE.SSI, transient elastography and VTQ , correlated significantly 
with histological fibrosis score (r = 0.79, p < .00001; r = 0.70, p < .00001; r = 0.64, 
p < .00001, respectively) with no significant differences between methods for the 
diagnosis of mild fibrosis and cirrhosis.
The second study [30] included 291 NAFLD patients in whom liver stiff-
ness was assessed by 2D SWE.SSI, transient elastography (M probe), and VTQ 
within 2 weeks prior to liver biopsy. The AUROC for 2D SWE.SSI, transient 
elastography, and VTQ were 0.86, 0.82, and 0.77 for diagnoses of ≥F2; 0.89, 
0.86, and 0.84 for ≥F3; and 0.88, 0.87, and 0.84 for F4, respectively. The cutoff 
values for 2D SWE.SSI and transient elastography for predicting fibrosis with a 
sensitivity ≥90% were very close: 6.3/6.2 kPa for ≥F2, 8.3/8.2 kPa for ≥F3, and 
10.5/9.5 kPa for F4.














F = 4 0.980 10.100 97.40 93.00 60.1 99.6
Zeng et al. 
[26]
2014 HBV 206 F ≥ 2 0.917 7.200 86.36 86.96 88.8 84.2
F = 4 0.945 11.700 91.89 89.70 66.7 98.0
Wu et al. 
[27]
2016 HBV 437 F ≥ 2 0.903 8.200 78.16 85.28 82.6 81.4
F = 4 0.926 11.256 91.80 84.31 48.7 98.4
Zhuang 
et al. [28]
2017 HBV 304 F ≥ 2 0.970 7.600 92.00 90.00 98.4 64.3
F = 4 0.980 10.400 94.60 94.90 95.7 93.5
Zeng et al. 
[29]
2017 HBV 257 F ≥ 2 0.882 7.100 88.89 76.38 76.2 89.0
F = 4 0.926 11.300 93.55 87.25 52.7 98.9
Cassinotto 
et al. [30]
2016 NAFLD 291 F ≥ 2 0.860 8.90 68.0 94.0
F = 4 0.880 10.00 95.0 69.0
Takeuchi 
et al. [31]
2018 NAFLD 71 F ≥ 2 0.750 11.57 52.0 44.0
F = 4 0.900 15.73 100.0 82.0
Thiele 
et al. [32]
2016 Alcohol 199 F ≥ 2 0.940 10.20 82.0 93.0 90.0 88.0
F = 4 0.950 16.40 94.0 91.0 71.0 99.0
Zeng et al. 
[33]
2017 Autoimmune 114 F ≥ 2 0.850 9.70 81.7 81.3 91.8 63.4
F = 4 0.860 16.30 87.0 80.2 52.6 96.1
Li et al. 
[34]
2018 Autoimmune 51 F ≥ 2 0.781 9.15 83.3 72.7
Table 1. 
Diagnostic performance of 2D SWE.SSI for significant fibrosis (F ≥ 2) and cirrhosis (F = 4) in different 
chronic liver diseases—adapted after Jeong JY et al. [19].
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In an individual patient data based on meta-analysis [36] that included 1340 
patients and compared 2D SWE.SSI with liver biopsy as reference method, 2D 
SWE.SSI showed a good to excellent performance in LS assessment in patients with 
HCV, HBV, and NAFLD, with AUROCs of 86.3, 91.6, and 85.9% for diagnosing sig-
nificant fibrosis (F ≥ 2) and 96.1, 97.1, and 95.5% for diagnosing cirrhosis (F = 4), 
respectively. The optimal cutoff for diagnosing significant fibrosis in all patients 
was 7.1 kPa, while for diagnosing liver cirrhosis was 13.5 kPa in HCV and NAFLD 
and 11.5 kPa in HBV patients.
Other three meta-analyses published that included more than 900 patients each  
[37–39] confirmed these results, with pooled sensitivities between 0.84 and 0.85, pooled 
specificities between 0.81 and 0.83 and AUROC between 0.85 and 0.87 for significant 
fibrosis and with pooled sensitivities between 0.87 and 0.89, and pooled specificities 
between 0.86 and 0.88 and AUROC between 0.93 and 0.94 for liver cirrhosis.
2.4 2D SWE.SSI for predicting liver cirrhosis complications
The method was studied also as a predictor for the presence of clinically sig-
nificant portal hypertension. Thus, while Kim et al. showed that for a cutoff value 
of 15.2 kPa, the sensitivity and specificity of 2D SWE.SSI for predicting clinically 
significant portal hypertension were 85.7 and 80%, respectively, (AUROC 0.819) 
(HVPG >10 mmHg) [40], Procopet et al. [7], by using standard deviation/median 
liver stiffness ≤0.10 and measurement depth < 5.6 cm as quality criteria, had better 
results for the optimal cutoff value of 15.4 kPa (AUROC =0.948, with sensitivity 
and specificity both higher than 90%).
Another study that included 79 patients with liver cirrhosis [41] evaluated LS 
and spleen stiffness (SS) by 2D SWE.SSI, TE, and HVPG measurements; 2D SWE.
SSI LS of more than 24.6 kPa had a sensitivity, specificity, and accuracy for clini-
cally significant portal hypertension of 81, 88, and 82%, respectively, with better 
performance than SS (AUROC of 0.87 vs. 0.64, P = 0.003).
In a larger study that enrolled 401 consecutive cirrhotic patients [42], the LS cutoff 
values for a NPV ≥90% for high-risk esophageal varices, history of ascites, Child-
Pugh B/C, variceal bleeding, and clinical decompensation were 12.8, 19, 21.4, 30.5, 
and 39.4 kPa, respectively, with AUROC of 0.77 for detection of esophageal varices.
Jeong et al. [43] looked on the role of 2D SWE in predicting the development of 
hepatocellular carcinoma, showing that patients with LS ≥10 kPa by 2D SWE had a 
fourfold higher risk of presenting hepatocellular carcinoma than those with LS <10 kPa.
More studies are needed to address these issues and conclude for the clinical 
practice.
2.5 2D SWE.SSI in pediatric population
The field of elastography, as noninvasive evaluation tool, became of interest also 
in pediatric population [44]. Thus a study that enrolled 54 consecutive children and 
adolescents with different chronic liver diseases that were examined by means of 
TE, ARFI, and 2D SWE.SSI showed a sensitivity of 2D SWE.SSI for detecting F1, 
F2, F3, and liver cirrhosis of 92.85, 83.33, 87.5, and 85.71%, respectively [45], better 
than a point SWE technique.
3. 2D SWE.GE
Another system that implemented the 2D SWE technique comes from General 
Electrics, embedded first in LOGIQ E9/LOGIQ E10 ultrasound systems.
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This new technique showed also good intra- and interobserver reproducibility. 
In a study that included 60 patients evaluated by 2D SWE.GE by three examiners 
with different levels of experience in ultrasound-based elastography and ultra-
sound, the overall agreement between examiners was excellent: 0.915 (95% confi-
dence interval [CI]: 0.870-0.946). The intra-observer reproducibility for each of 
the examiners was excellent; however, the inter-class correlation coefficients were 
higher for the examiners more experienced in elastography: 0.936 (95% CI: 0.896-
0.963) vs. 0.966 (95% CI: 0.943-0.980) vs. 0.984 (95% CI: 0. 973-0.991) [46].
The method showed also very good feasibility and reproducibility also in pedi-
atric population. In a study that enrolled 243 healthy participants aged 4–17 years, 
valid measurements were obtained in 242 of 243 (99.6%) subjects for 2D SWE.
GE, with an intraclass correlation coefficients between observers of 0.84 [47].
The mean LS measurement by 2D SWE.GE in healthy subjects was 5.1 ± 1.3 kPa, 
significantly higher than the LS measurement assessed by transient elastography 
(4.3 ± 0.9 kPa, p < 0.0001) and significantly higher for male vs. female, 5.9 ± 1.2 vs. 
4.7 ± 1.2 kPa (p = 0.0005) [48].
There are few data available in the literature regarding the performance of this 
method in evaluating liver fibrosis in chronic liver diseases, but the results are 
promising.
Thus in a study that enrolled 331 consecutive subjects with or without chronic 
hepatopathies [49] in whom LS was evaluated in the same session by means of 
two elastographic techniques, transient elastography and 2D SWE.GE, reliable LS 
measurements were obtained in 95.8% subjects by 2D SWE.GE and 94.2% by TE 
(p = 0.44), with a strong correlation between the LS values obtained by the two 
methods: r = 0.83, p < 0.0001. The best cutoff value for F ≥ 2, F ≥ 3, and for F = 4 
were 6.7, 8.2, and 9.3 kPa.
Similar results were obtained in an Italian study [50] that enrolled 54 healthy 
subjects and 174 patients with chronic liver diseases and compared 2D SWE.GE 
with liver biopsy as reference method and obtained reliable LS measurements 
in all subjects, with a strong correlation the LS measurements and liver fibrosis 
(r = 0.628). The AUROC values were better also for severe fibrosis: for F ≥ 2: 0.857, 
for F ≥ 3: 0.946, and for F = 4: 0.935.
4. 2D SWE with propagation map
2D SWE with propagation map (Figure 3), technique developed by Canon-
Toshiba, is a more recent technology that appeared on the market but also with 
good perspectives in the field of liver elastography. Thus, in a study [51] on 
115 consecutive patients that underwent 2D SWE by two different operators and 
transient elastography by sonographers during the same day, the correlation 
coefficient of the intraclass correlation test between an experienced radiologist 
and a third-year radiology resident was 0.878, and there was a moderate cor-
relation between 2D SWE and transient elastography (r = 0.511) in the diag-
nosis of liver fibrosis. The best cutoff values for predicting significant fibrosis 
and liver cirrhosis by 2D SWE were > 1.78 (AUROC = 0.777) and > 2.24 m/s 
(AUROC = 0.935), respectively.
5. Conclusion
Even if 2D SWE techniques are quite newer on the market, they proved to 
be reliable methods for liver fibrosis evaluation, and several advantages can be 
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highlighted: they are integrated into standard ultrasound systems, are real-time 
elastographic methods, and are feasible also in patients with ascites and with large 
and adjustable size of the ROI that will be evaluated. These techniques have better 
accuracy for predicting liver cirrhosis, with accuracy more than 95%, and they also 
have good accuracy (more than 85%) for predicting significant fibrosis (F2).
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Chapter 4
Quantification of Liver Steatosis
Ioan Sporea, Roxana Șirli and Alina Popescu
Abstract
The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) is increasing in themodernworld. Fatty infiltration of the liver
can be assessed by standard ultrasound, by controlled attenuation parameter (CAP)
using the FibroScan device or, more recently, by ultrasound systems that evaluate the
attenuation in the liver. Standard ultrasound (US) for steatosis evaluation was used for
a long time as a semi-quantitativemethod for steatosis assessment in the liver. A “bright
liver”with “posterior attenuation” is the typical US sign of liver steatosis. Considering
the attenuation severity, steatosis is subjectively graded as mild, moderate or severe.
Using the kidney/liver ratio, a more accurate evaluation can bemade. Controlled
attenuation parameter (CAP) was developed by EchoSens, France, and implemented
into the FibroScan device. CAPmanages an objective assessment of steatosis severity
with rather good accuracy. More recently, ultrasound companies such as Hitachi,
General Electric and Canon, implemented in their system algorithms which allow an
objective assessment of liver steatosis, using the attenuation of the ultrasound beams.
Keywords: non-alcoholic fatty liver disease, non-alcoholic steatohepatitis,
liver steatosis, standard ultrasound, controlled attenuation parameter
1. Introduction
In the last years, the field of hepatology changed regarding the etiology of
predominant liver diseases. New treatments with direct acting agents (DAA) for
HCV chronic infection, or modern analogues for HBV infection, decreased the
importance of the very precise evaluation of liver fibrosis severity in these two
diseases. Furthermore, the increasing number of patients with obesity, type 2 dia-
betes or hypertriglyceridemia in the developed world, increased the prevalence of
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH), changing the focus of hepatologists on these diseases.
Speaking about the risk factors for NAFLD, overweight and obesity play a
central role. Worldwide estimations show that approximately 1.9 billion people are
overweight and approximately 650 million are obese [1]. In such patients, fatty
infiltration of the liver is quite common, going from simple steatosis to NASH. On
the other hand, in adult population (and especially in aging population), the prev-
alence of type 2 diabetes mellitus can be as high as 1/11 individuals [2]. Thus, in this
huge cohort of patients, it became essential to make a confident and non-invasive
evaluation of liver disease severity. This assessment must reveal the severity of
steatosis, the severity of fibrosis and inflammation.
In this chapter, we will cover only the quantification of liver steatosis using
ultrasound methods. They are quite simple, inexpensive, and can be performed as
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Abstract
The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) is increasing in themodernworld. Fatty infiltration of the liver
can be assessed by standard ultrasound, by controlled attenuation parameter (CAP)
using the FibroScan device or, more recently, by ultrasound systems that evaluate the
attenuation in the liver. Standard ultrasound (US) for steatosis evaluation was used for
a long time as a semi-quantitativemethod for steatosis assessment in the liver. A “bright
liver”with “posterior attenuation” is the typical US sign of liver steatosis. Considering
the attenuation severity, steatosis is subjectively graded as mild, moderate or severe.
Using the kidney/liver ratio, a more accurate evaluation can bemade. Controlled
attenuation parameter (CAP) was developed by EchoSens, France, and implemented
into the FibroScan device. CAPmanages an objective assessment of steatosis severity
with rather good accuracy. More recently, ultrasound companies such as Hitachi,
General Electric and Canon, implemented in their system algorithms which allow an
objective assessment of liver steatosis, using the attenuation of the ultrasound beams.
Keywords: non-alcoholic fatty liver disease, non-alcoholic steatohepatitis,
liver steatosis, standard ultrasound, controlled attenuation parameter
1. Introduction
In the last years, the field of hepatology changed regarding the etiology of
predominant liver diseases. New treatments with direct acting agents (DAA) for
HCV chronic infection, or modern analogues for HBV infection, decreased the
importance of the very precise evaluation of liver fibrosis severity in these two
diseases. Furthermore, the increasing number of patients with obesity, type 2 dia-
betes or hypertriglyceridemia in the developed world, increased the prevalence of
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH), changing the focus of hepatologists on these diseases.
Speaking about the risk factors for NAFLD, overweight and obesity play a
central role. Worldwide estimations show that approximately 1.9 billion people are
overweight and approximately 650 million are obese [1]. In such patients, fatty
infiltration of the liver is quite common, going from simple steatosis to NASH. On
the other hand, in adult population (and especially in aging population), the prev-
alence of type 2 diabetes mellitus can be as high as 1/11 individuals [2]. Thus, in this
huge cohort of patients, it became essential to make a confident and non-invasive
evaluation of liver disease severity. This assessment must reveal the severity of
steatosis, the severity of fibrosis and inflammation.
In this chapter, we will cover only the quantification of liver steatosis using
ultrasound methods. They are quite simple, inexpensive, and can be performed as
point of care methods, by clinicians or by radiologists.
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Fatty infiltration of the liver can be assessed by standard ultrasound, by con-
trolled attenuation parameter (CAP) using the FibroScan device (EchoSens, Paris),
or, more recently, by ultrasound systems that evaluate the attenuation in the liver.
2. Standard ultrasound (US) for steatosis evaluation
Standard ultrasound (US) for steatosis evaluation was used for a long time as a
semi-quantitative method for steatosis assessment in the liver. A “bright liver” with
“posterior attenuation” is the typical US sign of liver steatosis (Figure 1). Consid-
ering the attenuation severity, steatosis is subjectively graded as mild, moderate or
severe. Using the kidney/liver ratio, a more accurate evaluation can be made
(knowing that in normal conditions, the liver and right kidney have similar ultra-
sound appearance) (Figure 2).
Some studies were published regarding the value of transabdominal ultrasound
for the quantification of steatosis, considering liver biopsy as the “gold standard”. In
a study performed by Palmentieri et al. [3] the ultrasound “bright liver” echo
pattern was compared to liver biopsy in a cohort of 235 patients. “Bright liver” was
found in 67% of patients with steatosis of any degree and in 89% of patients with
histologic steatosis ≥30%. The sensitivity (Se), specificity (Sp), positive predictive
value (PPV) and negative predictive value (NPV) of “bright liver” echo pattern and







respectively. However, when only severe steatosis was taken into consideration
(a subgroup of patients who had steatosis of ≥30%) the Se, Sp, PPV and NPV were
91, 93, 89 and 94%, respectively.
In another study performed byMathiesen et al. [4] liver ultrasound was compared
with hepatic histology for steatosis assessment in a series of 165 patients. The steatosis
was graded as none, mild, moderate or severe. In patients with increased
echogenicity, 86.7% had liver steatosis at least moderate. This study revealed that for
the detection of steatosis, standard US had 90% Se, 82% Sp, 87% PPV and 87% NPV.
Some studies tried to use Computer Assisted Diagnosis (CAD) to increase the
accuracy of US for the detection and evaluation of steatosis severity [5]. In a study
performed in 120 subjects, CAD was able to make a correct classification of steatosis
severity with 82.2% accuracy [6].
Similar results were obtained by the group of Xia [7] in a study on 127 subjects. In
this study, CAD was used to compare liver attenuation and liver/kidney index by US
to magnetic resonance spectroscopy considered as the “gold standard”. A very good
correlation of US findings with MRI steatosis quantification (r = 0.884) was observed.
Ultrasound hepatic/renal ratio in connection with hepatic attenuation can
increase the accuracy of liver fat quantification [8]. In a study performed by Zhang,
in a cohort of 170 subjects, where ultrasound was compared with magnetic reso-
nance spectroscopy, an equation of quantitative model for fatty liver prediction was
assessed, using ultrasound hepatic/renal ratio and hepatic echo-intensity attenua-
tion rate. In this quantitative ultrasound model, sensitivity and specificity for fatty
liver were 94.7 and 100%.
In review paper by Castera et al. [9] it was concluded that liver US has 60–94%
sensitivity and 84–95% specificity for detecting hepatic steatosis and that the sensi-
tivity increases with the severity of fatty infiltration.
Probably the most relevant study concerning the performance of US in diagnos-
ing liver steatosis is a large meta-analysis that included 49 studies and 4720 subjects
[10]. In this study, the sensitivity of US for moderate and severe steatosis was
84.8%, with 93.6% specificity as compared to liver biopsy, with the area under the
summary receiving operating characteristics curve of 0.93. Considering this study
as reference, we can say that standard transabdominal US can be used in clinical
practice to perform a semi-quantitative evaluation of steatosis, with quite good
accuracy. However, if we intend to follow-up these kind of patients, maybe a more
objective method is needed, with results expressed as numeric values. On the other
hand, the operator’s experience in ultrasound is important for steatosis quantifica-
tion, and, maybe, the quality of the ultrasound machine should be taken into
consideration.
3. Controlled attenuation parameter (CAP)
Controlled attenuation parameter (CAP) was developed by EchoSens, France,
and implemented into the FibroScan device. Initially the CAP algorithm was avail-
able only on the M probe (for non-obese patients), but more recently it is also
available on the XL probe (for obese) (Figure 3).
Many studies were published showing the value of CAP for liver steatosis
assessment, most of them using liver biopsy as the reference method. CAP measures
the total ultrasound attenuation, using vibration controlled Transient Elastography
(TE). The measurement results are expressed in dB/m, with values ranging between
100 and 400 dB/m. The first evaluation of CAP was performed in a cohort of 115
patients with liver histology [11]. CAP was very well correlated with steatosis
(Spearman ρ = 0.81, p < 0.00001) and the AUROCs for the detection of >10
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and >33% steatosis were 91 and 95% respectively. CAP was evaluated also with the
XL probe by the same author in a cohort of 59 patients [12]. In this study, the
AUROCs for the detection of >2 and >16% liver fat were 83/84% and 92/91% for the
M/XL probes, respectively.
Another study performed on 440 patients who had liver biopsy as referencemethod
showed that the AUROCs of CAP for the diagnosis of steatosis >10, >33 and >66%were
79, 84, and 84%, respectively [13]. Onmultivariate analysis, factors significantly asso-
ciatedwith elevated CAPwere BMI 25–30 kg/m2, BMI > 30 kg/m2,metabolic syndrome,
alcohol intake more than 14 drinks/week and liver stiffness >6 kPa.
In a study on 201 patients who also had undergone liver biopsy, histologic
steatosis was the only factor that independently influenced CAP values [14]. For
moderate and severe steatosis, CAP cut-off values of 285 and 294 dB/m had 82.0
and 81.5% accuracy, respectively. However, for mild steatosis, the accuracy was
only 76.1% at a cut-off 260 dB/m. These last two studies showed maybe a more
realistic value of CAP for liver steatosis assessment, the accuracy being around
80–85% (less for mild steatosis).
In another study in a cohort of 101 NAFLD patients with liver biopsy, CAP was
associated in a multivariate analysis with steatosis grade (odds ratio [OR] = 29.16,
p < 0.001), serum triglycerides (OR = 13.59, p = 0.037) and body mass index (BMI;
OR = 4.34, p < 0.001) [15]. In this study, the optimal CAP cut-offs for estimation of
steatosis grades S1 (5–33% of hepatocytes), S2 (>33–66% of hepatocytes), and S3
(>66% of the hepatocytes) were 263dB/m, 281dB/m, and 283dB/m, respectively,
and the AUROC’s for S1, S2, and S3 were 0.97, 0.86, and 0.75, respectively.
In a very recent multicenter study [16], where FibroScan was compared to liver
biopsy in patients with NAFLD, from 450 consecutive patients, 404 patients had
valid measurements using M and XL probes. AUROC of CAP for steatosis evalua-
tion was 0.87 for S ≥ S1, 0.77 for S ≥ S2, and 0.70 for S3. In the same study, the cut-
off values for S ≥ S1, S ≥ S2, and S = S3 were 302 dB/m, 331 dB/m, and 337 dB/m,
Figure 3.




respectively. Two important information came from this study: the AUROCs of
CAP are decreasing with the severity of steatosis, and the cut-off values of CAP are
higher than in other published studies, for all degrees of steatosis.
In different studies, different cut-off values were proposed for different degrees
of steatosis, the first being proposed by the manufacturer: 230 dB/m for mild
steatosis, 275 dB/m for moderate steatosis and 300 dB/m for severe steatosis. Other
studies obtained different values, but they were correlated with the cohort of
patients, with the severity of steatosis, the presence of diabetes and others.
The first meta-analysis evaluating the accuracy of CAP for steatosis quantifica-
tion showed that the optimal CAP cut-off values for mild, moderate and severe
steatosis were 232.5, 255 and 290 dB/m respectively [17]. In this study, the summa-
rized sensitivity and specificity values were 78 and 79% for mild, 85 and 79% for
moderate, and 83 and 79% for severe steatosis. However, this meta-analysis calcu-
lated a rather low specificity for CAP, being approx. 80%.
Another meta-analysis, comparing CAP with liver biopsy, was performed by
Karlas in a cohort of 2735 patients: 37% with chronic hepatitis B, 36% with chronic
hepatitis C, 20% with NAFLD/NASH, 7% with other chronic hepatitis. Histologic
steatosis distribution was as follows: 51/27/16/6% for S0/S1/S2/S3. In this meta-
analysis, the calculated optimal cut-offs were 248 dB/m for S0 vs. S1–S3, 268 dB/m
for S0–S1 vs. S2–S3 and 280 dB/m for S0–S2 vs. S3, with AUROCs of 0.82, 0.86 and
0.88 respectively [18].
Other studies compared CAP to MRI quantification of steatosis. Proton density
fat fraction (PDFF) by MRI was lately proposed as a sensitive modality of liver fat
evaluation. In a cohort of 104 consecutive patients, all with liver biopsy, MRI-PDFF
was compared with CAP for diagnosis of steatosis (grades 1–3 vs. 0) [19]. In this
study, MRI-PDFF detected any steatosis with an AUROC of 0.99, significantly
higher than that of CAP (AUROC 0.85). In the same time, MRI-PDFF identified S2
or S3 with AUROC values of 0.90 and 0.92, while CAP identified S2 or S3 with
AUROC values of 0.70 and 0.73.
In another comparative study between CAP and PDFF, performed in Japan in a
cohort of 142 patients with NAFLD and liver biopsy, CAP measurements identified
patients with S ≥ 2 with an AUROC of 0.73 and PDFF methods identified them with
an AUROC of 0.90 [20].
A comparative study between CAP and PDFF was performed in 119 adults with
liver biopsy, evaluating the performance to diagnose 5 and 10% fatty infiltration in
PDFF [21]. In this study, using CAP with M or XL probes, AUROC of CAP for the
detection of MRI-PDFF ≥ 5% was 0.80 (at the cut-point of 288 dB/m) and of MRI-
PDFF ≥ 10% was 0.87 (at the cut-point of 306 dB/m). When the authors considered
the IQR (interquartile range) as a qualitative parameter, it was shown that CAP
measurements with an IQR (inter quartile range) below 30 dB/m had a more robust
AUROC as compared to those with an IQR higher than this (0.92 versus 0.70,
p = 0.0117).
In the study performed by Wong et al. [22] in a prospective multicenter study,
including 754 patients, they found that the IQR of CAP was associated with the
accuracy of this method and that the AUROC of CAP was 0.90 in patients with IQR
<40 (and 0.77 if ≥40 dB/m, respectively, p = 0.004). Finally they proposed like a
qualitative criteria for CAP to use IQR < 40 dB/m.
These comparative studies clearly showed a better performance of MRI-PDFF
vs. CAP to diagnose steatosis, but we must have in mind that CAP can be a point of
care method and that the price of such investigation is much lower than the price of
MRI-PDFF. Most published papers concerning the accuracy of CAP for fat quanti-
fication calculated accuracies ranging from 0.75 to 0.85, increasing with the severity
of steatosis.
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4. Ultrasound systems evaluating the attenuation
For a long time the posterior attenuation of ultrasound beams in standard liver
evaluation was used as a subjective parameter for steatosis assessment. More
recently, ultrasound companies such as Hitachi, General Electric and Canon,
implemented in their system algorithms which allows an objective assessment of
liver steatosis, using the attenuation of the ultrasound beams.
4.1 Attenuation coefficient (ATT)
Attenuation coefficient (ATT) from Hitachi was evaluated in a prospective multi-
center cohort of 351 patients [23], where liver biopsy and ATT measurement were
performed in the same day. In this study, the median values of ATT for steatosis
grades S0, S1, S2, and S3 were 0.55, 0.63, 0.69 and 0.85 dB/cm/MHz, respectively,
increasing with the severity of steatosis (p < 0.001). In the same time, the AUROCs
for S ≥ 1, S ≥ 2, and S ≥ 3 were 0.79, 0.87, and 0.96, respectively.
The Combi-Elasto algorithm from Hitachi quantifies steatosis (ATT), but in the
same time the shear-waves speed is used for estimation of the stiffness or elasticity
(E) of the liver expressed in kPa and also to produce some indexes, such as Liver




ATT coefficient with ten measurement values.
54
Ultrasound Elastography
4.2 Ultrasound-guided attenuation parameter (UGAP)
Ultrasound-guided attenuation parameter (UGAP) from General Electric was
recently proposed for steatosis quantification. In a paper published by a Japanese
group, UGAP was compared with liver biopsy and CAP in a cohort of 163 patients
[24]. In this study, the median value of UGAP in patients with S0, S1, S2 and S3
grade steatosis were 0.485, 0.560, 0.660 and 0.720 respectively (increasing with the
severity of steatosis), and in the same time, the AUROCs of UGAP for identifying
>S1, >S2 and S3 were 0.900, 0.953 and 0.959, respectively, significantly better than
the results obtained with CAP.
4.3 Attenuation image (ATI)
Attenuation image (ATI) from Canon was introduced for liver steatosis quantifica-
tion. This method permit a simple quantification of liver steatosis, by using a region
of interest applied on the standard ultrasound image, where the attenuation is evalu-
ated. Values of this parameter are expressed in dB/cm/MHz and it also has a param-
eter of the quality of acquisition, that must be higher than R2 > 0.90 (Figure 6a).
Figure 6.
(a) Attenuation image from Canon and (b) evaluation of dispersion with Canon system.
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eter of the quality of acquisition, that must be higher than R2 > 0.90 (Figure 6a).
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In a preliminary study in which ATI was compared with CAP (FibroScan,
EchoSens), in a cohort of 113 consecutive subjects [25], a strong positive correlation
was found between the attenuation coefficients of steatosis obtained by the
2 methods, r = 0.81, p < 0.001. Using CAP as reference, the AUROCs of ATI for
≥S1, ≥S2 and ≥S3 were excellent (0.89, 0.88, respectively 0.95, p < 0.001) and the
proposed cut-off values for were: S1 = 0.64 dB/cm/mHz, S2 = 0.79 dB/cm/mHz and
S3 = 0.86 dB/cm/mHz.
The Canon system can also evaluate dispersion, considering the viscoelastic
properties of liver tissue (Figure 6b).
4.4 Attenuation parameter
Attenuation parameter from Aixplorer evaluates attenuation of ultrasound, con-
comitantly with the display of speed of sound (SoS), used for fatty infiltration
estimation. Similar to other modern ultrasound machines, the new system is able to
quantify the tissue viscosity, expressed in Pa s (Figure 7a and b).
Figure 7
(a) Attenuation quantification and (b) viscosity imaging.
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Many of the new ultrasound systems are able to estimate with the same machine
steatosis severity, liver stiffness and, more recently, inflammation. This is the next
step toward a multiparametric approach of liver diseases, using ultrasound machines.
In conclusion, quantification of liver steatosis using ultrasound is a good method
for daily practice. The low cost, easy feasibility and accessibility make these
methods useful for the large number of potential patients with fatty liver.
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Elastography in Chronic Liver 
Diseases
Samuel N. Gitau and Issa K. Menge
Abstract
Elastography is useful for diagnosing and grading hepatic fibrosis in patients 
with chronic liver diseases (CLD). In addition, it may be used as a noninvasive 
tool for surveillance and prognostication of patients with complications related to 
CLD. Elastography uses real-time ultrasound to assess for tissue elasticity and is a 
fast, simple, reproducible, and reliable method for noninvasive liver fibrosis evalua-
tion. Management of chronic liver disease is dependent on the grade of liver fibrosis 
to ascertain the urgency and choice of treatment and advice on further screening 
for cirrhosis and hepatocellular carcinoma. This chapter will highlight the role of 
elastography in the evaluation of chronic liver disease including hepatitis B and C 
and HIV-related liver disease and nonalcoholic fatty liver disease (NAFLD).
Keywords: diffuse liver disease, hepatitis B, hepatitis C,  
nonalcoholic fatty liver disease
1. Introduction
Chronic liver diseases are a major cause of morbidity and mortality worldwide 
with around 800,000 deaths per year attributable to liver cirrhosis [1]. There are a 
myriad of causes of chronic liver disease including viral infections, alcohol abuse, 
nonalcoholic fatty liver disease, biliary disease, autoimmune disease, genetic causes, 
and metabolic disorders [2]. Liver fibrosis results from chronic injury induced by a 
variety of causes with infection being the leading one. Most patients with chronic 
liver disease are often asymptomatic with symptoms only setting in when compli-
cations of the disease such as portal hypertension, cirrhosis, and hepatocellular 
carcinoma develop.
Management of chronic liver disease is dependent on the grade of liver fibrosis 
to ascertain the urgency and choice of treatment and advice on further screening 
for cirrhosis and hepatocellular carcinoma. Though liver biopsy has traditionally 
been the gold standard for diagnosis and staging of liver fibrosis, the procedure 
has paramount shortfalls as a medical screening test. It lacks the safety profile, 
accuracy, and accessibility of a standard medical screening test. It is an invasive 
technique with rates of morbidity of 3 in 100 and mortality of 3 in 10,000 reported 
[3]. In addition, sampling errors may arise because only 1/50,000 of the liver is 
sampled during the procedure. Inter- and intra-observer variability of between 10 
and 20% in interpretation and staging of hepatic fibrosis have been reported which 
may lead to under-staging or over-staging of fibrosis [4]. A study by Maharaj et al. 
[5], where three percutaneous liver biopsies were performed in the same patients 
using the same entry points, found a concordance rate for cirrhosis in all three 
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biopsy specimens of only 50%. Taking into consideration all these shortfalls, the 
“gold standard” for the true liver disease status would be the histological analysis 
of nearly the entire liver which is not feasible. Effectively, liver biopsy is an “imper-
fect gold standard,” and the definitive diagnosis of liver fibrosis in routine clinical 
practice is practically impossible [6].
Elastography uses real-time ultrasound to assess for tissue elasticity and is a fast, 
simple, reproducible, and reliable method for noninvasive liver fibrosis evaluation.
Elastography as a tool for evaluation of disease relates to one of the first physi-
cal exam skills every physician learns, i.e., palpation. This is based on the premise 
that diseased organs feel harder than the normal surrounding tissue. Using elas-
tography, tissue stiffness (or hardness) can be measured and converted into an 
image. Young’s modulus is used to quantify the elasticity or stiffness of a tissue and 
is calculated from the ratio between a uniform compression (stress, s) applied to 
the tissue and the resulting induced tissue deformation (strain, e) as shown in the 
equation below [7].
  Young"s modulus  (elasticity) = Stress / Strain or E = s / e (1)
Using a reference amount of force applied to the tissue, its elasticity can be 
determined. Elasticity is measured in pressure units, pascal, or kilopascals (kPa).
The stiffness (elasticity) of normal, healthy liver is very low (of the order of 
2 kPa, comparable to a soft gelatin gel) [8]. In response to inflammation, liver cells 
die and are replaced by scar tissue. As fibrosis progresses, the scar tissue becomes 
progressively rigid, and as a result the stiffness of the tissue increases. The stiffness 
of fibrotic liver is a reflection of the severity of the disease. Using elastography, an 
image of the shear stiffness of a tissue can be created [9]. It can therefore be used to 
monitor the extent of liver damage. Elastography is a painless and rapid procedure 
and does not require any preparation.
There are two main ways of performing elastography. The maiden method which 
has been widely used is transient elastography (TE) popularly known as FibroScan. 
The other relatively new methods are real-time elastography (RTE) using shear 
waves and acoustic radiation force impulse imaging (ARFI) [10–12].
Transient elastography uses both ultrasound (around 5 MHz) and low-fre-
quency (50 Hz) mechanically generated shear waves to determine tissue elasticity. 
The propagation velocity of the shear waves is directly related to elasticity with 
the speed greater in stiff (fibrosed) tissue than in a softer tissue. The shear wave is 
generated by an external low-frequency vibrator which strikes the patient’s skin and 
produces the shear wave whose propagation in the tissue of interest is measured and 
provided as an average elasticity [10]. In evaluation of liver elasticity, the measure-
ments are acquired from the right lobe of the liver through the intercostal space. 
Ten liver stiffness measurements are obtained and the median considered as the 
representative value.
The limitations of this technique include the low volume of parenchyma 
explored, absence of real-time ultrasound guidance, measurement difficulties in 
cases of obesity and presence of ascites, and lack of specificity for the distinction of 
significant fibrosis level. The learning curve in correctly performing the examina-
tion without imaging guidance also serves to limit its reproducibility [10]. These 
drawbacks have led to the quest for a better elastographic method the birth of which 
is real-time elastography (RTE).
RTE does not require an external vibrator to generate the shear wave as is the 
case with transient elastography. The probe of the ultrasound machine produces a 
localized radiation force deep in the tissue of interest. This radiation force induces 
a shear wave, which then propagates through the tissue from a focal point. Several 
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focal points are then generated in a line perpendicular to the surface of the patient’s 
skin (Figure 1).
The transmission of the shear wave is then detected by the rapid acquisition 
of ultrasound which takes only a few milliseconds, thus the patient or operator 
movement does not impact the result. The speed at which the shear wave propagates 
is then estimated from the measurement of the displacement induced by the shear 
wave and a real-time two-dimensional color map displayed. This color map is 
color-coded for the different shear wave speeds representing the degrees of stiffness 
from soft to hard. This color map is accompanied by an anatomic reference gray-
scale (or B-mode) image; hence the area of sampling can be identified on the image 
(Figure 2).
Elastographic reference ranges have been developed for distinguishing mild 
fibrosis from significant fibrosis and cirrhosis following using histology (METAVIR 
score) as the reference standard [13–15] (see details in Table 1).
2. Elastography in hepatitis B and C
An estimated 240 and 160 million people in the world have chronic hepatitis B 
and C virus infections, respectively, according to the Centers for Disease Control 
and Prevention [16].
Elastography has been validated as a surrogate marker of liver fibrosis in a great 
number of studies, mainly in patients with chronic hepatitis B and C infections, 
and has enabled decision on when to start antiviral treatment without the need of 
performing liver biopsy [17].
The recommended velocity cutoffs for degree of liver fibrosis in patients with 
hepatitis C using the different elastography techniques are summarized in Table 1 
[18]. These cutoffs have been adapted for all cases of chronic liver disease.
In chronic hepatitis C, elastography has been shown to perform better for 
diagnosis of significant fibrosis (METAVIR score F ≥ 2) and cirrhosis (METAVIR 
score F4). The area under the ROC curve (AUROC) for the assessment of significant 
fibrosis ranged from 0.77 to 0.90 (F ≥ 2) and 0.90 to 0.97 for assessment of cir-
rhosis [17, 19–21]. Similar findings have been observed in patients with chronic viral 
Figure 1. 
Image illustrating propagation of shear waves from a focal point.
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and has enabled decision on when to start antiviral treatment without the need of 
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The recommended velocity cutoffs for degree of liver fibrosis in patients with 
hepatitis C using the different elastography techniques are summarized in Table 1 
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In chronic hepatitis C, elastography has been shown to perform better for 
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Figure 1. 




A 39-year-old male with the human immunodeficiency virus and hepatitis B virus coinfection. (a) Grayscale 
ultrasound image of the liver shows a shear wave elastography acquisition box (arrow) with a high 
elastography score of 7.4 kPa. (b) a table showing 10 liver stiffness measurements readings for the same patient 
with a high median elastography score of 6.35 kPa (encircled). Source: [25].
Figure 2. 
Gray-scale image showing acquisition of an elastography reading using RTE.
Table 1. 
Recommended velocity cutoffs for degree of liver fibrosis in patients with hepatitis C using the different 
elastography techniques. Source: [18].
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hepatitis B where AUROC values ranged from 0.81 to 0.95 for significant fibrosis 
and from 0.80 to 0.98 for patients with cirrhosis [22, 23]. This shows that elastog-
raphy forms an important screening tool for identifying patients with significant 
fibrosis that would warrant treatment.
There has been an increase in the proportion of liver-related deaths due to HCC 
in patients with HIV (from 15% in 2000 to 25% in 2005) with underlying HIV-HCV 
coinfection in the majority of the deaths [24]. In a study on liver fibrosis in patients 
with HIV-HBV coinfection using shear wave elastography, HBV coinfection was 
associated with 4.5 times increase in the prevalence of significant fibrosis which 
impacts progress of liver disease with its potential associated morbidity and mortal-
ity in patients with HIV [25]. Monitoring of degree of fibrosis in these patients is 
therefore very important, and elastography provides a noninvasive means of doing 
this (Figure 3).
The World Health Organization recommends the use of elastography (where 
available) for screening for liver fibrosis in patients with chronic hepatitis B 
 infection [26].
3. Nonalcoholic fatty liver disease
Due to the increasing rates of sedentary lifestyle and obesity, nonalcoholic fatty 
liver disease (NAFLD) is now the most common cause of abnormal liver function 
tests (LFTs) in the Western world [27]. NAFLD is defined as the presence of more 
than 5% of steatotic hepatocytes in patients who do not consume excessive alcohol 
(less than 30 g/day for men and less than 20 g/day for women) [28, 29]. It is a spec-
trum of disease starting from simple steatosis progressing to nonalcoholic steato-
hepatitis (NASH), through advanced fibrosis and cirrhosis. Up to 80% of patients 
with central obesity and type 2 diabetes have evidence of NAFLD on imaging [28].
In most patients, NAFLD coexists with other liver pathologies including hepa-
titis C, hemochromatosis, and alcoholic liver disease. The presence of NAFLD on 
a background of these diseases causes more rapid disease progression. Treatment 
with steatogenic drugs including steroids, tamoxifen, and amiodarone can also 
cause fatty liver infiltration [30].
Most patients with NAFLD have simple steatosis, which has good clinical out-
come and no overall increase in mortality. However, up to a third of these patients 
have NASH which is the progressive form of NAFLD. Up to 40% of patients with 
NASH develop progressive liver fibrosis with 20–30% culminating in cirrhosis. 
Patients with cirrhosis secondary to NASH are at an increased risk of developing 
hepatocellular carcinoma (2.6% per year) [31–36].
NAFLD can be diagnosed by the demonstration of hepatic steatosis on imaging 
or histology where other etiologies of liver disease or steatosis have been excluded. 
Although most clinicians rely on deranged liver function tests to identify patients 
with NAFLD, this can be inaccurate as majority of the patients will remain within 
normal-range ALT levels. Furthermore, even for those patients identified to have 
elevated ALT, the ALT typically falls (and AST may rise) as fibrosis progresses to 
cirrhosis. Importantly ALT values do not demonstrate positive correlation with 
histological findings. Therefore, isolated measurement of ALT is of little value in 
both the diagnosis of NAFLD and determination of its severity [37–39].
When fatty liver disease is suspected clinically, this should be confirmed with 
imaging. Ultrasound is usually the first-line investigation for patients suspected to 
have hepatic steatosis. It provides a qualitative assessment of fatty infiltration of the 
liver where gray-scale findings are used. The echogenicity of the liver parenchyma is 




A 39-year-old male with the human immunodeficiency virus and hepatitis B virus coinfection. (a) Grayscale 
ultrasound image of the liver shows a shear wave elastography acquisition box (arrow) with a high 
elastography score of 7.4 kPa. (b) a table showing 10 liver stiffness measurements readings for the same patient 
with a high median elastography score of 6.35 kPa (encircled). Source: [25].
Figure 2. 
Gray-scale image showing acquisition of an elastography reading using RTE.
Table 1. 
Recommended velocity cutoffs for degree of liver fibrosis in patients with hepatitis C using the different 
elastography techniques. Source: [18].
65
Elastography in Chronic Liver Diseases
DOI: http://dx.doi.org/10.5772/intechopen.88228
hepatitis B where AUROC values ranged from 0.81 to 0.95 for significant fibrosis 
and from 0.80 to 0.98 for patients with cirrhosis [22, 23]. This shows that elastog-
raphy forms an important screening tool for identifying patients with significant 
fibrosis that would warrant treatment.
There has been an increase in the proportion of liver-related deaths due to HCC 
in patients with HIV (from 15% in 2000 to 25% in 2005) with underlying HIV-HCV 
coinfection in the majority of the deaths [24]. In a study on liver fibrosis in patients 
with HIV-HBV coinfection using shear wave elastography, HBV coinfection was 
associated with 4.5 times increase in the prevalence of significant fibrosis which 
impacts progress of liver disease with its potential associated morbidity and mortal-
ity in patients with HIV [25]. Monitoring of degree of fibrosis in these patients is 
therefore very important, and elastography provides a noninvasive means of doing 
this (Figure 3).
The World Health Organization recommends the use of elastography (where 
available) for screening for liver fibrosis in patients with chronic hepatitis B 
 infection [26].
3. Nonalcoholic fatty liver disease
Due to the increasing rates of sedentary lifestyle and obesity, nonalcoholic fatty 
liver disease (NAFLD) is now the most common cause of abnormal liver function 
tests (LFTs) in the Western world [27]. NAFLD is defined as the presence of more 
than 5% of steatotic hepatocytes in patients who do not consume excessive alcohol 
(less than 30 g/day for men and less than 20 g/day for women) [28, 29]. It is a spec-
trum of disease starting from simple steatosis progressing to nonalcoholic steato-
hepatitis (NASH), through advanced fibrosis and cirrhosis. Up to 80% of patients 
with central obesity and type 2 diabetes have evidence of NAFLD on imaging [28].
In most patients, NAFLD coexists with other liver pathologies including hepa-
titis C, hemochromatosis, and alcoholic liver disease. The presence of NAFLD on 
a background of these diseases causes more rapid disease progression. Treatment 
with steatogenic drugs including steroids, tamoxifen, and amiodarone can also 
cause fatty liver infiltration [30].
Most patients with NAFLD have simple steatosis, which has good clinical out-
come and no overall increase in mortality. However, up to a third of these patients 
have NASH which is the progressive form of NAFLD. Up to 40% of patients with 
NASH develop progressive liver fibrosis with 20–30% culminating in cirrhosis. 
Patients with cirrhosis secondary to NASH are at an increased risk of developing 
hepatocellular carcinoma (2.6% per year) [31–36].
NAFLD can be diagnosed by the demonstration of hepatic steatosis on imaging 
or histology where other etiologies of liver disease or steatosis have been excluded. 
Although most clinicians rely on deranged liver function tests to identify patients 
with NAFLD, this can be inaccurate as majority of the patients will remain within 
normal-range ALT levels. Furthermore, even for those patients identified to have 
elevated ALT, the ALT typically falls (and AST may rise) as fibrosis progresses to 
cirrhosis. Importantly ALT values do not demonstrate positive correlation with 
histological findings. Therefore, isolated measurement of ALT is of little value in 
both the diagnosis of NAFLD and determination of its severity [37–39].
When fatty liver disease is suspected clinically, this should be confirmed with 
imaging. Ultrasound is usually the first-line investigation for patients suspected to 
have hepatic steatosis. It provides a qualitative assessment of fatty infiltration of the 
liver where gray-scale findings are used. The echogenicity of the liver parenchyma is 
compared to that of the kidney and other internal liver structures such the vascular 
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walls to diagnose and grade hepatosteatosis. Normal liver is hypoechoic relative to 
the renal cortex and becomes relatively hyperechoic with the presence of fatty infil-
tration. Ultrasound is effective in diagnosing steatosis if the percentage of involved 
hepatocytes is >33%; its diagnostic performance is however low with lesser degrees 
of fatty liver infiltration. Consequently, a normal liver ultrasound finding does not 
invariably rule out the presence of mild liver steatosis. Additionally, conventional 
ultrasound cannot assess the degree of fibrosis [40].
Liver elastography technique can measure steatosis simultaneously with the 
assessment of liver stiffness. It is paramount to stage the degree of fibrosis in 
patients with NAFLD as this will help identify patients with advanced fibrosis 
and resultant increased risk of liver-related complications such as liver failure and 
hepatocellular carcinoma [41].
It has been shown that there is a positive correlation between shear wave veloc-
ity and increasing hepatic fibrosis. In a study of 246 subjects with NAFLD, the 
AUROCs for the detection of F ≥ 2 and F ≥ 3 were 0.84 and 0.93, respectively. The 
sensitivity and specificity for advanced fibrosis (F ≥ 3) were 91% and 75% with an 
elastography score cutoff of 7.9 kPa [42].
Inflammation is also known to increase shear wave velocity since the presence 
of edema results in reduced elasticity. It is therefore important to exclude active 
inflammation as this can confound the staging of liver fibrosis in the setting of 
NASH [43].
In summary, elastography plays a critical role in the evaluation of patients with 
NAFLD since early diagnosis of severe liver fibrosis allows for the institution of 
appropriate therapy as well as prognostication.
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Abstract
Two hundred healthy children aged 3–18 years were included in the study to 
determine liver stiffness indices by means of shear wave elastometry. The difference 
is significant when we compared shear wave velocity in children aged 3–6 years, on 
the one hand, and in children aged 7–18 years, on the other (p = 0.001). Liver stiff-
ness indices in boys and girls were not different. As a result, liver stiffness indices in 
children in various age groups have been obtained, which can be recommended as 
normal ones for pediatric patients.
Keywords: ultrasound diagnostics, shear wave elastography, fibrosis, liver, children
1. Relevance
Chronic diffuse liver diseases are an urgent issue in present children gastroen-
terology. Interest to this group of liver diseases is due to their increasing incidence, 
frequent severe course, tendency to progression, and unfavorable outcomes. This 
problem requires great attention as chronic liver diseases are often polyetiological 
and their course is insufficiently symptomatic because of the great compensatory 
capacities of the organ. Clinical manifestations and patient presentation often take 
place when severe morphological changes have already occurred and adaptation 
and compensatory mechanisms have been wasted. [1]. Regardless of the etiology, 
cirrhosis is the cause of fatal outcome in patients due to the development of com-
plications, i.e., hemorrhage from the esophageal varices, ascites, encephalopathy, 
hemorrhagic syndrome, and transformation to hepatocellular carcinoma [2]. In 
children chronic liver diseases develop as a result of influence of various etiologic 
factors such as viruses, autoantibodies, cholestasis, metabolic disorders, toxic 
agents, etc. on the liver parenchyma for a long time. Most often the process evolves 
due to bile duct disorders (75.6%), alpha-1 antitrypsin insufficiency (63.6%), 
autoimmune hepatitis (56.9%), chronic hepatitis D (57.4%), and Wilson-Konovalov 
disease (45.6%) [3].
Diagnostics of early fibrosis changes in the liver is prognostically important in 
the evaluation of the disease course. Presently, “the gold standard” of diagnostic 
method in diffuse liver disease is considered transcutaneous puncture biopsy with 
histologic investigation of tissue sampling, which enables to confirm, specify, and 
even alter the clinical diagnosis. However, the method is invasive and may cause a 
number of complications; moreover, in children their number is greater coming up 
to 4%. There are objective reasons limiting the use of biopsy method, i.e., a small 
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size of the tissue sampling. As liver fibrosis may have irregular distribution, dif-
ferent locations may show different stages of liver fibrosis and histologic activity 
[4, 5]. Thus, in pediatric medical practice, specialists are encouraged to search for 
noninvasive methods enabling not only to reveal liver changes but also to dynami-
cally follow up the fibrosis process.
Ultrasound elastography is a great breakthrough in the evolution of noninvasive 
methods of visualization of liver conditions in general and ultrasound diagnostics 
in particular. There are only a few publications describing indices of liver stiff-
ness in children obtained by one-dimensional and two-dimensional shear wave 
elastography (SWE). While studying stiffness indices in kPa (kilopascal) and 
m/s, the scientists pay attention to the data on liver stiffness obtained by different 
ultrasound and elastography techniques which cannot be compared. Normal indices 
for various age and gender groups are not clearly defined in the literature. Taking all 
these into account, the purpose of our study is to determine gender-age indices of 
liver “stiffness” in healthy children.
2. Material and methods
Two hundred healthy children aged 3–18 years were included in the study. 
Written informed consent was obtained from the legal representatives of all chil-
dren. The study was approved by the ethics committee of FGBOU DPO, Moscow. 
All patients were allocated to three age groups according to age periodization of 
Mazurin and Vorantsov [6]. The first group consisted of 103 children, the second 
one consisted of 52, and the third one consisted of 45. According to this periodiza-
tion, extrauterine period (besides the neonatal, infancy, and early childhood 
periods) includes preschool period (from 3 to 6 years), junior school period (from 
7 to 11 years), and senior school period (from 12 to 18 years). There were 103 girls 
and 97 boys among them. The following criteria were considered allocating children 
to the control group: height and weight of each child within the interval from 5th 
to 95th percentile of age norm [7]; absence of liver diseases and (or) congestive 
heart failure in the anamnesis: absence of inflammatory alterations according to 
general and biochemical blood analysis (signs of cholestasis, cytolysis); absence 
of pathology of the liver, bile ducts, pancreas, and spleen according to ultrasound 
study in the grayscale and Doppler study (chromatic Doppler mapping, impulse-
wave Doppler) modes; and a quiet behavior of a child during examination. The 
examination was performed on Aixplorer device (SuperSonic Imagine, France) by 
broadband convex sensor acting within frequency range of 1–6 MHz. The study was 
done when a patient was fasting after standard ultrasound examination of abdomi-
nal organs and retroperitoneal space. Finishing the grayscale mode and Doppler 
ultrasound, elastography shear wave (SWE ) mode was started. Tissue stiffness was 
demonstrated on the screen as a chromatic coded map (qualitative characteristics), 
and quantitative value of stiffness was evaluated in kilopascal (kPa).
After SWE mode activation, there appeared two images on the screen: the first 
one, displayed in the real-time mode a scanned area in the B-mode, and the second 
one, the same image with elastogram (Figure 1).
The mapping color depended on the chosen type of chromatic map. The chosen 
type of chromatic map colored stiffer tissues in red, while softer tissues in blue. The 
tissues of “mean” stiffness were colored in intermediate colors from light blue and 
green to yellow.
Elastometry was performed in elder children during breath-holding for not 
more than 10 s or during shallow breathing in. The patients were in a supine or 
pronation position. To visualize the liver, subcostal, intercostal, longitudinal, and 
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transversal epigastric accesses were used. The sensor was placed perpendicularly 
to the body surface. Measurements were taken in different segments of the right 
and left hepatic lobes and in the areas free from the vascular structures, fixing the 
zone of scanning at the depth of 3–5 cm from the capsule. The area of interest (a 
light window) was chosen with subsequent expectation of image stabilization to get 
a homogeneous coloring of the light window. The measurement was considered suc-
cessful when region of interest (ROI) was filled with color by more than 90%. Not 
<10 measurements were made, which enabled to calculate the mean value of liver 
stiffness.
3. Statistical analysis of data
Statistical analysis of data was performed by IBM SPSS Statistics 19. If the 
parameters were normal, Kolmogorov-Smirnov criterion with Liljefors significance 
adjustment was used. As the distribution of characteristic in one of the groups 
deviated from normal, Kruskal-Wallis criterion was used with subsequent pairwise 
comparison by means of nonparametric Mann-Whitney test. All quantitative 
values were presented as M (mean value), m (standard error of the mean value), σ 
(standard deviation), median (50th percentile), and 25th–75th percentiles of both 
minimal and maximal values. Comparison of quantitative parameters was per-
formed using Mann–Whitney test, and qualitative ones were compared by Fisher 
criterion of accuracy. Differences (p < 0.05) were considered significant.
4. Results
Elastography image of the unchanged liver in all patients in the comparison 
group was characterized by parenchyma coloring of both lobes in homogeneous 
blue without areas of local stiffness increase (Figure 2).
Median of Emean value in the comparison group was 5.00 kPa, Emax—6.3 kPa. The 
obtained data are presented in Table 1.
Figure 1. 
ESB mode study. Bellow a scanned area in the B-mode, above the same image with elastogram.
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a homogeneous coloring of the light window. The measurement was considered suc-
cessful when region of interest (ROI) was filled with color by more than 90%. Not 
<10 measurements were made, which enabled to calculate the mean value of liver 
stiffness.
3. Statistical analysis of data
Statistical analysis of data was performed by IBM SPSS Statistics 19. If the 
parameters were normal, Kolmogorov-Smirnov criterion with Liljefors significance 
adjustment was used. As the distribution of characteristic in one of the groups 
deviated from normal, Kruskal-Wallis criterion was used with subsequent pairwise 
comparison by means of nonparametric Mann-Whitney test. All quantitative 
values were presented as M (mean value), m (standard error of the mean value), σ 
(standard deviation), median (50th percentile), and 25th–75th percentiles of both 
minimal and maximal values. Comparison of quantitative parameters was per-
formed using Mann–Whitney test, and qualitative ones were compared by Fisher 
criterion of accuracy. Differences (p < 0.05) were considered significant.
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Median in the age group 3–6 years (n = 103) was 4.90 kPa, Emax—6.18 kPa. 
Median in the age group 7–11 years (n = 52) was 5.03 kPa, Emax—6.00 kPa. Median 
in the age group 12–18 years (n = 45) was 5.24 kPa, Emax——6.20 kPa. The obtained 
data on unchanged liver parenchyma values in different age groups are presented in 
Table 2.
To adjust gender differences in the values of unchanged liver parenchyma, 
Young modulus analysis in girls (n = 103) and in boys (n = 97) was performed. Emean 
median in boys is 5.08 kPa and in girls is 4.99 kPa (p = 0.345). The analysis results 
are presented in Table 3.
Age groups N = 200 Young modulus, kPa





3–6 years (n = 103) 4.89 ± 0.04 4.90 3.48–6.18 4.56–5.22 0.45
7–11 years (n = 52) 5.09 ± 0.07 5.03 3.00–6.00 4.98–5.41 0.48
12–18 years (n = 45) 5.18 ± 0.08 5.24 4.05–6.20 4.77–5.54 0.51
Table 2. 
Young modulus value (Emean, kPa) of parenchyma of unchanged liver in different age groups.
Figure 2. 
An example of liver stiffness evaluation in a healthy child aged 5 years: B-mode (below) and two-dimensional 
shear wave elastography mode (above). These are the results of one of 10 measurements. Emean = 4.0 kPa. 









3–18 years 5.01 ± 0.03 5.00 3.00–6.30 4.70–5.38 0.49
Table 1. 
Young modulus value (Emean, kPa) of the unchanged liver parenchyma in the study group of healthy children.
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Thus, normal elastography picture of the liver is characterized by homoge-
neous coloring of parenchyma in the color window without areas of local stiffness 
increase. Mean value of Young modulus is 5.01 ± 0.03 kPa, and median of Emean 
value in the comparison group was—5.00 kPa (4.70–5.38). Significant increase of 
liver stiffness in children older than 6 years was established. Significant gender 
differences in stiffness were not found.
According to the results of other research groups, the values of the shear wave 
velocity in the liver parenchyma of the right and left lobes do not have statisti-
cally significant differences. Point shear wave elastography (ARFI elastography) 
was performed by Feoktistova et al. [8] in 100 children aged from 6 months up to 
16 years. There were no any significant differences of shear wave speed between the 
right and left lobes [8]. The authors believed it is possible to measure the stiffness of 
both the right and left lobes of the liver due to the relatively lesser force of the aortic 
pulsation, as well as the small thickness of the anterior abdominal wall with a small 
degree of subcutaneous and preperitoneal fat tissue in the epigastrium. To deter-
mine the standard shear wave velocity values [9], 103 children aged from 2 weeks to 
17 years were examined. The authors indicate that during statistical processing of 
data, no significant differences were found in the lobes of the liver [9].
Taking into account literature data testifying the absence of significant differ-
ences between the right and left lobe stiffness, measurements were made in both of 
them. The findings were combined to further analyze the quantitative data. Mean 
liver stiffness value was calculated in 10 measurements in two lobes of each child.
Interestingly, the mean value of stiffness in the control group (5.01 ± 0.03) kPa 
coincided more with the study of researchers Huang et al. (509 healthy adult 
volunteers) [10] and Shin et al. (76 healthy children [11], which were 5.10 ± 1.02 
and 5.5 ± 1.3 kPa, respectively) (two-dimensional elastometry). The mean value of 
stiffness in the study of Engelmann et al. (TE) was 4.7 kPa [12]. The results differed 
from the findings of Franchi-Abella et al. [13] and Tutar et al. [14] where the mean 
value of stiffness obtained by convex sensor was higher: 6.94 ± 1.42 and 7.41 kPa, 
respectively. But one should take into consideration that both studies were per-
formed on control groups consisting of 50 healthy children, which may reduce their 
statistical power.
To adjust age-specific features of unchanged parenchyma stiffness, all study 
patients were allocated to three groups according to Mazurin and Vorontsov age 
periodization. Subgroup 1 consisted of 103 children aged 3–6 years. Subgroup 2 
consisted of 52 children aged 7–11 years. Subgroup 3 consisted of 45 children aged 
12–18 years. Median in the age group 3–6 years (n = 103) was 4.90 kPa, in the age 
group 7–11 years (n = 52) was 5.03 kPa, and in the age group 12–18 years (n = 45) 
was 5.24 kPa (Table 2). Significant differences of stiffness were obtained compar-
ing the values in age groups 3–6 and 7–11 years (p = 0.001) and 3–6 and 12–18 years 
(p = 0.001). Statistically significant differences between subgroups 2 and 3 were not 
established (p > 0.001). Thus, liver stiffness values in children older than 6 years 
Group Young modulus, kPa





Boys (n = 97) 5.07 ± 0.07 5.08 4.06–6.00 4.82–5.50 0.48
Girls (n = 103) 5.03 ± 0.05 4.99 4.26–5.70 4.78–5.33 0.36
Table 3. 
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are significantly higher. Probably, in a larger sampling, there will appear a tendency 
to stiffness increase as patients get older.
The same results of stiffness increase with age were established by Engelmann 
et al. and Sagir et al. [15] who studied normal indices of stiffness by transient 
elastography method in groups of 240 and 198 children. Engelmann et al. [12] 
established the values of stiffness median for age group 0–5 years, 4.40 kPa; for age 
group 6–11 years, 4.73 kPa; and for age group 11–18 years, 5.10 kPa (p = 0.001). 
Sagir et al. [15] also observed age and stiffness dependence: 4.8 ± 1.4 kPa 
(0–5 years), 5.6 ± 1.3 kPa (6–11 years), and 5.7 ± 1.7 kPa (12–18 years). Stiffness 
values in these age groups coincided with the results obtained in our study.
As a result of the study, there were no established statistically significant dif-
ferences in gender stiffness values: Emean median in boys is 5.08 kPa and in girls is 
4.99 kPa (p = 0.345). Comparing the two groups, statistically significant differences 
were considered (p > 0.001).
Gender characteristics of parenchyma stiffness were analyzed in the work of 
Franchi-Abella et al. where any differences in stiffness depending on the gender 
were also not established [13].
5. Conclusion
Young modulus values obtained from healthy children may be recommended 
as a standard investigation. The use of shear wave elastometry within a complex 
ultrasound evaluation will contribute to better early diagnostics of the changed 
parenchyma. Prospectively, a widespread use of ultrasound elastography will result 
in decreasing the number of biopsies.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Abstract
Breast cancer remains the second cause of mortality in women, even if the mor-
tality rates linked to it have drastically dropped at the present time. Invasive lobular 
carcinoma (ILC) accounts for 5–15% of the breast cancers and it is the second most 
encountered type among invasive carcinomas. There has been reported a high rate 
for bilateral lesions (6–47%), multifocality/multicentricity (21%), all affecting 
ILC overall survival. Due to its nonspecific symptoms and to the fact that it does 
not invoke a vigorous desmoplastic response and has a low likelihood of producing 
calcifications, the ILC tends to be insidious on mammography. Contrast enhanced 
MRI has the lowest false negative rate in detecting ILC and it is the most accurate 
method of determining the lesion extension, though it is expensive and not widely 
available. Therefore, the ultrasound (US) plays a significant role in the diagnosis 
of ILC. US elastography imaging (EI) individualizes malignant breast lesions with 
high sensitivity and specificity. Recent studies suggested that US elastography can 
even diagnose lobular cancers that have benign findings on conventional imaging. 
Goal: present various US aspects and exemplify the added diagnostic value of strain 
elastography—how it may change the BIRADS category and further therapeutic 
management?
Keywords: breast cancer, invasive lobular carcinoma, elastography,  
ultrasound, BI-RADS
1. Introduction
Breast cancer remains the second cause of mortality in women, even if the 
mortality rates linked to it have drastically dropped at the present time. Based on 
the origin of the cancer cells, there are two types of breast cancer subtypes: ductal 
and lobular. Both include an “in situ” and an “invasive” form, depending on their 
extension to the neighboring tissues. We will further address invasive lobular cancer 
(ILC), which accounts for 5–15% of the breast cancers and is the second most 
encountered type among invasive carcinomas.
2. Epidemiology
ILC has an estimated incidence of 2.7 per 100.000 people, with a mean diagnos-
tic age higher than for invasive ductal carcinoma. About two-thirds of women are 55 
or older at the time of the diagnosis, ILC tending to occur even later in life [1].
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3. Pathology and ILC subtypes
The tumor develops at the terminal ductal-lobular unit (TDLU), and it is 
composed of cancer cells that are individually dispersed or arranged in a single-file 
pattern. Often, the cells form a target-like configuration around normal breast 
ducts. Two main histology findings are characteristic for invasive lobular cancer: 
the noncohesive cell pattern and the minimal desmoplastic response. The first is 
an effect of the E-cadherin (CDH1) germline mutation encountered in about 85% 
of the tumors, which results in the loss of adhesion proteins and a discohesive 
morphologic pattern [2]. The second is due to the fact that malignant cells grow in 
the mammary stroma and adipose tissue and induce less desmoplastic reaction than 
ductal carcinoma, which has important repercussions on the imaging aspects [3].
As it regards the ILC subtypes, occasionally the classic single-file formation is 
absent, and there is a different pattern encountered: solid (large sheets with little 
stroma), alveolar (groups of 20 cells), or tubular-lobular (tubelike structures 
together with single-file pattern) [2, 3].
The classic ILC presents with tumor cells that are usually small, uniform, and 
round with minimal pleomorphism. Otherwise, a less often subtype cell might be 
reported: pleomorphic or signet-ring cells.
The majority of ILC are positive for estrogen and progesterone receptors and are 
negative for the HER2 amplification (consistent with a luminal A category).
4. Signs and symptoms
The invasive lobular carcinoma may be asymptomatic. Due to the typical spread pat-
tern, some of the patients may present with the first sign of ILC as a skin thickening or 
hardening of the breast rather than a distinct lump. Basically there are no ILC-specific 
signs or symptoms; the patients’ physical examination may reveal general breast cancer-
related changes such as a swelling area, skin irritation or dimpling, breast or nipple pain, 
nipple discharge (other than breast milk), and even an axillary lump [4].
Due to the lack and nonspecific symptoms, up to 10% of the patients present 
with metastatic disease at the time of diagnosis [1].
5. Diagnosis of ILC
Breast cancer in general might be diagnosed using different complementary 
methods or techniques, starting with a physical breast examination; whether we 
are using screening or diagnostic mammography (Mx), ultrasound, or magnetic 
resonance (MRI), it is well known that imaging often underestimates this disease’s 
extension. The tissue analysis remains the gold standard for tumor diagnostic, 
regardless if the tumor tissue originates from a biopsy or a surgical excision.
Regarding the tumor appearance, a high rate for bilateral lesions (6–47%) has 
been reported, multifocality/multicentricity (21%), all affecting the ILC overall 
survival (Figure 1) [1].
5.1 Mammography
The sensitivity of mammography is reported to be lower for ILC than for 
invasive ductal carcinoma, ranging from 34–72%, and it is frequently seen in only 
one view (often on cranio-caudal compared to mediolateral oblique) [5]. Most 
commonly, the tumor presents as a spiculated mass lesion without calcifications. 
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In some cases, architectural distortions or asymmetrical densities are observed; 
moreover, up to 16% of ILC remains mammographically occult or are attributed to 
benign lesions (Figure 2).
5.2 Ultrasound
The studies reported a sensibility of 98% in the ultrasound diagnostic of ILC 
[6]. The tumor usually presents as a hypoechoic mass, with ill-defined margins and 
posterior acoustic shadowing (58%), occasionally without shadowing (27%) [6]. 
Contrary to ductal carcinoma, which commonly presents as a lesion perpendicular 
to the surface, ILC may exhibit a so-called “wider than tall” shape, a tumor that is 
parallel to the skin. In some cases, the mass might be heterogeneous with an iso- or 
hyperechoic halo (Figure 3).
5.2.1 B-mode
Two classic signs of ILC were described using B-mode of ultrasound. First, 
the Golden Gate sign resulted from 2 to 3 adjacent Cooper‘s ligaments involved 
by cancer so that the shadowing area (hypoechoic area) resembles the shape of a 
suspension bridge seen from the profile. The second one, named the picket fence 
sign, is observed when more numerous and more closely spaced Cooper‘s ligaments 
are involved in cancer and the shadowing area resembles the profile of a picket 
fence (Figure 4).
Figure 1. 
Multifocal ILC. Ultrasound suspect lesions located in the right breast, first at 11 o’clock (A) and second at 9 o’clock (B).
Figure 2. 
Subtle ILC mammographic findings: An asymmetry of density is seen on the CC view (B, arrow), without a 
correspondent on MLO projection (A). Note the same density of the lesion as of the normal tissue breast. The 
ultrasound (CD) revealed a 5 mm, spiculated, hypoechoic lesion with vascularization on color Doppler.
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Classic sign of ILC: Golden Gate bridge (A) and picket fence (B).
5.2.2 Doppler mode
The Doppler mode highlights the presence of the blood vessels within the tumor, 
whether it is a mild, moderate, or intensely vascularized tumor mass. The vessel’s 
spreading pattern is not characteristic, usually the tumor presenting with diffusely dis-
tributed vascularization. Rarely, a malignant mass may present as an avascular tumor, 
due to the present-day limitation of the technique (vessels too small to be highlighted).
5.2.3 Elastography
In breast ultrasound, both strain (static) and shear wave (dynamic) elastography 
are used. Ultrasound elastography of the ILC masses exhibits various patterns, from 
soft to mosaic and predominantly hard tumors. Tsukuba score (TS) is often used to 
qualitatively classify the elasticity of the masses, from 1 (soft) to 5 (extensively hard 
lesions) (Table 1).
The elasticity varies between different lobular cancer masses, which may 
even have an elastography score similar with the normal adjacent breast tissue. 
An important take-home message lies in the lesion’s grayscale aspect: if the 
B-mode indicates any sign of malignancy, a normal hardness should not delay 
the following biopsy.
ILC commonly presents as hard masses (Tsukuba 4 or 5 score). Sometimes a mosaic 
pattern might be obtained, and rarely a blue-green-red (BGR) appearance may be noted.
A topic of interest nowadays is represented by the US prediction regarding the 
breast cancer tumor grades. The mean elasticity/B-mode ratio was reported as 
statistically different between ILC and grade III ductal carcinoma, versus mucinous 
or grade I and II ductal cancers [7].
Figure 3. 
ILC presented as a heterogeneous mass, with small cystic areas included and ill-defined margins (A), 
vascularized on color Doppler (B). Note the mass orientation, parallel to the surface, with a “wider than tall” 
appearance.
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On the topic of shear wave elastography, the method provides a quantitative assess-
ment and tissue stiffness values, represented in kilopascals (kPa). A value higher than 




























Tsukuba qualitative score. The left column displays the elastography score, the middle column shows the 
elastography/B-mode appearances, and the right column describes the score meaning. All the abovementioned 
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Tsukuba qualitative score. The left column displays the elastography score, the middle column shows the 
elastography/B-mode appearances, and the right column describes the score meaning. All the abovementioned 
lesions were proven to be invasive lobular cancers.
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A comparison of strain and shear wave ultrasound elastography in differ-
entiating benign and malignant breast lesions concluded that strain ultrasound 
elastography is more specific (93.7%) and less sensitive (81.7%), while shear wave 
ultrasound elastography is more sensitive (95.8%) and less specific (84.8%) in dif-
ferentiating benign from malignant breast lesions [9].
There are three additional and important EI key aspects that help in the ILC 
diagnostic:
1. Highlighting hardly visible lesions—Sometimes a breast lesion might be isoec-
hoic to the surrounding breast tissue, scarcely visible in grayscale; in some cases 
elastography may help us in identifying those hard lesions with greater confi-
dence (the lesions will appear as isoechoic on B-mode and blue on strain EI).
2. Identifying pseudo-benign lesions—EI may indicate lobular cancers that have 
benign or normal findings on conventional imaging as suspicious [10].
3. Suggesting a larger lesion—It is known that imaging often underestimates 
ILC. Even so, EI may sometimes suggest a lesion’s extension by highlighting a 
hard area that exceeds the grayscale lesion (lesions with Tsukuba 5 score).
To conclude, whether or not it is a strain or a shear wave, elastography methods 
are adding value to the ILC diagnostic and should be definitely used in the assess-
ment of every patient. Moreover, it may change the BI-RADS category from a prob-
able benign lesion (score 3) to a suspicious lesion (score 4). Thereby, elastography 
has an important impact in the patient’s therapeutic management, which translates 
in certain cases, in switching from a short-time follow-up to biopsy.
By educational purposes, all ultrasound characteristics presented above will be 
highlighted in the following case-based section. The various ILC imaging appear-
ances were grouped in subcategories, as it follows:
a. Hypoechoic mass with posterior acoustic shadowing (Figure 6).
b. Hypoechoic mass without posterior acoustic shadowing (Figure 7).
c. Architectural distortion (Figures 8 and 9).
d. Iso- or hypoechoic area or non-mass lesion (Figures 10 and 11).
e. Hyperechoic lesion. Even if the hyperechoic appearance usually represents a 
benign entity, up to 5% of the ILC were reported as hyperechoic lesions, out of 
which 48% were associated with posterior acoustic shadowing (Figure 12) [11].
Figure 5. 
Breast elastography techniques. (A) Vascularized lesion, hard on strain elastography. (B) Vascularized area, 
soft on shear wave elastography. Note the difference between stiffness’ color coding: Blue in strain EI = hard, 
blue in share wave EI = soft.
87
Strain Elastography in Invasive Lobular Carcinoma
DOI: http://dx.doi.org/10.5772/intechopen.88077
f. Well-defined nodule. Studies reported up to 2–12% of the ILC cases as a 
pseudo-benign, well-defined nodule (Figure 13) [12].
g. Occult lesion. Not often, ILC may not be highlighted by ultrasound. Authors 
report up to 10% of the cases missed on US [12]. Sometimes, a lesion might be 
detected during a second-look US after an MRI depiction (Figure 14).
h. Axillary abnormality. Regarding the US sensitivity in the metastasis detec-
tion, the technique was reported positive in about 50% of the N1 cases. 
Furthermore, US is able to exclude 96% of the N2 and N3 axillary metastasis 
(more than four positive lymph nodes). The fine needle biopsy is less sensi-
tive in ILC than invasive ductal carcinoma (IDC vs. ILC; 98.4% vs. 53.6%; 
p < 0.001) (Figure 15) [13].
Figure 6. 
ILC lesion presents as a hypoechoic mass with intense posterior acoustic shadowing (A), vascularized (B), and 
hard on elastography (C, TS 5).
Figure 7. 
ILC lesion presents as an ill-defined, hypoechoic mass without posterior acoustic shadowing (A), hypovascular 
(B), and hard on elastography (C, TS 5).
Figure 8. 
ILC lesion presents as an architectural distortion with mild posterior acoustic shadowing, hardly visible on 
grayscale (A). The area is hypovascular (B) and hard on elastography (C, TS 4).
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Figure 6. 
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hard on elastography (C, TS 5).
Figure 7. 
ILC lesion presents as an ill-defined, hypoechoic mass without posterior acoustic shadowing (A), hypovascular 
(B), and hard on elastography (C, TS 5).
Figure 8. 
ILC lesion presents as an architectural distortion with mild posterior acoustic shadowing, hardly visible on 




Hardly visible ILC isoechoic lesion (A) associated with a hypovascular architectural distortion (B). The lesion 
is easily spotted on elastography, as a hard area (C, TS 4).
Figure 10. 
Hypoechoic area with hyperechoic halo resembling the picket fence sign (A), with minimal vascularization on 
color Doppler (B). The core needle biopsy (C) revealed an ILC lesion, with positive estrogen and progesterone 
receptors RE = 100%, RP = 25%, Ki67 = 15%, and HER2 negative.
Figure 11. 
Hypoechoic, hypovascular area which presents with mild posterior acoustic shadowing (AC). Note that the 
hard area is larger on elastography than grayscale (B, TS 5).
Figure 12. 
Hyperechoic, ill-defined lesion (A), apparently avascular (B), but hard on elastography (C, TS 4). At the time 
of diagnosis, the patient presented peritoneal metastasis.
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i. ILC with BGR appearance. Rarely, ILC may display a blue-green-red sign due to 
a necrotic component. Even if the BGR sign is commonly attributed to cysts, its 
presence in a solid, suspicious mass may never delay a biopsy (Figure 16).
j. ILC lesions in which elastography changed the BI-RADS score. It was previously 
established that in order to achieve an accurate breast cancer diagnosis, US B-mode 
should be combined with Color Doppler and elastography. Regarding EI, there 
was a positive impact in breast cancer diagnosis, especially for small lesions [14]. 
Moreover, in invasive lobular cancer, EI demonstrated to improve the BI-RADS 
classification, particularly for lesions smaller than 13 mm (Figures 17–19) [15].
Figure 13. 
A patient with a history of ILC treated with mastectomy 24 years ago. The present US revealed a well-defined, 
hypoechoic nodule in the area of mastectomy (A). The nodule is intensely vascularized (B) and hard on 
elastography (C, TS 4). Initially considered a BI-RADS 4a lesion, after EI the lesion has been assigned to a 
higher BI-RADS 4b score. The core needle biopsy showed an ILC relapse.
Figure 14. 
A breast lesion with suspect features was detected at US and proven to be an ILC (AB). The following staging 
MRI highlighted not one, but two lesions (C), concluding that one of the lesions was US occult.
Figure 15. 
The mammography shows a highly dense right breast and an abnormal axillary mass (A, arrow). The US 
revealed an enlarged, rounded lymph node (B), with intense and chaotic vascularization (C). The core needle 
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elastography (C, TS 4). Initially considered a BI-RADS 4a lesion, after EI the lesion has been assigned to a 
higher BI-RADS 4b score. The core needle biopsy showed an ILC relapse.
Figure 14. 
A breast lesion with suspect features was detected at US and proven to be an ILC (AB). The following staging 
MRI highlighted not one, but two lesions (C), concluding that one of the lesions was US occult.
Figure 15. 
The mammography shows a highly dense right breast and an abnormal axillary mass (A, arrow). The US 
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Intensely hypoechoic nodule with partially well-defined, partially ill-defined margins (A), moderately 
vascularized on color Doppler examination (B). The elastography displays a blue-green-red appearance (C). 
Core biopsy revealed an ILC lesion.
Figure 17. 
BI-RADS 3 to BI-RADS 4a. ILC presented as a small hypoechoic lesion with indistinct margins (A), 
hypovascular (B), and hard aspect on EI (C, TS 4/5). The lesion was upgraded from BI-RADS 3 to BI-RADS 
4a after the elastography criterion was added.
Figure 18. 
BI-RADS 4a to BI-RADS 4b. A small, avascular, hyperechoic lesion with indistinct margins (A) and hard 
on EI (B, TS 4). The core needle biopsy revealed ILC (C). The lesion was upgraded from BI-RADS 4a to 
BI-RADS 4b after the elastography criterion was added.
Figure 19. 
Doppler US reveals a hypoechoic round lesion with partially angulated margins and peripheral vascularity 
(A). On strain elastography (B), the entire lesion and its surrounding parenchyma were shaded blue (TS 5). 
The lesion was upgraded from BI-RADS 4B to BI-RADS 4C after the elastography criterion was added.
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5.3 MRI
Due to its propensity for bilaterality and multicentricity, breast MRI is 
usually recommended when histology of a lesion reveals an ILC. MRI easily 
highlights occult Mx and US lesions and has the lowest false-negative rate in 
detecting ILC [16]. In addition, MRI has the highest accuracy in measuring ILC 
sizes, whether it is a mass or non-mass enhancement pattern. ILC kinetic is 
rarely a type III curve (washout) or type I curve, more often displaying a type II 
(plateau) curve (Figure 20).
6. Treatment and prognosis
Depending on the disease’s stage, there is a local ILC treatment represented by 
surgery and radiation therapy and a systemic treatment characterized by chemo-
therapy, hormonal therapy, or targeted therapies. Due to its diffuse invasive nature, 
positive resection margins are common.
ILC spreads slowly outside the breast, but when it does, it tends to manifests 
with atypical metastases, affecting the gastrointestinal tract (as a diffuse spread-
ing process of the colon 26%, stomach, or small bowel), ovaries (21%), perito-
neum (as Krukenberg syndrome, 30%), retroperitoneum, leptomeningeal, or 
bone. It may also cause lymph node, lung, or liver metastasis.
Despite the multifocality, the bilateral lesions, and the atypical metastases, 
the prognosis for ILC patients with a given size and stage is believed to be slightly 
higher than for patients with invasive ductal carcinoma.
7. Conclusion
The ultrasound plays a significant role in the diagnosis of invasive lobular car-
cinoma. Ultrasound elastography imaging individualizes malignant breast lesions 
with high sensitivity and specificity, being sometimes a “problem-solving” method. 
Moreover, it may change the BI-RADS category and have an important impact on 
the patient’s therapeutic management.
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Figure 20. 
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Abstract
Shearwave elastography is a new advance technique of the ultrasound with
ultrafast shearwave mode which displays evaluation of the elasticity in real time. As
the disease process tend to affect stiffness of the tissue thereby distorting its archi-
tecture. This architectural change makes the basic principal of the palpation part of
the clinical examination. The shearwave elastography uses the principal of palpa-
tion. The output of shearwave is displayed in qualitative mode in the form of color
change (ranging from blue to red) and quantitative mode as measure of elasticity in
kilopascals (ranging from 0 to 300). The soft tissues are penetrated easily giving a
homogenous pattern with blue to green color while cancers show color from red to
dark red portraying high elasticity. The scoring system for interpretation of the
shearwave results suggest that benign lesions show less (i.e., <200 kPa) elasticity
while cancers reach high levels (upto 300 kPa). Shearwave elastography has shown
superiority as compared to B-mode ultrasound and mammogram in determining
the nature of the breast lesions. It has shown high sensitivity in BIRAD 3 and
4 lesions to downgrade and helps in making accurate diagnosis. It has also shown
potential in predicting response of neoadjuvant chemotherapy.
Keywords: breast shearwave elastography, scoring system, breast radiology,
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1. Introduction
All the tissues of the body have some elasticity due to presence of variable
amount of elastic tissue. Pathological insult of the tissues causes change in tissue
architecture by disturbing elastic tissue proportion. These pathological insults
invariably include chronic inflammatory conditions and cancers as well. Thus the
physical examination of the body to make idea of the tissue architecture was the
fundamental part of the diagnosis making from the ancient period. Palpation was
the sole method of diagnosis in ancient period dates back to more than 5000 years
ago during the era of Pharaoh. With advancements in technology, different modes
of assessment have been introduced in clinical practice notably imaging techniques.
Ultrasound and X-rays are the most commonly used economical, non-invasive and
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1. Introduction
All the tissues of the body have some elasticity due to presence of variable
amount of elastic tissue. Pathological insult of the tissues causes change in tissue
architecture by disturbing elastic tissue proportion. These pathological insults
invariably include chronic inflammatory conditions and cancers as well. Thus the
physical examination of the body to make idea of the tissue architecture was the
fundamental part of the diagnosis making from the ancient period. Palpation was
the sole method of diagnosis in ancient period dates back to more than 5000 years
ago during the era of Pharaoh. With advancements in technology, different modes
of assessment have been introduced in clinical practice notably imaging techniques.
Ultrasound and X-rays are the most commonly used economical, non-invasive and
highly reliable techniques in clinical practice. Measurement of the stiffness is quite
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old method, the same principal was followed by elastography which measures tissue
stiffness and displays it in the output window. Initially strain elastography was
introduced where tissue was displaced by applying pressure on tissue by using
probe [1].
Shearwave elastography (SWE) is a relatively new (i.e., 2003) advancement of
the ultrasound system which uses ultrafast shearwaves for assessment of elasticity
of the tissue by using acoustic radiation force excitation and displays in real time
[2]. Shearwave elastography has been used in combination with B-mode ultrasound
in order to enhance its diagnostic accuracy. A number of studies have been
conducted till date showing role of elastography notably assessment of liver fibrosis
in chronic hepatitis patients, assessment of thyroid and breast lesions. In all organs
it has shown its superiority than conventional B-mode ultrasound in determining
the nature of the lesions. In breast diseases it has been studied for its role not only in
differentiating benign and malignant lesions, but also investigated in predicting
response to neoadjuvant chemotherapy in locally advanced breast cancers. The
diagnostic significance of SWE has been studied since its introduction in clinical
practice; nevertheless many aspects are still under investigation. In addition, most
of the research works done till date has investigated its role in diagnostics; however
its role in screening has not been studied yet. This book chapters looks at the basic
mechanism of the shearwave elastography, technique of using shearwave
elastography in breast, its clinical application in differentiating benign and malig-
nant breast lesions.
2. Mechanism/physics of shearwave elastography
Shearwaves are ultrafast mechanical waves whose propagation is measured
while it passes through tissues. The movement of the waves is influenced by the
stiffness of the concerned tissue. The mechanism of the shearwaves follows Young’s
modulus, which has capability to assess difference in the characteristics of different
biological tissues and secondly it quantitatively presents tissue stiffness [1]. This
reproduction of the stiffness corresponds the palpation of the tissue on clinical
examination.
The shearwave elastography is based on two mechanisms including a Mach
cone, where different spherical waves in single plane make a Mach cone which
allows propagation and rebuilding map of Young’s modulus. Secondly the ultrafast
mode allows up to 5000–30,000 frames per second depending on the nature of the
tissue. In situations of smooth propagation of the waves the real time image gener-
ated tends to be clear and homogenous while the areas of stiff tissues show distur-
bances in the traveling and show high intensity colors with heterogeneous echo
pattern. In the areas of extreme hardness the waves do not propagate at all resulting
in back area known as signal void area or punched out lesions. The technique is
implanted in Aixplorer (Supersonic Imagine, Aix-en-Province, France) equipment
[1]. The equipment has wide acceptance for assessment of liver fibrosis stage in
chronic hepatitis patients where this has largely replaced biopsy. However, for
breast tissue it has not yet achieved due popularity among clinicians.
3. Elasticity differences of normal and pathological breast tissues
As the normal understanding the elasticity of the tissue varies with the disease
progression. The particular diseases like chronic inflammation and cancers have
higher tendency to show higher level of stiffness. It is also a general concept that
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the cancers tend to be harder than the normal tissue and the benign lesions
(Figures 1 and 2). Although it is not applicable in all situations as some benign
conditions show harder consistency such as a cyst and some cancers show soft
consistency like mucinous type. The study conducted on normal tissue showing the
soft consistency with averagely blue color on qualitative assessment and normal
tissue elasticity of the breast reported to be 30.68  9.11 kPa in the four quadrants
while in the nipple areola it was 31.35 kPa [3]. The stiffness shows negative rela-
tionship with the age of the patients. As the age advances in particular older women
the breast parenchyma is largely replaced by fat. Fat is naturally much softer than
the breast parenchyma thus understandably elasticity reduces. In contrast younger
patients have more breast parenchyma and firmer breast thus relatively higher
elasticity, though within limits of the normal range.
4. Breast shearwave probe and technique
A linear array probe with maximum frequency of 12–14 MHz is used for breast
elastography (Figure 3). Technique of applying SWE is crucial. The application of
probe for SWE is just to place it on the skin, no additional pressure is required. In
the experience of the author if pressure is applied on breast tissues it causes false
positive results. Thus just placing the probe and holding it perpendicular to the skin
Figure 1.
Qualitative appearance of normal breast tissue and benign cyst on shearwave elastography.
Figure 2.
Invasive ductal carcinoma breast appearance on shearwave elastography.
97
Shearwave Elastography in Differentiating Benign and Malignant Breast Lesions
DOI: http://dx.doi.org/10.5772/intechopen.87244
old method, the same principal was followed by elastography which measures tissue
stiffness and displays it in the output window. Initially strain elastography was
introduced where tissue was displaced by applying pressure on tissue by using
probe [1].
Shearwave elastography (SWE) is a relatively new (i.e., 2003) advancement of
the ultrasound system which uses ultrafast shearwaves for assessment of elasticity
of the tissue by using acoustic radiation force excitation and displays in real time
[2]. Shearwave elastography has been used in combination with B-mode ultrasound
in order to enhance its diagnostic accuracy. A number of studies have been
conducted till date showing role of elastography notably assessment of liver fibrosis
in chronic hepatitis patients, assessment of thyroid and breast lesions. In all organs
it has shown its superiority than conventional B-mode ultrasound in determining
the nature of the lesions. In breast diseases it has been studied for its role not only in
differentiating benign and malignant lesions, but also investigated in predicting
response to neoadjuvant chemotherapy in locally advanced breast cancers. The
diagnostic significance of SWE has been studied since its introduction in clinical
practice; nevertheless many aspects are still under investigation. In addition, most
of the research works done till date has investigated its role in diagnostics; however
its role in screening has not been studied yet. This book chapters looks at the basic
mechanism of the shearwave elastography, technique of using shearwave
elastography in breast, its clinical application in differentiating benign and malig-
nant breast lesions.
2. Mechanism/physics of shearwave elastography
Shearwaves are ultrafast mechanical waves whose propagation is measured
while it passes through tissues. The movement of the waves is influenced by the
stiffness of the concerned tissue. The mechanism of the shearwaves follows Young’s
modulus, which has capability to assess difference in the characteristics of different
biological tissues and secondly it quantitatively presents tissue stiffness [1]. This
reproduction of the stiffness corresponds the palpation of the tissue on clinical
examination.
The shearwave elastography is based on two mechanisms including a Mach
cone, where different spherical waves in single plane make a Mach cone which
allows propagation and rebuilding map of Young’s modulus. Secondly the ultrafast
mode allows up to 5000–30,000 frames per second depending on the nature of the
tissue. In situations of smooth propagation of the waves the real time image gener-
ated tends to be clear and homogenous while the areas of stiff tissues show distur-
bances in the traveling and show high intensity colors with heterogeneous echo
pattern. In the areas of extreme hardness the waves do not propagate at all resulting
in back area known as signal void area or punched out lesions. The technique is
implanted in Aixplorer (Supersonic Imagine, Aix-en-Province, France) equipment
[1]. The equipment has wide acceptance for assessment of liver fibrosis stage in
chronic hepatitis patients where this has largely replaced biopsy. However, for
breast tissue it has not yet achieved due popularity among clinicians.
3. Elasticity differences of normal and pathological breast tissues
As the normal understanding the elasticity of the tissue varies with the disease
progression. The particular diseases like chronic inflammation and cancers have
higher tendency to show higher level of stiffness. It is also a general concept that
96
Ultrasound Elastography
the cancers tend to be harder than the normal tissue and the benign lesions
(Figures 1 and 2). Although it is not applicable in all situations as some benign
conditions show harder consistency such as a cyst and some cancers show soft
consistency like mucinous type. The study conducted on normal tissue showing the
soft consistency with averagely blue color on qualitative assessment and normal
tissue elasticity of the breast reported to be 30.68  9.11 kPa in the four quadrants
while in the nipple areola it was 31.35 kPa [3]. The stiffness shows negative rela-
tionship with the age of the patients. As the age advances in particular older women
the breast parenchyma is largely replaced by fat. Fat is naturally much softer than
the breast parenchyma thus understandably elasticity reduces. In contrast younger
patients have more breast parenchyma and firmer breast thus relatively higher
elasticity, though within limits of the normal range.
4. Breast shearwave probe and technique
A linear array probe with maximum frequency of 12–14 MHz is used for breast
elastography (Figure 3). Technique of applying SWE is crucial. The application of
probe for SWE is just to place it on the skin, no additional pressure is required. In
the experience of the author if pressure is applied on breast tissues it causes false
positive results. Thus just placing the probe and holding it perpendicular to the skin
Figure 1.
Qualitative appearance of normal breast tissue and benign cyst on shearwave elastography.
Figure 2.
Invasive ductal carcinoma breast appearance on shearwave elastography.
97
Shearwave Elastography in Differentiating Benign and Malignant Breast Lesions
DOI: http://dx.doi.org/10.5772/intechopen.87244
is just appropriate. However, in deep seated lesions minimal compression may be
applied without putting unnecessary pressure on the tumor.
The first stage and important stage is to get good quality homogenous B-mode
images. The B-mode provides basis for generation of the SWE. Placing the probe
parallel to the duct then moving it in clock wise fashion in all quadrants of the breast
allows superficial assessment of whole breast (Figure 4). This is the general
screening. In case if there is any lesion visible then detailed examination of the
lesion is to be done in addition to the general assessment. The initial qualitative
assessment is done followed by application of ROI for measurement of the elasticity.
5. Reliability of SWE as imaging modality in breast
5.1 SWE differentiating benign and malignant breast lesions
Since SWE was brought in clinical practice a number of studies have been
conducted on its reliability and compared it with the conventional modes of imaging
including ultrasound and mammograms. In addition to individual studies a number
of meta-analysis has also been done [4–6]. Invariably all the studies showed superi-
ority of SWE over ultrasound and mammograms alone in particular BIRAD 3 and 4
cases. However, SWE did not differentiate among molecular classes of breast cancer,
though higher grades were associated with high elasticity [7]. Another study com-
pared ultrasound and combined ultrasound with SWE to differentiate mastitis and
malignancy. With addition of SWE specificity was increased from 11.5 to 96% [8].
Figure 3.
Linear-array probe used for breast shearwave elastography.
Figure 4.
Clockwise fashion of assessing breast by shearwave elastography.
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There were studies available to suggest that SWE stiffness of the breast cancer
has been linked with prediction of the poor survival [9, 10]. The harder the tumor,
the poorer the survival. This can be biologically explained by having hard aggressive
tumors with high grades and solid consistency resulting in poor survival [11]. A












2019 396 Malignant and benign breast lesions show
significant difference in elasticity on SWE.
Application of SWE reduces the rate of false
positives by 25% in general while for BIRAD






2019 428 Combined approach with B-mode ultrasound and
SWE significantly enhance diagnostic accuracy even






2019 458 BIRAD category four lesions were evaluated on B-







2018 2273 Multi-center study compared B-mode ultrasound
and SWE and compared with histopathology. SWE




Clinical Imaging 2018 209 Breast lesions were compared on B-mode with and
without SWE. The addition of SWE improved






2017 126 Addition of SWE to conventional B-mode increases





2016 116 Non palpable breast lesions were evaluated.
Addition of SWE increases sensitivity and
specificity of diagnosis and differentiating benign
and malignant non palpable breast lesions
8 Kim
[18]
Medicine 2015 177 Addition of SWE to B-mode increases diagnostic






2015 140 Complex cystic and solid masses showed that
addition of SWE increases the chance of accurate






2014 79 Addition of SE or SWE improved the diagnostic






2014 1 (a case
report)
DCIS was detected within the fibroadenoma
12 Lee
[22]










Radiology 2014 137 Addition of shearwave with stiff rim setting makes











2014 86 In smaller tumors ≤15 cm in size addition of the
peri-tumoral rim on SWE in addition to the
grayscale measurement make better comparability
with the pathological size of the cancer
99
Shearwave Elastography in Differentiating Benign and Malignant Breast Lesions
DOI: http://dx.doi.org/10.5772/intechopen.87244
is just appropriate. However, in deep seated lesions minimal compression may be
applied without putting unnecessary pressure on the tumor.
The first stage and important stage is to get good quality homogenous B-mode
images. The B-mode provides basis for generation of the SWE. Placing the probe
parallel to the duct then moving it in clock wise fashion in all quadrants of the breast
allows superficial assessment of whole breast (Figure 4). This is the general
screening. In case if there is any lesion visible then detailed examination of the
lesion is to be done in addition to the general assessment. The initial qualitative
assessment is done followed by application of ROI for measurement of the elasticity.
5. Reliability of SWE as imaging modality in breast
5.1 SWE differentiating benign and malignant breast lesions
Since SWE was brought in clinical practice a number of studies have been
conducted on its reliability and compared it with the conventional modes of imaging
including ultrasound and mammograms. In addition to individual studies a number
of meta-analysis has also been done [4–6]. Invariably all the studies showed superi-
ority of SWE over ultrasound and mammograms alone in particular BIRAD 3 and 4
cases. However, SWE did not differentiate among molecular classes of breast cancer,
though higher grades were associated with high elasticity [7]. Another study com-
pared ultrasound and combined ultrasound with SWE to differentiate mastitis and
malignancy. With addition of SWE specificity was increased from 11.5 to 96% [8].
Figure 3.
Linear-array probe used for breast shearwave elastography.
Figure 4.
Clockwise fashion of assessing breast by shearwave elastography.
98
Ultrasound Elastography
There were studies available to suggest that SWE stiffness of the breast cancer
has been linked with prediction of the poor survival [9, 10]. The harder the tumor,
the poorer the survival. This can be biologically explained by having hard aggressive
tumors with high grades and solid consistency resulting in poor survival [11]. A












2019 396 Malignant and benign breast lesions show
significant difference in elasticity on SWE.
Application of SWE reduces the rate of false
positives by 25% in general while for BIRAD






2019 428 Combined approach with B-mode ultrasound and
SWE significantly enhance diagnostic accuracy even






2019 458 BIRAD category four lesions were evaluated on B-







2018 2273 Multi-center study compared B-mode ultrasound
and SWE and compared with histopathology. SWE




Clinical Imaging 2018 209 Breast lesions were compared on B-mode with and
without SWE. The addition of SWE improved






2017 126 Addition of SWE to conventional B-mode increases





2016 116 Non palpable breast lesions were evaluated.
Addition of SWE increases sensitivity and
specificity of diagnosis and differentiating benign
and malignant non palpable breast lesions
8 Kim
[18]
Medicine 2015 177 Addition of SWE to B-mode increases diagnostic






2015 140 Complex cystic and solid masses showed that
addition of SWE increases the chance of accurate






2014 79 Addition of SE or SWE improved the diagnostic






2014 1 (a case
report)
DCIS was detected within the fibroadenoma
12 Lee
[22]










Radiology 2014 137 Addition of shearwave with stiff rim setting makes











2014 86 In smaller tumors ≤15 cm in size addition of the
peri-tumoral rim on SWE in addition to the
grayscale measurement make better comparability
with the pathological size of the cancer
99
Shearwave Elastography in Differentiating Benign and Malignant Breast Lesions
DOI: http://dx.doi.org/10.5772/intechopen.87244
summary of the studies reporting on role of SWE in differentiating benign and
malignant lesions is given in Table 1.
5.2 SWE predicting response to neo-adjuvant chemotherapy in locally
advanced breast cancer
Shearwave elastography was evaluated to assess its potential role in predicting
response to chemotherapy in a number of studies (Table 2). Each tumor has cellular
component and the tumor stroma. When there is compact cellular component the
tumor tend to show hardness which appears as high elasticity on SWE.While with the
action of the chemotherapy; cells start to die and there comes softness which appears
as reduction in elasticity of the tumors. Those tumors show response to chemotherapy
present with reduced stiffness earlier in the course of treatment (Table 2). Thus
invariably all the studies showed that those tumor showing pathological complete
response have also shown reduction in the elasticity on SWE earlier [33].
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6. Reporting of breast SWE
The probe needs to be placed very gently on the breast without application of any
pressure. For breast evaluation clockwise 12 measurements have to be taken. The
reporting is to be done by using qualitative as well as quantitative findings of the breast
tissue including color of the tissue and maximum elasticity values (Figure 5a and b). If
there is any additional finding such as signal void area then it has to be described along
with its location in the breast. The ROI is placed in all the areas with maximum
elasticity level are to be taken into account. The size of the ROI is to be adjusted
according to the size of the tumor and the proportion of the heterogeneous tissue
including hard and soft parts. The cancers show more heterogeneity then the benign
lesions. Thus the highest elasticity is taken as well as reading from heterogenous area to
take the ratio of the low elasticity and high elasticity. The breast areas are to be
reported followed by the detailed report of the lesion. The specific area report should
include color, elasticity and the presence of signal void area.
7. Interpretation of shearwave elastography
Shearwaves are ultra-fast waves generated by acoustic force radiation travel
transversely into the tissues and display output in qualitative and quantitative
mode. The qualitative outcome is displayed in the form of color change that ranges
from dark blue (i.e., normal tissue) to yellow, orange (i.e., benign) and finally red
and dark red (i.e., malignancy) (Figures 5a, 6–9). The corresponding quantitative
measurement ranges from 0 to 300 (Figure 5b). The tissue elasticity of the breast
Figure 5.
Qualitative parameter (a) and quantitative parameters (b) of breast lesion assessment on shearwave
elastography.
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showed negative correlation with the age i.e., as the age advances the tissue elastic-
ity reduces [3]. This can be explained by natural evolution of the breast where with
advancing age breast parenchyma replaced by fat tissue. This should always be
borne in mind that high resolution good quality images can only be interpreted. In
case if there is so much of background noise and the images are not giving a clear
description it’s better to avoid interpretation of such images. In this regard the best
approach is to do a combine approach with B-mode first. With the B-mode imaging
identify the lesion and its characteristics then SWE be applied on the lesion in order
to avoid influence of artifacts.
Figure 6.
Benign breast cyst on shearwave elastography.
Figure 7.
Invasive lobular carcinoma appearance on shearwave elastography.
Figure 8.
Invasive ductal carcinoma appearance with signal void area on shearwave elastography.
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As the elasticity increases the kilopascal measurements also rises. However, in
certain situations where intrinsic factors of the tumor show false negative results such
as in situ cancers. While age of the patients, high risk lesions, tumors closer to the
chest wall or overlying skin or deep seated tumors were likely to develop false
positives results [13]. The study including 428 smaller tumor (≤2 cm) compared
conventional B-mode ultrasound with SWE combined approach. The results showed
that SWE combined approach was superior than B-mode alone, however in situ
cancers showed false negative results [13]. Another study showed that presence of in
situ tumor, calcifications and tumors near the nipple are likely to produce inaccurate
results [34]. The study was conducted on non-palpable breast lesions including
79 malignant and 73 benign breast lesions. The smaller size of the lesion was also
associated with inaccurate results in the study [34]. The inaccuracies in SWE inter-
pretation could be explained by the nature of the lesion such as the case of in situ
cancers, which has not yet produced that high reaction of the surrounding
peri-tumoral tissue. The age of the patient and the location of the tumor potentially
have influence of the breast tissue elasticity. The study including 1137 tumors to differ-
entiate characteristics of the types of breast cancers on SWE. There was no character-
istic difference in different histological types of cancers with exception of tubular type
which showed less elasticity [35]. The fibroadenomas on the other hand show false
positive expression if they were larger in size [36]. Interestingly lobular carcinoma has
potential to display itself as benign or probably benign on B-mode ultrasound or
mammogram but SWE showed higher rate of picking up lobular cancers [37].
The characteristics of the benign and malignant lesions were evaluated in a
prospective cross-sectional study including 119 women. These patients underwent
clinical breast examination, followed by conventional ultrasound then SWE and
finally ultrasound guided tissue biopsy. The results showed that the benign lesions
tend to be oval or round in shape with homogenous echopattern. Their color ranges
from blue to yellow and green but reasonably homogenous with low elasticity. On the
other hand malignant lesions were in contrast with irregular margins, heterogeneous
echopattern and color from red to dark red in correlation with high elasticity [38].
The debatable issue lies with SWE is the operator dependency which is attached
to B-mode ultrasound by default. The application of the probe is crucial with
dependency on the operator; however there is less influence on the results if the
technique of the probe application is correct.
In this regard, a study compared an operator with 15 years experience with that
having 1 year [39]. The reproducibility of the results was high with SWE showing
Figure 9.
Invasive ductal carcinoma appearance on shearwave elastography—without signal void area.
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Figure 9.
Invasive ductal carcinoma appearance on shearwave elastography—without signal void area.
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less dependency on operator experience for interpretation, while intra-observer
reproducibility has been reported to be 0.789 on SWE [25].
There are a number of parameters which could be utilized for interpretation
such as mean elasticity value, minimum elasticity value and maximum elasticity.
Most of the studies showed maximum elasticity value in kilopascals as the most
reliable to be considered. However, all parameters need to be observed in cases of
highly heterogeneous cancers.
8. Breast lesion scoring system
The authors have developed a scoring system for better diagnostic yield of
shearwave elastographyby combining qualitative andquantitative characteristics of the
breast lesions. The scoring system takes into account the change of color, quantitative
measurement of stiffness in kilopascals (kPa) and presence or absence of the signal void
area (i.e., punched out lesion). A summary of the scoring system is given inTable 3.
Hard solid tumors showed dark color on qualitative measure, while benign soft
tumors show natural color including blue, yellow orange. Normal breast tissue is
blue in color. Fibrocystic lesion change color from blue to yellow or even orange but
none of the benign lesions turn dark red. Similarly all the malignant lesion were red
in different shades. Quantitative measurement of the kPa of benign lesions was low
with less stiffness while solid tumor and cancers show score >200. Dark red color on
qualitative scale and >250 kPa was invariably seen in cancers. When the cancer gets
really hard and shear waves fail to penetrate resulting in signal void area punched
out lesion. There was an exception of breast abscess which also showed signal void
area due to cavity. The differing point of the breast abscess and the malignant breast
lesion was based on color and mean kPa score while signal void area was seen in
majority of both cases. Figures 10–12 portray the breast lesion from benign to
malignant pathologies.
Parameter Score 1 Score 2 Score 3
Color Blue, yellow, orange Red, dark red Dark red
Mean kPa range <200 >200 but <250 >250
Punched out lesion status Absent Present May be present
Table 3.
Scoring system to interpret Shearwave elastography findings of breast lesions.
Figure 10.




Shearwave elastography is a new advanced technique with ultrafast mode of
shearwaves to assess elasticity of the tissue. It has established role in assessment of
the liver fibrosis. The available literature favors use of shearwave elastography in
combination with B-mode ultrasound to enhance diagnostic accuracy of the con-
ventional ultrasound. However, it has not been widely used in clinical practice.
Though it has shown great potential in differentiating BIRAD 3 and 4 categories and
successfully avoiding negative biopsies.
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Pancreatic elastography represents a challenging new procedure for inflam-
matory pathology or tumour masses. There are technical difficulties for accurate 
assessment of pancreatic stiffness due to deep localization. But the new software for 
both conventional and endoscopic ultrasound are promising techniques for differ-
ential diagnosis between malignant tumours and different forms of chronic pancre-
atitis (groove pancreatitis or autoimmune pancreatitis). Early diagnosis of chronic 
pancreatitis, noninvasively by transabdominal shear wave elastography, is actively 
studied nowadays. Elastography might offer a predictive tool for the occurrence of 
pancreatic fistula after pancreatoduodenectomy. This chapter introduces the recent 
innovation of pancreatic elastography and makes recommendations for its use.
Keywords: pancreas, elastography, pancreatic cancer, chronic pancreatitis
1. Introduction
The pancreatic pathology assessment represents a challenge even today when 
many imaging techniques are available. The differentiation between chronic 
pancreatitis and malignant lesions requires sometimes many imaging combined 
procedures, even histology, without an accurate assessment. The elastography 
development used the principle that the assessment of a tissue elasticity of tis-
sue might differentiate a benign soft lesion from a malignant hard tissue. But the 
stiffness assessment and measurement of this small organ, deeply localised in the 
retroperitoneum, are difficult. High accuracy and reproducibility of pancreatic 
elastography are not easily obtained, as the histology is not always available [1].
Nowadays both transabdominal ultrasound (US) and endoscopic ultrasound 
(EUS) allow pancreatic elastography assessment. There are two types of pancreatic 
elastography: strain elastography and shear wave speed elastography [1]. In the case 
of strain elastography, the stiffness of pancreatic tissue is estimated by measuring 
the grade of strain generated by external pressure. For shear speed elastography, the 
stiffness is estimated by measuring the propagation speed of the shear wave (the 
transverse wave) generated by acoustic radiation force impulse (ARFI) [1].
The results of elastography can be the strain, which has a negative correlation 
with tissue stiffness, and the shear wave speed, which has a positive correlation 
with tissue stiffness [2].
Elastography that measures shear wave speed is classified into shear wave elas-
tography, which uses ARFI as the method to excite shear waves, and transient elas-
tography, in which shear waves are excited in a mechanical manner. Fibroscan™, 
the only transient elastography device, is not used for the pancreas due to its 
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Elastography that measures shear wave speed is classified into shear wave elas-
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tography, in which shear waves are excited in a mechanical manner. Fibroscan™, 
the only transient elastography device, is not used for the pancreas due to its 
localization [2]. Shear wave speed might be displayed by two different methods: as 
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the average speed within a small region (target ROI) and as an image reflecting the 
distribution of the speeds in the ROI [2].
2. Transabdominal ultrasound: strain elastography
The stiffness of pancreatic tissue is estimated through transabdominal ultra-
sound by measuring the grade of strain generated by aortic pulsation [1–4]. The 
relationship between the grade of strain and the stiffness of target tissue is nega-
tive correlation: the greater the strain, the softer pancreatic tissue is. For a proper 
assessment, the target tissue should be located in line between the probe and the 
aorta [1]. A fine elastogram can be easily obtained in the pancreatic body, except for 
the patients with severe arteriosclerosis. The elastograms obtained in the pancreatic 
head and tail should be interpreted with caution [1].
Strain elastography of the pancreas can be obtained with transabdominal 
ultrasound (US) and with EUS.
First clinical application of US elastography had been reported with real-time 
tissue elastography™ (RTE) produced by Hitachi Aloka [5, 6]. In the conventional 
RTE, only qualitative diagnosis using colour map was possible. This technique 
measures compression-induced tissue deformation (strain) within a region of inter-
est (ROI), which is visualised using a transparent colour overlaying on the B-mode 
image. In this colour map, the hardest tissue is displayed as blue, and the softest 
tissue is displayed as red. In RTE, pancreatic cystic lesions cannot be evaluated, due 
to artefacts, when fluid component of cyst was assessed.
The first report of the usefulness of US elastography for the pancreas in clinical 
practice was published by Uchida et al. in 2009 [7]. They defined typical colour 
map observed in US-RTE for different clinical scenarios: homogeneous colour in 
normal pancreas, markedly hard area with soft spots, was in pancreatic ductal 
adenocarcinoma, uniform and soft comparable to parenchyma in neuroendocrine 
tumour and mixture of various colours in chronic pancreatitis. The same authors 
reported the 70–80% diagnostic accuracy for pancreatic tumours of B-mode alone; 
when B-mode was combined with US-RTE, the diagnostic accuracy was more than 
90% [7].
This qualitative diagnosis using colour map was subjective and highly opera-
tor dependent; quantitative diagnosis using strain ratio was established since the 
second generation of RTE. Strain ratio was defined as the ratio of the strain of 
reference tissue (B) divided by the strain of target tissue (A).
Strain ratio was adapted from the theory called “fat lesion ratio” reported in 
the breast, which means the ratio of the strain of fat around the mammary gland 
divided by the strain of target tissue. The initial principal considered that the stiff-
ness of fat was almost equal in different individuals [1]. To date no consensus exists 
for the reference area, on non-tumorous area inside the pancreatic parenchyma 
[8, 9] or on red area around the pancreas, estimated to be fat [10, 11]. There is no 
evidence if red area around pancreas is really fat. The strain ratios calculated for the 
same target tissue quite differ according to wherever the reference area is set [1].
The cutoff levels of strain ratio for differential diagnosis between malignant and 
benign varied in reported studies [9–11], meaning that pancreatic RTE is highly 
operator dependent and lacks adequate reproducibility.
A fine B-mode image is required for a fine elastogram, and this is obtained 
within 6 cm in depth from the body surface in US. Therefore, pancreatic elastogram 
is quite difficult in the obese. Also B-mode image is easily affected by gastrointesti-
nal gas in US. These problems will occur less frequently in EUS.




• The most important is to obtain a quality B-mode images with as few artefacts 
as possible.
• Examination is made from the epigastric fossa in a dorsal position, (semi) 
sitting position, or left lateral decubitus position.
• No vibration should be caused by the probe, which should lightly touch the 
abdominal wall.
• The patient should hold his breath.
• Two settings for ROI are accepted [12]: (1) ROI is set only within the target 
area; (2) ROI is set both within the target area and the surrounding tissue. The 
second is recommended for neoplastic cancer assessment.
• The colours in an elastogram minutely vary with the passage of time according 
to cardiovascular pulsation. It is desirable that elastograms with good repro-
ducibility are taken at every pulsation by recording the images of elastograms 
in a range of 5–10 pulsations.
3. Transabdominal ultrasound: shear wave elastography
For this type of elastography, emission of ARFI is possible for the entire pan-
creas. Virtual Touch™ quantification (VTQ ) produced by Siemens is a representa-
tive instrument. VTQ displays the stiffness of pancreatic tissue digitally shear wave 
velocity being measured. SWV is expressed in m/s. If an error occurs, X,XX m/s is 
displayed on the right part of the screen instead of digits [1].
Even if this technique is very promising for the pancreas, there are some issue to 
be considered. There is a limit to the acoustic radiation force impulse that is cer-
tainly safe within the body [2]. Also, when the tissue in the ROI is hard, measure-
ment error tends to occur, because it is difficult to generate sufficient shear waves. 
When SWV of a pancreatic tumour cannot be assessed, ROI should be placed on 
a tip of the tumour [2]. If the target area is far from the probe, the attenuation of 
the focused ultrasound reduces the acoustic radiation force impulse, which in turn 
reduces the amplitude of the shear waves, making it difficult to detect the shear 
waves [12]. The safety standards are accomplished by the focused ultrasound 
[2], but the transmission waveform and wavelength are different from the usual 
ultrasonic pulses. A concern is represented by its influence on the body, through a 
possible increase in temperature [13]. Its safety in simultaneous use with contrast 
media is not confirmed yet [14].
It is recommended to repeat three times the same measurement for the same 
site about if the reproducibility is high. If the reproducibility is low, a measurement 
should be repeated 10 times for the same site and the median is used [2].
New ARFI software are developed (ElastPQ™ (Philips), Virtual Touch™ IQ: 
VTIQ (Siemens)), but their use for the pancreatic pathology is still limited.
Instead the Shear Wave™ Elastography (SWE) (Super Sonic Imaging) uses a 
new approach. In SWE, ultrasonic beams are continuously emitted to different 
depths in the tissue, and thus a conically shaped wave surface of shear waves is 
formed [2]. By an ultrafast imaging method, the shear wave speed is measured. 
The transducers repeat outgoing/incoming transmissions of ultrasonic waves. A 
colour map is displayed in the ROI, which can be defined in any location [2]. The 
mean ± SD, the minimum value, and the maximum value of the shear wave speed 
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in the ROI are displayed. A ratio is calculated when two ROIs in different locations 
are compared. The study conducted by Arda et al. [15] reported measurement of 
stiffness for normal pancreas: 11.1 ± 3.2 kPa for males and 10.8 ± 3.1 kPa for females.
4. Echo-endoscopy elastography: strain elastography
The first report of EUS elastography was published in 2005 by Hirooka et al. [5]. 
Then many papers reported their experience using RTE for pancreatic EUS elastog-
raphy, being for many years the only system available. In RTE obtained by EUS, the 
diagnosis is qualitative. It is recommended that the ROI to be set to include peripan-
creatic tissue [2]. Red colour corresponds to the softest tissue within ROI, and blue 
corresponds to the hardest tissue within ROI. The remaining tissue is displayed as 
a coordinated colour between red and blue according to its stiffness. As the colour 
map depends on the size of ROI in RTE, it is not an absolute one [1].
Some technique aspects should be kept in mind for a qualitative elastogram [2]. 
The EUS probe should be lightly touching the wall of the stomach or the duodenum. 
The selected image must be without artefacts. The ultrasonic beam should be 
towards the aorta, and the strain should be generated in the depth direction. The 
RTE image should be stably generated for a certain period (5 s or longer in normal 
cases). For the evaluation of vibration energy, it would be preferable to refer to 
a strain indicator or to a strain graph. A good-quality B-mode image should be 
obtained to suit the RTE image [2].
The main debated issue was the differentiation of benign vs. malignant. The 
diagnostic criteria to differentiate malignancy from benignancy considered two 
aspects: (1) the dominant colour within colour map and (2) the homogeneity of 
colour map [1].
In a multicentre study on 121 patients with pancreatic tumours (92 malignant 
and 29 benign), Giovannini et al. [16] proposed a scoring system: score 1, homo-
geneous green represents normal tissue; score 2, heterogeneous soft tissue (green, 
yellow, and red) corresponds to inflammatory tissue; score 3, mixed colour or 
honeycombed can be attributed to any pathology; score 4, small green central area 
surrounded by mainly blue; and score 5, mainly blue with heterogeneous green and 
red, represents advanced malignant lesion. Scores 1 and 2 were considered benign, 
and scores 4 and 5 were assigned to malignant pathology. The sensitivity and 
specificity for this score were 92.3 and 80% [16].
The (semi) quantitative evaluation is possible, being more objective, but the 
analytical procedure is complicated. The image quantitative analysis reported 
included strain ratio [9, 10, 17], strain histogram [18, 19], and neural network 
[20–22]. A comparison between different analysis methods has not been conducted, 
so there is no consensus about which of these methods is the best.
5. Clinical applications for pancreatic elastography
Uchida et al. [7] published the first report evaluating the usefulness of US 
elastography for the pancreas in 2009. They reviewed elastograms performed for 10 
normal pancreas and reported the typical colour map for normal pancreas assessed 
by RTE as homogeneous colour.
The normal reference values of pancreas stiffness using ARFI elastography 
through Virtual Touch Tissue Quantification (Siemens) were reported by Zaro et al. 
in 2016 [23]: from the entire parenchyma—1.216 m/s ± 0.36 (head, 1.224 m/s; body, 




between increasing age and elastographic parameters [24]. Using SWE (Super Sonic 
Imaging) Arda et al. [15] reported measurement of stiffness for normal pancreas: 
11.1 ± 3.2 kPa for males and 10.8 ± 3.1 kPa for females.
6. Benign vs. malignant mass pancreatic lesions
The most frequent use of elastography in pancreatic pathology is for differential 
diagnosis between benign and malignant focal lesions.
The number of reports on strain elastography with US is extremely small in 
comparison with EUS.
Uchida et al. [7] used strain elastography with US to evaluate the colour patterns 
of the pancreatic cancers, pancreatic endocrine tumours, and chronic pancreatitis. 
They concluded that adding strain elastography to the B-mode observations the 
Figure 1. 
Advanced pancreatic adenocarcinoma assessed by EUS-RTE. Elastogram is mainly blue with heterogeneous 
green and red corresponding to score 5 from Giovannini classification.
Figure 2. 
Small neuroendocrine tumour at the tail of the pancreas assessed by EUS-RTE. Elastogram depicts 
heterogeneous small points surrounded by mainly blue corresponding to score 4 from Giovannini classification.
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(a) EUS B-mode. Dilated common bile duct and suspicion of periampular tumour. (b) A “tumour-like 
image, suspected of malignancy” on elastogram, due to its blue (hard) appearance. This false elastogram is 
due to the angulations of distal tip of echo-endoscope. (c) A correct assessment of the stiffness of the ampular 
region displays a mixed inflamed tissue: heterogeneous soft tissue (green and red) corresponding to score 2 in 
Giovannini classification.
diagnosis sensitivity is improved [7]. Kawada et al. [8] reported the use of strain 
ratio to distinguish between malignancy and benignancy of pancreatic solid 
tumours. The evaluation of the pancreatic tumours by transabdominal shear wave 




of the pathological parenchyma indicated an increase of the SWV at the tumoral 
(cephalic) level corresponding to 1.54 ± 0.32 m/s compared to 1.21 ± 0.27 m/s for 
normal pancreas in the control group. Future research is needed to validate this 
data.
Most reports regarding EUS elastography for the pancreas are associated with 
the differential diagnosis between benign and malignant solid pancreatic tumours, 
being published several meta-analyses related to the differential diagnosis of 
pancreatic tumours [26, 27]. Elastograms for pancreatic adenocarcinoma and 
neuroendocrine tumours are displayed in Figures 1 and 2.
The sensitivity of EUS elastography for the differential diagnosis of pancreatic 
tumours is reported to be excellent ranging from 95 to 99%, while its specificity is 
reported to be inadequate ranging from 67 to 76% [1, 26, 27]. This low specificity 
is explained by the increased stiffness of benign nodule from chronic pancreatitis 
due to severe fibrosis. Fine needle aspiration through EUS is still mandatory even in 
cases with proper assessment of pancreatic tissue stiffness. There are few selective 
cases in which EUS-FNA cannot be performed, and the malignant diagnosis argu-
ments include elastography [28]. But consensus criteria for differential diagnosis 
between malignant and benign pancreatic tumours were not established.
In clinical practice there are many challenging diagnosis. The images obtained 
with EUS elastography should be integrated in the clinical context of the patient, 
being complementary to other imaging techniques. Small tumour-like images, with 
suggestive malignant features at elastogram, should be interpreted with caution. 
To assess the quality and reproducibility of the elastography image, a consistent 
colour pattern obtained in a number of consecutive frames is indicated. If there are 
different elastograms obtained for the same tumour-like image (Figure 3a–c), all 
the technical adjustments should be rechecked.
7. Chronic pancreatitis
Chronic pancreatitis is frequently diagnosed in advance stages. Echo-endoscopy 
may be a useful method for the early diagnosis of chronic pancreatitis, even its 
diagnostic criteria are operator dependent.
Shear wave elastography using transabdominal US might be an objective and 
noninvasive method for the early diagnosis of pancreatic fibrosis. Yashima et al. 
[29] subjected 46 patients with chronic pancreatitis and 52 normal pancreas and 
measured SWV at the head, the body, and the tail of the pancreas for 10 times in 
each case and reported a sensitivity of 75% and a specificity of 72% for detec-
tion of chronic pancreatitis. They also determined the cutoff of SWV optimal 
for diagnosing chronic pancreatitis as 1.40 m/s by ROC analysis. Multivariate 
analysis detected that severe alcohol intake (OR = 3.87, p = 0.005) and deeper 
depth of the pancreas from the body surface ≥4.2 cm (OR = 0.10, p = 0.002) 
were associated with the stiffness of the pancreas (>1.40 m/s) [12]. Kuwahara 
et al. [30] reported that chronic pancreatitis might be diagnosed noninvasively 
and objectively using SW-EG without performing EUS, the diagnosis accuracy 
being 77%.
Many reports evaluated the accuracy of EUS elastography for the diagnosis of 
pancreatic fibrosis. An elastogram in a patient with chronic pancreatitis is dis-
played in Figure 4. Itoh et al. [18] performed EUS elastography preoperatively for 
the proximal side of the pancreatic tumour and compared the elastograms with 
microscopic findings of the resected specimens. They found significant correlation 
between objective parameters assessed by elastography (mean, standard deviation, 




(a) EUS B-mode. Dilated common bile duct and suspicion of periampular tumour. (b) A “tumour-like 
image, suspected of malignancy” on elastogram, due to its blue (hard) appearance. This false elastogram is 
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Giovannini classification.
diagnosis sensitivity is improved [7]. Kawada et al. [8] reported the use of strain 
ratio to distinguish between malignancy and benignancy of pancreatic solid 
tumours. The evaluation of the pancreatic tumours by transabdominal shear wave 




of the pathological parenchyma indicated an increase of the SWV at the tumoral 
(cephalic) level corresponding to 1.54 ± 0.32 m/s compared to 1.21 ± 0.27 m/s for 
normal pancreas in the control group. Future research is needed to validate this 
data.
Most reports regarding EUS elastography for the pancreas are associated with 
the differential diagnosis between benign and malignant solid pancreatic tumours, 
being published several meta-analyses related to the differential diagnosis of 
pancreatic tumours [26, 27]. Elastograms for pancreatic adenocarcinoma and 
neuroendocrine tumours are displayed in Figures 1 and 2.
The sensitivity of EUS elastography for the differential diagnosis of pancreatic 
tumours is reported to be excellent ranging from 95 to 99%, while its specificity is 
reported to be inadequate ranging from 67 to 76% [1, 26, 27]. This low specificity 
is explained by the increased stiffness of benign nodule from chronic pancreatitis 
due to severe fibrosis. Fine needle aspiration through EUS is still mandatory even in 
cases with proper assessment of pancreatic tissue stiffness. There are few selective 
cases in which EUS-FNA cannot be performed, and the malignant diagnosis argu-
ments include elastography [28]. But consensus criteria for differential diagnosis 
between malignant and benign pancreatic tumours were not established.
In clinical practice there are many challenging diagnosis. The images obtained 
with EUS elastography should be integrated in the clinical context of the patient, 
being complementary to other imaging techniques. Small tumour-like images, with 
suggestive malignant features at elastogram, should be interpreted with caution. 
To assess the quality and reproducibility of the elastography image, a consistent 
colour pattern obtained in a number of consecutive frames is indicated. If there are 
different elastograms obtained for the same tumour-like image (Figure 3a–c), all 
the technical adjustments should be rechecked.
7. Chronic pancreatitis
Chronic pancreatitis is frequently diagnosed in advance stages. Echo-endoscopy 
may be a useful method for the early diagnosis of chronic pancreatitis, even its 
diagnostic criteria are operator dependent.
Shear wave elastography using transabdominal US might be an objective and 
noninvasive method for the early diagnosis of pancreatic fibrosis. Yashima et al. 
[29] subjected 46 patients with chronic pancreatitis and 52 normal pancreas and 
measured SWV at the head, the body, and the tail of the pancreas for 10 times in 
each case and reported a sensitivity of 75% and a specificity of 72% for detec-
tion of chronic pancreatitis. They also determined the cutoff of SWV optimal 
for diagnosing chronic pancreatitis as 1.40 m/s by ROC analysis. Multivariate 
analysis detected that severe alcohol intake (OR = 3.87, p = 0.005) and deeper 
depth of the pancreas from the body surface ≥4.2 cm (OR = 0.10, p = 0.002) 
were associated with the stiffness of the pancreas (>1.40 m/s) [12]. Kuwahara 
et al. [30] reported that chronic pancreatitis might be diagnosed noninvasively 
and objectively using SW-EG without performing EUS, the diagnosis accuracy 
being 77%.
Many reports evaluated the accuracy of EUS elastography for the diagnosis of 
pancreatic fibrosis. An elastogram in a patient with chronic pancreatitis is dis-
played in Figure 4. Itoh et al. [18] performed EUS elastography preoperatively for 
the proximal side of the pancreatic tumour and compared the elastograms with 
microscopic findings of the resected specimens. They found significant correlation 
between objective parameters assessed by elastography (mean, standard deviation, 
skewness, kurtosis) and the grade of fibrosis evaluated by histology. Iglesias-Garcia 
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et al. [31] reported a positive correlation between strain ratio and Rosemont clas-
sification (r = 0.813, p < 0.0001).
EUS elastography could predict pancreatic exocrine dysfunction in patients with 
chronic pancreatitis [32]. Iglesias-Garcia et al. [31] found significant correlation 
between strain ratio and pancreatic exocrine dysfunction evaluated by 13C-mixed 
triglyceride breath test.
In autoimmune pancreatitis the specific elastogram detected in five cases was 
homogenous stiffness of the whole organ, different from the circumscribed mass 
lesion in ductal adenocarcinoma [33].
8. Prediction of pancreatic fistula after pancreatic surgery
There are studies reporting that the stiffness of the pancreas measured preoper-
atively could predict the incidence of postoperative pancreatic juice fistula [34–36]. 
The postoperative fistula was observed more frequently in patients with lower 
stiffness of the pancreas (SWV < 1.54 m/s) than in patients with higher stiffness of 
the pancreas (63 vs. 17%, p < 0.001) [34].
9. Conclusions
The aim of pancreatic elastography for the pancreas is to reflect accurately the 
histological structure. The pancreatic elastography is challenging, as the access 
to this small organ is not easy, deep in the centre of the body. Also the biopsy 
specimens are difficult to obtain for direct comparison. Many of the challenges 
were resolved by the new technical achievements in the recent years. Both transab-
dominal US and EUS elastography might offer the clinicians an important tool for 
depiction of early chronic pancreatitis and a reliable tool for differential diagnosis 
between malignant and benign pancreatic masses.
Figure 4. 
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Assessment of De Quervain 




Elastography was introduced to clinical practice almost two decades back, to 
further enhance ultrasound imaging for illustrating the difference in mechanical 
properties between diseased and healthy tissues, i.e., difference in tissue stiffness, 
in a qualitative and quantitative way. In the nineteenth century, Fritz De Quervain 
reported patients with pain and swelling at the wrist. It is an entrapment condition 
of the tendons within the first extensor compartment. The advantages of ultrasound 
(U/S), in general, is being a rapid bed-side test, low cost, availability, and great 
patient compliance all of which elastography makes use of. Elastography imaging for 
liver fibrosis assessment is a well-known technique; yet recent territories for tissue 
elasticity assessment are emerging. One of these large territories is muscle tendons 
elasticity assessment in different pathologic conditions. One of these areas is changes 
in tendons stiffness. Fifty-two subjects were studied, 30 diseased and 22 healthy. The 
main complaint of the diseased group was pain at the radial side of the wrist, while 
healthy subjects were symptom free. Sensitivity was 92%, while specificity was 93%. 
From my work, I reached the conclusion of that the disease can be diagnosed with 
strain-based elastography in a quantitative way with confidence and reliability.
Keywords: ultrasound, elastography, strain-based elastography, strain elastography, 
wrist joint, De Quervain tenosynovitis
1. Introduction
Elastography was introduced to clinical practice almost two decades back, to 
further enhance ultrasound imaging [1] and illustrate the difference in mechanical 
properties between diseased and healthy tissue [2], i.e., difference in tissue stiff-
ness, in a qualitative and quantitative way. The basic idea of elastography is to take 
advantage of the changed tissue elasticity/stiffness during tissue disease as com-
pared to adjacent similar normal tissues.
The advantages of ultrasound (U/S)—in general—is being a rapid bed-side test, low 
cost, availability, and great patient compliance all of which elastography makes use of.
Elastography imaging for liver fibrosis assessment is a well-known technique; 
yet recent territories for tissue elasticity assessment are emerging. One of these large 
territories is muscle tendons elasticity assessment in different pathologic condi-
tions. One of these areas is changes in tendons stiffness.
In the nineteenth century, Fritz De Quervain reported patients with pain and 
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Elastography was introduced to clinical practice almost two decades back, to 
further enhance ultrasound imaging for illustrating the difference in mechanical 
properties between diseased and healthy tissues, i.e., difference in tissue stiffness, 
in a qualitative and quantitative way. In the nineteenth century, Fritz De Quervain 
reported patients with pain and swelling at the wrist. It is an entrapment condition 
of the tendons within the first extensor compartment. The advantages of ultrasound 
(U/S), in general, is being a rapid bed-side test, low cost, availability, and great 
patient compliance all of which elastography makes use of. Elastography imaging for 
liver fibrosis assessment is a well-known technique; yet recent territories for tissue 
elasticity assessment are emerging. One of these large territories is muscle tendons 
elasticity assessment in different pathologic conditions. One of these areas is changes 
in tendons stiffness. Fifty-two subjects were studied, 30 diseased and 22 healthy. The 
main complaint of the diseased group was pain at the radial side of the wrist, while 
healthy subjects were symptom free. Sensitivity was 92%, while specificity was 93%. 
From my work, I reached the conclusion of that the disease can be diagnosed with 
strain-based elastography in a quantitative way with confidence and reliability.
Keywords: ultrasound, elastography, strain-based elastography, strain elastography, 
wrist joint, De Quervain tenosynovitis
1. Introduction
Elastography was introduced to clinical practice almost two decades back, to 
further enhance ultrasound imaging [1] and illustrate the difference in mechanical 
properties between diseased and healthy tissue [2], i.e., difference in tissue stiff-
ness, in a qualitative and quantitative way. The basic idea of elastography is to take 
advantage of the changed tissue elasticity/stiffness during tissue disease as com-
pared to adjacent similar normal tissues.
The advantages of ultrasound (U/S)—in general—is being a rapid bed-side test, low 
cost, availability, and great patient compliance all of which elastography makes use of.
Elastography imaging for liver fibrosis assessment is a well-known technique; 
yet recent territories for tissue elasticity assessment are emerging. One of these large 
territories is muscle tendons elasticity assessment in different pathologic condi-
tions. One of these areas is changes in tendons stiffness.
In the nineteenth century, Fritz De Quervain reported patients with pain and 
swelling at the wrist. It is an entrapment condition (tendon inflammation) of the 
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tendons within the first extensor (dorsal) compartment of the wrist back of the 
wrist; patients suffered pain during motion of the thumb. The tenosynovitis affects 
the abductor pollicis longus (APL) and the extensor pollicis brevis (EPB) tendons-
muscle tendons at the back of the wrist [3].
Anatomically, the first extensor compartment of wrist joint is lying between the 
radial styloid process and the base of the thumb, containing two muscle tendons: 
the abductor pollicis longus (APL).
De Quervain disease is considered the second most common tendon entrap-
ment condition after trigger finger. Because of repeated trauma, the first dorsal 
extensor compartment tendons thicken, hindering their gliding through the tight 
 fibro-osseous tunnel.
In B-mode ultrasound scan of the first dorsal compartment, we can find one 
or more of the following criteria: fluid collection, thickening of tissues, or tis-
sue edema. Colored Doppler application to the tissue under investigation shows 
increased blood flow to the area.
2. Elastography techniques
Tissue elasticity is assessed with ultrasound tissue elastography. Elasticity of a 
tissue is its tendency to resist deformation when applying force the tissue in ques-
tion, or regaining its original shape after cessation of the force. The idea of elastog-
raphy is based on assuming that the tissue under examination is entirely elastic and 
has no viscosity [4].
Two main techniques are developed to measure tissue elasticity quantitatively 
using ultrasound machines:
1. Strain technique: apply normal stress to the tissue and the normal strain of the 
tissue is calculated; where tissue strain is its ability to expand after removal of 
the stress [4].
2. Shear-wave technique: a dynamic stress applied to the tissue under examina-
tion using different techniques to apply such a dynamic stress, and the tissue 
strain is calculated [4].
3. Strain technique
Strain technique is first to evolve between the two techniques mentioned above, 
and it uses two methods for strain calculation: either strain elastography or acoustic 
radiation force impulse (ARFI). What we are concerned here is about the first 
method, i.e., strain elastography.
Strain elastography can be achieved by two methods of excitation:
1. Manual compression by the operator using the ultrasound transducer; pro-
vided that the examined tissue is superficial.
2. No manual compression; where tissue displacement occur physiologically with 
internal organs as cardiovascular or respiratory systems, hence deeper struc-
tures could be studied.
What we are concerned with here is manual compression that is explained in 
details later on.
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4. Tsukuba score for tissue elasticity
Tsukuba elasticity score is a 1–5 score scale; built upon a map of stiffness of 
tissues in and around the pathologically affected segment, and the score calculated 
based upon the stiffness of the lesion in relation to the surrounding tissues.
a. Lesions scored (1): lesion has less or equal stiffness to surrounding tissues;
b. Lesions scored (2): lesion has mixed areas of stiffness;
c. Lesions scored (3): lesion is stiffer than surrounding tissue, and on elastogram 
has lesser size than B-mode ultrasound;
d. Lesions scored (4): lesion is stiffer than the surrounding tissue, and on elasto-
gram has same size as B-mode ultrasound; and
e. Lesions scored (5): lesion is stiffer than the surrounding tissue, and larger on 
elastogram than B-mode ultrasound.
5. Study goal
My hypothesis was that with the pathological changes in the first extensor com-
partment tendons of the wrist by virtue of the disease, we could use the Tsukuba 
score for tissue elasticity [5] to quantitatively assess the elasticity or hardness of the 
affected tendons.
6. Ultrasound and strain-based elastography examination technique
Ultrasound examinations performed using Philips IU22 xMatrix machine 
(Philips Ultrasound, Bothell, WA, USA) with linear transducer (12–15 MHz). 
Advanced small parts option and elastography QLAB were used.
The patient positioned in sitting at the edge of the examination couch with 
legs dependent, i.e., both knees flexed at right angle with forearm under examina-
tion positioned over the ipsilateral thigh in pronation with a clean plastic sheet in 
between the thigh and forearm of the patient.
B-mode ultrasound examination of the compartment retinaculum and tendons 
performed at the start to scrutinize the full spectrum of the lesion in transverse and 
longitudinal views.
Strain-based elastography was then performed by applying controlled pressure 
over the compartment guided by colored column on screen of ultrasound machine 
to achieve the proper pressure amount for strain-based elastography calculation by 
the machine.
Strain-based elastography mean and standard deviation calculations readings 
are then displayed.
Three strain-based elastography readings are taken for the patient and 
averaged to calculate the final reading, which will be used to diagnose the 
condition.
7. The problem
The condition is an entrapment syndrome.
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The first extensor compartment of wrist joint is lying between the radial styloid 
process and the base of the thumb, containing two muscle tendons: the abductor 
pollicis longus (APL), which is inserted into the base of the first metacarpal bone, 
or into trapezium bone and extensor pollicis brevis (EPB), which is inserted into the 
proximal phalanx of the thumb [6].
The APL and EPB muscle tendons with their synovial sheets travel under the 
extensor retinaculum, which are attached to radial styloid forming tight fibro-
osseous tunnel.
9. Epidemiology
De Quervain tenosynovitis is considered the second most common tendon 
entrapment condition after stenosing tenosynovitis-trigger finger [7].
The condition occurs in middle-aged persons with 3:1 female to male ratio [7].
The condition occurs by the virtue of repetitive wrist movement associated with 
thumb radial abduction with wrist extension and radial wrist deviation [8].
The classic populations are mothers and childcare workers; however, secretaries 
and nurses much presented [7, 8]. Other populations affected are golf players or 
frequent hammer users [9, 10].
Modern life style escalated the incidence of De Quervain tenosynovitis because 
of computer and cellular phones excessive use [11].
10. Clinical presentation
Main patient complaint is pain and swelling over the styloid process of the 
radius [12].
On examination, swelling and tenderness over radial styloid found. Crepitus 
and triggering may be also found [12].
Finkelstein’s test, the clinical test examination, involves flexion of the meta-
carpophalangeal joint of the thumb in a closed hand followed by ulnar deviation 
passively of the wrist joint can replicate the pain at radial styloid [9, 12].
11. Pathology
Because of repeated trauma, the APL and EPB tendons thicken, hindering their 
gliding through the tight fibro-osseous tunnel [13, 14].
Pathologically, the tendons are thickened by virtue of degenerative changes such 
as myxoid degeneration, deposition of mucopolysaccharides, and fibrocartilag-
enous metaplasia [13, 14].
Hence, it is a misnomer to call the condition tenosynovitis, as the pathological 
changes do not involve tendons inflammation [15].
12. B-mode ultrasound findings
Several findings could be detected in B-mode ultrasound scan of the first dorsal 
compartment prior to strain-based elastography application; these findings include [16]:
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• Fluid collection in the tendon sheaths (Figure 1).
• Thickened overlying retinaculum.
• Thickened synovial sheaths (Figure 2).
• Thick edematous tendons of APL and EPB (Figure 3) at level of styloid process 
of the radius (compared with contralateral side).
• Halo sign; due to edema in the tissues surrounding the tendons.
• Doppler application reveals hyperemia surrounding the tendons.
Figure 1. 
Fluid collection in the synovial sheaths of APL and EPB muscle tendons in transverse ultrasound image of a 
patient with De Quervain tenosynovitis.
Figure 2. 
Thickened synovial sheaths of APL and EPB muscle tendons with fluid collection in tendon sheath in transverse 
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Fifty-two subjects were studied; 30 diseased comprised group 1 and 22 healthy 
comprised group 2.
The main complaint of the diseased group was pain at the radial side of the wrist 
with positive Finkelstein test, while healthy subjects were symptom-free with nega-
tive Finkelstein test.
There was no significant difference (p > 0.01) between groups in regards to age 
and sex.
Strain-based elastography indices are illustrated in Table 1.
The mean elastography value for the diseased was 2.3; while for healthy sub-
jects, it was 6.1 with statistically significant difference between the two groups 
(p < 0.001). For strain ratio details, refer to Table 2.
The threshold for diagnosing De Quervain disease was 4.
B-mode ultrasound findings displayed in Table 2 [3].
14. Discussion
In De Quervain tendinopathy tendon increased cross section, increased water 
content of the tendons, abnormal degenerative materials deposited, and changes 
in collagen fibers properties all lead to changes of the elastic characteristics of the 









Thick edematous tendon of APL muscle in longitudinal ultrasound image of a patient with De Quervain 
tenosynovitis.






Strain-based elastography ratios in De Quervain tenosynovitis patients and volunteers.
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In my work, I found lower sensitivity (92%) than specificity (93%) for the 
quantitative assessment of the disease, in accordance with the remarks of Sébastien 
Aubry studying the Achilles tendinopathy with shear-wave elastography [18].
De Zordo et al. [19] stated that normal Achilles tendons show hard consistency 
as compared to diseased tendons, going with my work results of 6.1 elastography 
mean value for healthy subjects and 2.3 for diseased. Moreover, Dirrichs et al. 
[20] studied epicondylar, Achilles, and prepatellar pathologic tendons and found 
that the diseased tendons returned decreased elastography values as compared to 
healthy volunteers regardless of anatomical location.
In my study, I found statistically significant difference (p < 0.001) between 
healthy and diseased subjects in regards to elastography readings in accordance with 
Chen and coworkers concluding that elastography is an important tool for mechani-
cal information assessment of Achilles function [21].
In two healthy subjects, we found low strain ratio, which could be explained by the 
fact that they were having subclinical tenosynovitis as postulated by De Zordo et al. [22].
Moreover, not possibly to explain the three diseased tendons showing high elas-
tography values except for one patient with cyst formation under the retinaculum 
raising the tension inside the compartment.
More study is needed for the true benefit of strain-based elastography of the 
condition comparing the results with histopathological specimens—if possible—of 
the affected tendons, for a definitive proof of the presence or absence of the disease 
and the state of progression of the disease.
15. Conclusion
We can conclude that the disease can be diagnosed with strain-based elastogra-
phy in a quantitative way with confidence and reliability.
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